id	sid	tid	token	lemma	pos
cord-023873-fidpskcs	1	1	key	key	NN
cord-023873-fidpskcs	1	2	:	:	:
cord-023873-fidpskcs	2	1	cord-023873-fidpskcs	cord-023873-fidpskcs	JJ
cord-023873-fidpskcs	2	2	authors	author	NNS
cord-023873-fidpskcs	2	3	:	:	:
cord-023873-fidpskcs	2	4	Meersseman	Meersseman	NNP
cord-023873-fidpskcs	2	5	,	,	,
cord-023873-fidpskcs	2	6	Wouter	Wouter	NNP
cord-023873-fidpskcs	2	7	title	title	NN
cord-023873-fidpskcs	2	8	:	:	:
cord-023873-fidpskcs	2	9	Invasive	invasive	JJ
cord-023873-fidpskcs	2	10	Aspergillosis	Aspergillosis	NNP
cord-023873-fidpskcs	2	11	in	in	IN
cord-023873-fidpskcs	2	12	the	the	DT
cord-023873-fidpskcs	2	13	Intensive	Intensive	NNP
cord-023873-fidpskcs	2	14	Care	Care	NNP
cord-023873-fidpskcs	2	15	Unit	Unit	NNP
cord-023873-fidpskcs	2	16	:	:	:
cord-023873-fidpskcs	3	1	Beyond	beyond	IN
cord-023873-fidpskcs	3	2	the	the	DT
cord-023873-fidpskcs	3	3	Typical	Typical	NNP
cord-023873-fidpskcs	3	4	Haematological	Haematological	NNP
cord-023873-fidpskcs	3	5	Patient	Patient	NNP
cord-023873-fidpskcs	3	6	date	date	NN
cord-023873-fidpskcs	3	7	:	:	:
cord-023873-fidpskcs	3	8	2009	2009	CD
cord-023873-fidpskcs	3	9	-	-	SYM
cord-023873-fidpskcs	3	10	05	05	CD
cord-023873-fidpskcs	3	11	-	-	HYPH
cord-023873-fidpskcs	3	12	04	04	CD
cord-023873-fidpskcs	3	13	journal	journal	NN
cord-023873-fidpskcs	3	14	:	:	:
cord-023873-fidpskcs	4	1	Aspergillosis	aspergillosis	NN
cord-023873-fidpskcs	4	2	:	:	:
cord-023873-fidpskcs	5	1	From	from	IN
cord-023873-fidpskcs	5	2	Diagnosis	Diagnosis	NNP
cord-023873-fidpskcs	5	3	to	to	IN
cord-023873-fidpskcs	5	4	Prevention	Prevention	NNP
cord-023873-fidpskcs	5	5	DOI	DOI	NNP
cord-023873-fidpskcs	5	6	:	:	:
cord-023873-fidpskcs	6	1	10.1007/978	10.1007/978	LS
cord-023873-fidpskcs	6	2	-	-	SYM
cord-023873-fidpskcs	6	3	90	90	CD
cord-023873-fidpskcs	6	4	-	-	HYPH
cord-023873-fidpskcs	6	5	481	481	CD
cord-023873-fidpskcs	6	6	-	-	HYPH
cord-023873-fidpskcs	6	7	2408	2408	CD
cord-023873-fidpskcs	6	8	-	-	HYPH
cord-023873-fidpskcs	6	9	4_29	4_29	CD
cord-023873-fidpskcs	6	10	sha	sha	NN
cord-023873-fidpskcs	6	11	:	:	:
cord-023873-fidpskcs	7	1	63585e03b75f151138ad1e2b682dff0e227a26f6	63585e03b75f151138ad1e2b682dff0e227a26f6	CD
cord-023873-fidpskcs	7	2	doc_id	doc_id	CD
cord-023873-fidpskcs	7	3	:	:	:
cord-023873-fidpskcs	7	4	23873	23873	CD
cord-023873-fidpskcs	7	5	cord_uid	cord_uid	NNS
cord-023873-fidpskcs	7	6	:	:	:
cord-023873-fidpskcs	8	1	fidpskcs	fidpskcs	NNP
cord-023873-fidpskcs	8	2	Data	Data	NNP
cord-023873-fidpskcs	8	3	about	about	IN
cord-023873-fidpskcs	8	4	incidence	incidence	NN
cord-023873-fidpskcs	8	5	of	of	IN
cord-023873-fidpskcs	8	6	invasive	invasive	JJ
cord-023873-fidpskcs	8	7	aspergillosis	aspergillosis	NN
cord-023873-fidpskcs	8	8	in	in	IN
cord-023873-fidpskcs	8	9	intensive	intensive	JJ
cord-023873-fidpskcs	8	10	care	care	NN
cord-023873-fidpskcs	8	11	units	unit	NNS
cord-023873-fidpskcs	8	12	(	(	-LRB-
cord-023873-fidpskcs	8	13	ICU	ICU	NNP
cord-023873-fidpskcs	8	14	)	)	-RRB-
cord-023873-fidpskcs	8	15	are	be	VBP
cord-023873-fidpskcs	8	16	scarce	scarce	JJ
cord-023873-fidpskcs	8	17	and	and	CC
cord-023873-fidpskcs	8	18	variable	variable	JJ
cord-023873-fidpskcs	8	19	.	.	.
cord-023873-fidpskcs	9	1	Incidences	incidence	NNS
cord-023873-fidpskcs	9	2	ranging	range	VBG
cord-023873-fidpskcs	9	3	from	from	IN
cord-023873-fidpskcs	9	4	2	2	CD
cord-023873-fidpskcs	9	5	to	to	TO
cord-023873-fidpskcs	9	6	24	24	CD
cord-023873-fidpskcs	9	7	%	%	NN
cord-023873-fidpskcs	9	8	have	have	VBP
cord-023873-fidpskcs	9	9	been	be	VBN
cord-023873-fidpskcs	9	10	reported	report	VBN
cord-023873-fidpskcs	9	11	,	,	,
cord-023873-fidpskcs	9	12	which	which	WDT
cord-023873-fidpskcs	9	13	might	may	MD
cord-023873-fidpskcs	9	14	reflect	reflect	VB
cord-023873-fidpskcs	9	15	different	different	JJ
cord-023873-fidpskcs	9	16	autopsy	autopsy	JJ
cord-023873-fidpskcs	9	17	policies	policy	NNS
cord-023873-fidpskcs	9	18	amongst	amongst	IN
cord-023873-fidpskcs	9	19	centres	centre	NNS
cord-023873-fidpskcs	9	20	.	.	.
cord-023873-fidpskcs	10	1	Recent	recent	JJ
cord-023873-fidpskcs	10	2	studies	study	NNS
cord-023873-fidpskcs	10	3	have	have	VBP
cord-023873-fidpskcs	10	4	shown	show	VBN
cord-023873-fidpskcs	10	5	that	that	IN
cord-023873-fidpskcs	10	6	many	many	JJ
cord-023873-fidpskcs	10	7	patients	patient	NNS
cord-023873-fidpskcs	10	8	with	with	IN
cord-023873-fidpskcs	10	9	invasive	invasive	JJ
cord-023873-fidpskcs	10	10	aspergillosis	aspergillosis	NN
cord-023873-fidpskcs	10	11	do	do	VBP
cord-023873-fidpskcs	10	12	not	not	RB
cord-023873-fidpskcs	10	13	have	have	VB
cord-023873-fidpskcs	10	14	a	a	DT
cord-023873-fidpskcs	10	15	haematological	haematological	JJ
cord-023873-fidpskcs	10	16	diagnosis	diagnosis	NN
cord-023873-fidpskcs	10	17	.	.	.
cord-023873-fidpskcs	11	1	Instead	instead	RB
cord-023873-fidpskcs	11	2	,	,	,
cord-023873-fidpskcs	11	3	conditions	condition	NNS
cord-023873-fidpskcs	11	4	such	such	JJ
cord-023873-fidpskcs	11	5	as	as	IN
cord-023873-fidpskcs	11	6	chronic	chronic	JJ
cord-023873-fidpskcs	11	7	obstructive	obstructive	JJ
cord-023873-fidpskcs	11	8	pulmonary	pulmonary	JJ
cord-023873-fidpskcs	11	9	disease	disease	NN
cord-023873-fidpskcs	11	10	and	and	CC
cord-023873-fidpskcs	11	11	liver	liver	NN
cord-023873-fidpskcs	11	12	failure	failure	NN
cord-023873-fidpskcs	11	13	became	become	VBD
cord-023873-fidpskcs	11	14	recognized	recognize	VBN
cord-023873-fidpskcs	11	15	as	as	IN
cord-023873-fidpskcs	11	16	important	important	JJ
cord-023873-fidpskcs	11	17	risk	risk	NN
cord-023873-fidpskcs	11	18	factors	factor	NNS
cord-023873-fidpskcs	11	19	.	.	.
cord-023873-fidpskcs	12	1	The	the	DT
cord-023873-fidpskcs	12	2	diagnosis	diagnosis	NN
cord-023873-fidpskcs	12	3	remains	remain	VBZ
cord-023873-fidpskcs	12	4	difficult	difficult	JJ
cord-023873-fidpskcs	12	5	in	in	IN
cord-023873-fidpskcs	12	6	these	these	DT
cord-023873-fidpskcs	12	7	patients	patient	NNS
cord-023873-fidpskcs	12	8	,	,	,
cord-023873-fidpskcs	12	9	since	since	IN
cord-023873-fidpskcs	12	10	diagnostic	diagnostic	JJ
cord-023873-fidpskcs	12	11	tests	test	NNS
cord-023873-fidpskcs	12	12	have	have	VBP
cord-023873-fidpskcs	12	13	not	not	RB
cord-023873-fidpskcs	12	14	been	be	VBN
cord-023873-fidpskcs	12	15	widely	widely	RB
cord-023873-fidpskcs	12	16	validated	validate	VBN
cord-023873-fidpskcs	12	17	outside	outside	IN
cord-023873-fidpskcs	12	18	the	the	DT
cord-023873-fidpskcs	12	19	haematological	haematological	JJ
cord-023873-fidpskcs	12	20	boundaries	boundary	NNS
cord-023873-fidpskcs	12	21	.	.	.
cord-023873-fidpskcs	13	1	Mechanical	mechanical	JJ
cord-023873-fidpskcs	13	2	ventilation	ventilation	NN
cord-023873-fidpskcs	13	3	precludes	preclude	VBZ
cord-023873-fidpskcs	13	4	the	the	DT
cord-023873-fidpskcs	13	5	interpretation	interpretation	NN
cord-023873-fidpskcs	13	6	of	of	IN
cord-023873-fidpskcs	13	7	clinical	clinical	JJ
cord-023873-fidpskcs	13	8	signs	sign	NNS
cord-023873-fidpskcs	13	9	and	and	CC
cord-023873-fidpskcs	13	10	radiological	radiological	JJ
cord-023873-fidpskcs	13	11	diagnosis	diagnosis	NN
cord-023873-fidpskcs	13	12	is	be	VBZ
cord-023873-fidpskcs	13	13	clouded	cloud	VBN
cord-023873-fidpskcs	13	14	by	by	IN
cord-023873-fidpskcs	13	15	underlying	underlie	VBG
cord-023873-fidpskcs	13	16	lung	lung	NN
cord-023873-fidpskcs	13	17	pathology	pathology	NN
cord-023873-fidpskcs	13	18	.	.	.
cord-023873-fidpskcs	14	1	Respiratory	respiratory	JJ
cord-023873-fidpskcs	14	2	cultures	culture	NNS
cord-023873-fidpskcs	14	3	lack	lack	VBP
cord-023873-fidpskcs	14	4	sensitivity	sensitivity	NN
cord-023873-fidpskcs	14	5	and	and	CC
cord-023873-fidpskcs	14	6	specificity	specificity	NN
cord-023873-fidpskcs	14	7	.	.	.
cord-023873-fidpskcs	15	1	At	at	IN
cord-023873-fidpskcs	15	2	the	the	DT
cord-023873-fidpskcs	15	3	moment	moment	NN
cord-023873-fidpskcs	15	4	,	,	,
cord-023873-fidpskcs	15	5	diagnosis	diagnosis	NN
cord-023873-fidpskcs	15	6	is	be	VBZ
cord-023873-fidpskcs	15	7	best	well	RBS
cord-023873-fidpskcs	15	8	made	make	VBN
cord-023873-fidpskcs	15	9	by	by	IN
cord-023873-fidpskcs	15	10	testing	test	VBG
cord-023873-fidpskcs	15	11	for	for	IN
cord-023873-fidpskcs	15	12	galactomannan	galactomannan	NNP
cord-023873-fidpskcs	15	13	in	in	IN
cord-023873-fidpskcs	15	14	bronchoalveolar	bronchoalveolar	NNP
cord-023873-fidpskcs	15	15	fluid	fluid	NN
cord-023873-fidpskcs	15	16	samples	sample	NNS
cord-023873-fidpskcs	15	17	(	(	-LRB-
cord-023873-fidpskcs	15	18	sensitivity	sensitivity	NN
cord-023873-fidpskcs	15	19	and	and	CC
cord-023873-fidpskcs	15	20	specificity	specificity	NN
cord-023873-fidpskcs	15	21	of	of	IN
cord-023873-fidpskcs	15	22	>	>	$
cord-023873-fidpskcs	15	23	87	87	CD
cord-023873-fidpskcs	15	24	%	%	NN
cord-023873-fidpskcs	15	25	)	)	-RRB-
cord-023873-fidpskcs	15	26	.	.	.
cord-023873-fidpskcs	16	1	Testing	test	VBG
cord-023873-fidpskcs	16	2	galactomannan	galactomannan	NNP
cord-023873-fidpskcs	16	3	in	in	IN
cord-023873-fidpskcs	16	4	sera	sera	NNP
cord-023873-fidpskcs	16	5	has	have	VBZ
cord-023873-fidpskcs	16	6	limited	limit	VBN
cord-023873-fidpskcs	16	7	sensitivity	sensitivity	NN
cord-023873-fidpskcs	16	8	for	for	IN
cord-023873-fidpskcs	16	9	the	the	DT
cord-023873-fidpskcs	16	10	non	non	JJ
cord-023873-fidpskcs	16	11	-	-	JJ
cord-023873-fidpskcs	16	12	neutropenic	neutropenic	JJ
cord-023873-fidpskcs	16	13	.	.	.
cord-023873-fidpskcs	17	1	Modern	modern	JJ
cord-023873-fidpskcs	17	2	diagnostic	diagnostic	JJ
cord-023873-fidpskcs	17	3	tests	test	NNS
cord-023873-fidpskcs	17	4	such	such	JJ
cord-023873-fidpskcs	17	5	as	as	IN
cord-023873-fidpskcs	17	6	PCR	PCR	NNP
cord-023873-fidpskcs	17	7	and	and	CC
cord-023873-fidpskcs	17	8	beta	beta	NN
cord-023873-fidpskcs	17	9	-	-	HYPH
cord-023873-fidpskcs	17	10	glucan	glucan	NN
cord-023873-fidpskcs	17	11	have	have	VBP
cord-023873-fidpskcs	17	12	never	never	RB
cord-023873-fidpskcs	17	13	been	be	VBN
cord-023873-fidpskcs	17	14	validated	validate	VBN
cord-023873-fidpskcs	17	15	in	in	IN
cord-023873-fidpskcs	17	16	an	an	DT
cord-023873-fidpskcs	17	17	ICU	ICU	NNP
cord-023873-fidpskcs	17	18	population	population	NN
cord-023873-fidpskcs	17	19	.	.	.
cord-023873-fidpskcs	18	1	Due	due	IN
cord-023873-fidpskcs	18	2	mostly	mostly	RB
cord-023873-fidpskcs	18	3	to	to	IN
cord-023873-fidpskcs	18	4	major	major	JJ
cord-023873-fidpskcs	18	5	delays	delay	NNS
cord-023873-fidpskcs	18	6	in	in	IN
cord-023873-fidpskcs	18	7	the	the	DT
cord-023873-fidpskcs	18	8	diagnosis	diagnosis	NN
cord-023873-fidpskcs	18	9	,	,	,
cord-023873-fidpskcs	18	10	mortality	mortality	NN
cord-023873-fidpskcs	18	11	exceeds	exceed	VBZ
cord-023873-fidpskcs	18	12	50	50	CD
cord-023873-fidpskcs	18	13	%	%	NN
cord-023873-fidpskcs	18	14	.	.	.
cord-023873-fidpskcs	19	1	Although	although	IN
cord-023873-fidpskcs	19	2	our	-PRON-	PRP$
cord-023873-fidpskcs	19	3	therapeutic	therapeutic	JJ
cord-023873-fidpskcs	19	4	armamentarium	armamentarium	NN
cord-023873-fidpskcs	19	5	against	against	IN
cord-023873-fidpskcs	19	6	invasive	invasive	JJ
cord-023873-fidpskcs	19	7	aspergillosis	aspergillosis	NN
cord-023873-fidpskcs	19	8	has	have	VBZ
cord-023873-fidpskcs	19	9	improved	improve	VBN
cord-023873-fidpskcs	19	10	in	in	IN
cord-023873-fidpskcs	19	11	recent	recent	JJ
cord-023873-fidpskcs	19	12	years	year	NNS
cord-023873-fidpskcs	19	13	,	,	,
cord-023873-fidpskcs	19	14	data	datum	NNS
cord-023873-fidpskcs	19	15	concerning	concern	VBG
cord-023873-fidpskcs	19	16	safety	safety	NN
cord-023873-fidpskcs	19	17	and	and	CC
cord-023873-fidpskcs	19	18	efficacy	efficacy	NN
cord-023873-fidpskcs	19	19	of	of	IN
cord-023873-fidpskcs	19	20	new	new	JJ
cord-023873-fidpskcs	19	21	antifungal	antifungal	JJ
cord-023873-fidpskcs	19	22	agents	agent	NNS
cord-023873-fidpskcs	19	23	in	in	IN
cord-023873-fidpskcs	19	24	the	the	DT
cord-023873-fidpskcs	19	25	ICU	ICU	NNP
cord-023873-fidpskcs	19	26	setting	setting	NN
cord-023873-fidpskcs	19	27	are	be	VBP
cord-023873-fidpskcs	19	28	lacking	lack	VBG
cord-023873-fidpskcs	19	29	.	.	.
cord-023873-fidpskcs	20	1	Autopsy	autopsy	JJ
cord-023873-fidpskcs	20	2	studies	study	NNS
cord-023873-fidpskcs	20	3	show	show	VBP
cord-023873-fidpskcs	20	4	the	the	DT
cord-023873-fidpskcs	20	5	emergence	emergence	NN
cord-023873-fidpskcs	20	6	of	of	IN
cord-023873-fidpskcs	20	7	Aspergillus	aspergillus	NN
cord-023873-fidpskcs	20	8	as	as	IN
cord-023873-fidpskcs	20	9	a	a	DT
cord-023873-fidpskcs	20	10	major	major	JJ
cord-023873-fidpskcs	20	11	pathogen	pathogen	NN
cord-023873-fidpskcs	20	12	,	,	,
cord-023873-fidpskcs	20	13	as	as	RB
cord-023873-fidpskcs	20	14	well	well	RB
cord-023873-fidpskcs	20	15	as	as	IN
cord-023873-fidpskcs	20	16	the	the	DT
cord-023873-fidpskcs	20	17	expansion	expansion	NN
cord-023873-fidpskcs	20	18	of	of	IN
cord-023873-fidpskcs	20	19	the	the	DT
cord-023873-fidpskcs	20	20	spectrum	spectrum	NN
cord-023873-fidpskcs	20	21	of	of	IN
cord-023873-fidpskcs	20	22	patients	patient	NNS
cord-023873-fidpskcs	20	23	at	at	IN
cord-023873-fidpskcs	20	24	risk	risk	NN
cord-023873-fidpskcs	20	25	for	for	IN
cord-023873-fidpskcs	20	26	IA	IA	NNP
cord-023873-fidpskcs	20	27	.	.	.
cord-023873-fidpskcs	21	1	In	in	IN
cord-023873-fidpskcs	21	2	a	a	DT
cord-023873-fidpskcs	21	3	non	non	JJ
cord-023873-fidpskcs	21	4	-	-	JJ
cord-023873-fidpskcs	21	5	selected	selected	JJ
cord-023873-fidpskcs	21	6	patient	patient	JJ
cord-023873-fidpskcs	21	7	population	population	NN
cord-023873-fidpskcs	21	8	,	,	,
cord-023873-fidpskcs	21	9	the	the	DT
cord-023873-fidpskcs	21	10	prevalence	prevalence	NN
cord-023873-fidpskcs	21	11	of	of	IN
cord-023873-fidpskcs	21	12	invasive	invasive	JJ
cord-023873-fidpskcs	21	13	fungal	fungal	JJ
cord-023873-fidpskcs	21	14	infections	infection	NNS
cord-023873-fidpskcs	21	15	in	in	IN
cord-023873-fidpskcs	21	16	an	an	DT
cord-023873-fidpskcs	21	17	academic	academic	JJ
cord-023873-fidpskcs	21	18	hospital	hospital	NN
cord-023873-fidpskcs	21	19	rose	rise	VBD
cord-023873-fidpskcs	21	20	from	from	IN
cord-023873-fidpskcs	21	21	2.2	2.2	CD
cord-023873-fidpskcs	21	22	to	to	TO
cord-023873-fidpskcs	21	23	5.1	5.1	CD
cord-023873-fidpskcs	21	24	%	%	NN
cord-023873-fidpskcs	21	25	over	over	IN
cord-023873-fidpskcs	21	26	a	a	DT
cord-023873-fidpskcs	21	27	12-year	12-year	JJ
cord-023873-fidpskcs	21	28	period	period	NN
cord-023873-fidpskcs	21	29	,	,	,
cord-023873-fidpskcs	21	30	largely	largely	RB
cord-023873-fidpskcs	21	31	due	due	JJ
cord-023873-fidpskcs	21	32	to	to	IN
cord-023873-fidpskcs	21	33	an	an	DT
cord-023873-fidpskcs	21	34	increase	increase	NN
cord-023873-fidpskcs	21	35	in	in	IN
cord-023873-fidpskcs	21	36	Aspergillus	aspergillus	NN
cord-023873-fidpskcs	21	37	infections	infection	NNS
cord-023873-fidpskcs	21	38	[	[	-LRB-
cord-023873-fidpskcs	21	39	1	1	CD
cord-023873-fidpskcs	21	40	]	]	-RRB-
cord-023873-fidpskcs	21	41	.	.	.
cord-023873-fidpskcs	22	1	However	however	RB
cord-023873-fidpskcs	22	2	,	,	,
cord-023873-fidpskcs	22	3	estimates	estimate	VBZ
cord-023873-fidpskcs	22	4	about	about	IN
cord-023873-fidpskcs	22	5	the	the	DT
cord-023873-fidpskcs	22	6	incidence	incidence	NN
cord-023873-fidpskcs	22	7	of	of	IN
cord-023873-fidpskcs	22	8	IA	IA	NNP
cord-023873-fidpskcs	22	9	in	in	IN
cord-023873-fidpskcs	22	10	critically	critically	RB
cord-023873-fidpskcs	22	11	ill	ill	JJ
cord-023873-fidpskcs	22	12	patients	patient	NNS
cord-023873-fidpskcs	22	13	are	be	VBP
cord-023873-fidpskcs	22	14	sparse	sparse	JJ
cord-023873-fidpskcs	22	15	and	and	CC
cord-023873-fidpskcs	22	16	variable	variable	JJ
cord-023873-fidpskcs	22	17	.	.	.
cord-023873-fidpskcs	23	1	For	for	IN
cord-023873-fidpskcs	23	2	various	various	JJ
cord-023873-fidpskcs	23	3	reasons	reason	NNS
cord-023873-fidpskcs	23	4	,	,	,
cord-023873-fidpskcs	23	5	figures	figure	NNS
cord-023873-fidpskcs	23	6	about	about	IN
cord-023873-fidpskcs	23	7	the	the	DT
cord-023873-fidpskcs	23	8	true	true	JJ
cord-023873-fidpskcs	23	9	incidence	incidence	NN
cord-023873-fidpskcs	23	10	are	be	VBP
cord-023873-fidpskcs	23	11	difficult	difficult	JJ
cord-023873-fidpskcs	23	12	to	to	TO
cord-023873-fidpskcs	23	13	generate	generate	VB
cord-023873-fidpskcs	23	14	.	.	.
cord-023873-fidpskcs	24	1	First	first	RB
cord-023873-fidpskcs	24	2	,	,	,
cord-023873-fidpskcs	24	3	in	in	IN
cord-023873-fidpskcs	24	4	case	case	NN
cord-023873-fidpskcs	24	5	of	of	IN
cord-023873-fidpskcs	24	6	a	a	DT
cord-023873-fidpskcs	24	7	positive	positive	JJ
cord-023873-fidpskcs	24	8	culture	culture	NN
cord-023873-fidpskcs	24	9	for	for	IN
cord-023873-fidpskcs	24	10	Aspergillus	aspergillus	NN
cord-023873-fidpskcs	24	11	species	specie	NNS
cord-023873-fidpskcs	24	12	,	,	,
cord-023873-fidpskcs	24	13	discriminating	discriminate	VBG
cord-023873-fidpskcs	24	14	between	between	IN
cord-023873-fidpskcs	24	15	colonisation	colonisation	NN
cord-023873-fidpskcs	24	16	and	and	CC
cord-023873-fidpskcs	24	17	infection	infection	NN
cord-023873-fidpskcs	24	18	remains	remain	VBZ
cord-023873-fidpskcs	24	19	challenging	challenging	JJ
cord-023873-fidpskcs	24	20	.	.	.
cord-023873-fidpskcs	25	1	Second	second	RB
cord-023873-fidpskcs	25	2	,	,	,
cord-023873-fidpskcs	25	3	very	very	RB
cord-023873-fidpskcs	25	4	few	few	JJ
cord-023873-fidpskcs	25	5	institutions	institution	NNS
cord-023873-fidpskcs	25	6	perform	perform	VBP
cord-023873-fidpskcs	25	7	post	post	JJ
cord-023873-fidpskcs	25	8	-	-	JJ
cord-023873-fidpskcs	25	9	mortem	mortem	JJ
cord-023873-fidpskcs	25	10	examinations	examination	NNS
cord-023873-fidpskcs	25	11	routinely	routinely	RB
cord-023873-fidpskcs	25	12	,	,	,
cord-023873-fidpskcs	25	13	while	while	IN
cord-023873-fidpskcs	25	14	in	in	IN
cord-023873-fidpskcs	25	15	most	most	JJS
cord-023873-fidpskcs	25	16	cases	case	NNS
cord-023873-fidpskcs	25	17	,	,	,
cord-023873-fidpskcs	25	18	this	this	DT
cord-023873-fidpskcs	25	19	is	be	VBZ
cord-023873-fidpskcs	25	20	the	the	DT
cord-023873-fidpskcs	25	21	only	only	JJ
cord-023873-fidpskcs	25	22	way	way	NN
cord-023873-fidpskcs	25	23	for	for	IN
cord-023873-fidpskcs	25	24	proving	prove	VBG
cord-023873-fidpskcs	25	25	the	the	DT
cord-023873-fidpskcs	25	26	definite	definite	JJ
cord-023873-fidpskcs	25	27	nature	nature	NN
cord-023873-fidpskcs	25	28	of	of	IN
cord-023873-fidpskcs	25	29	the	the	DT
cord-023873-fidpskcs	25	30	diagnosis	diagnosis	NN
cord-023873-fidpskcs	25	31	.	.	.
cord-023873-fidpskcs	26	1	Third	third	JJ
cord-023873-fidpskcs	26	2	,	,	,
cord-023873-fidpskcs	26	3	characteristic	characteristic	JJ
cord-023873-fidpskcs	26	4	radiological	radiological	JJ
cord-023873-fidpskcs	26	5	signs	sign	NNS
cord-023873-fidpskcs	26	6	of	of	IN
cord-023873-fidpskcs	26	7	IA	IA	NNP
cord-023873-fidpskcs	26	8	are	be	VBP
cord-023873-fidpskcs	26	9	usually	usually	RB
cord-023873-fidpskcs	26	10	absent	absent	JJ
cord-023873-fidpskcs	26	11	in	in	IN
cord-023873-fidpskcs	26	12	the	the	DT
cord-023873-fidpskcs	26	13	non	non	JJ
cord-023873-fidpskcs	26	14	-	-	JJ
cord-023873-fidpskcs	26	15	neutropenic	neutropenic	JJ
cord-023873-fidpskcs	26	16	ICU	ICU	NNP
cord-023873-fidpskcs	26	17	patient	patient	NN
cord-023873-fidpskcs	26	18	.	.	.
cord-023873-fidpskcs	27	1	Finally	finally	RB
cord-023873-fidpskcs	27	2	,	,	,
cord-023873-fidpskcs	27	3	to	to	IN
cord-023873-fidpskcs	27	4	date	date	NN
cord-023873-fidpskcs	27	5	,	,	,
cord-023873-fidpskcs	27	6	the	the	DT
cord-023873-fidpskcs	27	7	diagnostic	diagnostic	JJ
cord-023873-fidpskcs	27	8	utility	utility	NN
cord-023873-fidpskcs	27	9	of	of	IN
cord-023873-fidpskcs	27	10	recently	recently	RB
cord-023873-fidpskcs	27	11	available	available	JJ
cord-023873-fidpskcs	27	12	non	non	JJ
cord-023873-fidpskcs	27	13	-	-	JJ
cord-023873-fidpskcs	27	14	culture	culture	JJ
cord-023873-fidpskcs	27	15	based	base	VBN
cord-023873-fidpskcs	27	16	microbiological	microbiological	JJ
cord-023873-fidpskcs	27	17	tools	tool	NNS
cord-023873-fidpskcs	27	18	,	,	,
cord-023873-fidpskcs	27	19	including	include	VBG
cord-023873-fidpskcs	27	20	the	the	DT
cord-023873-fidpskcs	27	21	detection	detection	NN
cord-023873-fidpskcs	27	22	of	of	IN
cord-023873-fidpskcs	27	23	fungal	fungal	JJ
cord-023873-fidpskcs	27	24	antigens	antigen	NNS
cord-023873-fidpskcs	27	25	and	and	CC
cord-023873-fidpskcs	27	26	the	the	DT
cord-023873-fidpskcs	27	27	detection	detection	NN
cord-023873-fidpskcs	27	28	of	of	IN
cord-023873-fidpskcs	27	29	Aspergillus	aspergillus	NN
cord-023873-fidpskcs	27	30	-	-	HYPH
cord-023873-fidpskcs	27	31	specific	specific	JJ
cord-023873-fidpskcs	27	32	DNA	dna	NN
cord-023873-fidpskcs	27	33	through	through	IN
cord-023873-fidpskcs	27	34	polymerase	polymerase	NN
cord-023873-fidpskcs	27	35	chain	chain	NN
cord-023873-fidpskcs	27	36	reaction	reaction	NN
cord-023873-fidpskcs	27	37	(	(	-LRB-
cord-023873-fidpskcs	27	38	PCR	PCR	NNP
cord-023873-fidpskcs	27	39	)	)	-RRB-
cord-023873-fidpskcs	27	40	techniques	technique	NNS
cord-023873-fidpskcs	27	41	,	,	,
cord-023873-fidpskcs	27	42	has	have	VBZ
cord-023873-fidpskcs	27	43	not	not	RB
cord-023873-fidpskcs	27	44	been	be	VBN
cord-023873-fidpskcs	27	45	properly	properly	RB
cord-023873-fidpskcs	27	46	validated	validate	VBN
cord-023873-fidpskcs	27	47	in	in	IN
cord-023873-fidpskcs	27	48	the	the	DT
cord-023873-fidpskcs	27	49	non	non	JJ
cord-023873-fidpskcs	27	50	-	-	JJ
cord-023873-fidpskcs	27	51	haematology	haematology	JJ
cord-023873-fidpskcs	27	52	ICU	ICU	NNP
cord-023873-fidpskcs	27	53	population	population	NN
cord-023873-fidpskcs	27	54	.	.	.
cord-023873-fidpskcs	28	1	In	in	IN
cord-023873-fidpskcs	28	2	addition	addition	NN
cord-023873-fidpskcs	28	3	,	,	,
cord-023873-fidpskcs	28	4	typical	typical	JJ
cord-023873-fidpskcs	28	5	ICU	ICU	NNP
cord-023873-fidpskcs	28	6	patients	patient	NNS
cord-023873-fidpskcs	28	7	such	such	JJ
cord-023873-fidpskcs	28	8	as	as	IN
cord-023873-fidpskcs	28	9	those	those	DT
cord-023873-fidpskcs	28	10	with	with	IN
cord-023873-fidpskcs	28	11	chronic	chronic	JJ
cord-023873-fidpskcs	28	12	obstructive	obstructive	JJ
cord-023873-fidpskcs	28	13	pulmonary	pulmonary	JJ
cord-023873-fidpskcs	28	14	disease	disease	NN
cord-023873-fidpskcs	28	15	(	(	-LRB-
cord-023873-fidpskcs	28	16	COPD	COPD	NNP
cord-023873-fidpskcs	28	17	)	)	-RRB-
cord-023873-fidpskcs	28	18	or	or	CC
cord-023873-fidpskcs	28	19	liver	liver	NN
cord-023873-fidpskcs	28	20	disorders	disorder	NNS
cord-023873-fidpskcs	28	21	were	be	VBD
cord-023873-fidpskcs	28	22	not	not	RB
cord-023873-fidpskcs	28	23	considered	consider	VBN
cord-023873-fidpskcs	28	24	amongst	amongst	IN
cord-023873-fidpskcs	28	25	hosts	host	NNS
cord-023873-fidpskcs	28	26	at	at	IN
cord-023873-fidpskcs	28	27	high	high	JJ
cord-023873-fidpskcs	28	28	risk	risk	NN
cord-023873-fidpskcs	28	29	for	for	IN
cord-023873-fidpskcs	28	30	IA	IA	NNP
cord-023873-fidpskcs	28	31	in	in	IN
cord-023873-fidpskcs	28	32	the	the	DT
cord-023873-fidpskcs	28	33	recently	recently	RB
cord-023873-fidpskcs	28	34	updated	update	VBN
cord-023873-fidpskcs	28	35	EORTC	EORTC	NNP
cord-023873-fidpskcs	28	36	/	/	SYM
cord-023873-fidpskcs	28	37	MSG	MSG	NNP
cord-023873-fidpskcs	28	38	guidelines	guideline	NNS
cord-023873-fidpskcs	28	39	[	[	-LRB-
cord-023873-fidpskcs	28	40	2	2	CD
cord-023873-fidpskcs	28	41	]	]	-RRB-
cord-023873-fidpskcs	28	42	.	.	.
cord-023873-fidpskcs	29	1	A	a	DT
cord-023873-fidpskcs	29	2	summary	summary	NN
cord-023873-fidpskcs	29	3	of	of	IN
cord-023873-fidpskcs	29	4	available	available	JJ
cord-023873-fidpskcs	29	5	studies	study	NNS
cord-023873-fidpskcs	29	6	in	in	IN
cord-023873-fidpskcs	29	7	ICU	ICU	NNP
cord-023873-fidpskcs	29	8	patients	patient	NNS
cord-023873-fidpskcs	29	9	is	be	VBZ
cord-023873-fidpskcs	29	10	listed	list	VBN
cord-023873-fidpskcs	29	11	in	in	IN
cord-023873-fidpskcs	29	12	Table	Table	NNP
cord-023873-fidpskcs	29	13	1	1	CD
cord-023873-fidpskcs	29	14	[	[	-LRB-
cord-023873-fidpskcs	29	15	3	3	CD
cord-023873-fidpskcs	29	16	]	]	-RRB-
cord-023873-fidpskcs	29	17	[	[	-LRB-
cord-023873-fidpskcs	29	18	4	4	CD
cord-023873-fidpskcs	29	19	]	]	-RRB-
cord-023873-fidpskcs	29	20	[	[	-LRB-
cord-023873-fidpskcs	29	21	5	5	CD
cord-023873-fidpskcs	29	22	]	]	-RRB-
cord-023873-fidpskcs	29	23	[	[	-LRB-
cord-023873-fidpskcs	29	24	6	6	CD
cord-023873-fidpskcs	29	25	]	]	-RRB-
cord-023873-fidpskcs	29	26	[	[	-LRB-
cord-023873-fidpskcs	29	27	7	7	CD
cord-023873-fidpskcs	29	28	]	]	-RRB-
cord-023873-fidpskcs	29	29	[	[	-LRB-
cord-023873-fidpskcs	29	30	8	8	CD
cord-023873-fidpskcs	29	31	]	]	-RRB-
cord-023873-fidpskcs	29	32	[	[	-LRB-
cord-023873-fidpskcs	29	33	9	9	CD
cord-023873-fidpskcs	29	34	]	]	-RRB-
cord-023873-fidpskcs	29	35	.	.	.
cord-023873-fidpskcs	30	1	In	in	IN
cord-023873-fidpskcs	30	2	a	a	DT
cord-023873-fidpskcs	30	3	medical	medical	JJ
cord-023873-fidpskcs	30	4	ICU	ICU	NNP
cord-023873-fidpskcs	30	5	,	,	,
cord-023873-fidpskcs	30	6	we	-PRON-	PRP
cord-023873-fidpskcs	30	7	have	have	VBP
cord-023873-fidpskcs	30	8	observed	observe	VBN
cord-023873-fidpskcs	30	9	high	high	JJ
cord-023873-fidpskcs	30	10	incidences	incidence	NNS
cord-023873-fidpskcs	30	11	of	of	IN
cord-023873-fidpskcs	30	12	IA	IA	NNP
cord-023873-fidpskcs	30	13	in	in	IN
cord-023873-fidpskcs	30	14	two	two	CD
cord-023873-fidpskcs	30	15	separate	separate	JJ
cord-023873-fidpskcs	30	16	retrospective	retrospective	JJ
cord-023873-fidpskcs	30	17	autopsy	autopsy	NN
cord-023873-fidpskcs	30	18	-	-	HYPH
cord-023873-fidpskcs	30	19	controlled	control	VBN
cord-023873-fidpskcs	30	20	studies	study	NNS
cord-023873-fidpskcs	30	21	.	.	.
cord-023873-fidpskcs	31	1	In	in	IN
cord-023873-fidpskcs	31	2	the	the	DT
cord-023873-fidpskcs	31	3	largest	large	JJS
cord-023873-fidpskcs	31	4	one	one	CD
cord-023873-fidpskcs	31	5	,	,	,
cord-023873-fidpskcs	31	6	127	127	CD
cord-023873-fidpskcs	31	7	of	of	IN
cord-023873-fidpskcs	31	8	1850	1850	CD
cord-023873-fidpskcs	31	9	(	(	-LRB-
cord-023873-fidpskcs	31	10	6.9	6.9	CD
cord-023873-fidpskcs	31	11	%	%	NN
cord-023873-fidpskcs	31	12	)	)	-RRB-
cord-023873-fidpskcs	31	13	hospitalised	hospitalise	VBN
cord-023873-fidpskcs	31	14	patients	patient	NNS
cord-023873-fidpskcs	31	15	had	have	VBD
cord-023873-fidpskcs	31	16	microbiological	microbiological	JJ
cord-023873-fidpskcs	31	17	or	or	CC
cord-023873-fidpskcs	31	18	histopathological	histopathological	JJ
cord-023873-fidpskcs	31	19	evidence	evidence	NN
cord-023873-fidpskcs	31	20	of	of	IN
cord-023873-fidpskcs	31	21	aspergillosis	aspergillosis	NN
cord-023873-fidpskcs	31	22	during	during	IN
cord-023873-fidpskcs	31	23	their	-PRON-	PRP$
cord-023873-fidpskcs	31	24	ICU	ICU	NNP
cord-023873-fidpskcs	31	25	stay	stay	NN
cord-023873-fidpskcs	31	26	,	,	,
cord-023873-fidpskcs	31	27	including	include	VBG
cord-023873-fidpskcs	31	28	89	89	CD
cord-023873-fidpskcs	31	29	cases	case	NNS
cord-023873-fidpskcs	31	30	(	(	-LRB-
cord-023873-fidpskcs	31	31	70	70	CD
cord-023873-fidpskcs	31	32	%	%	NN
cord-023873-fidpskcs	31	33	)	)	-RRB-
cord-023873-fidpskcs	31	34	without	without	IN
cord-023873-fidpskcs	31	35	underlying	underlie	VBG
cord-023873-fidpskcs	31	36	haematological	haematological	JJ
cord-023873-fidpskcs	31	37	malignancy	malignancy	NN
cord-023873-fidpskcs	31	38	.	.	.
cord-023873-fidpskcs	32	1	The	the	DT
cord-023873-fidpskcs	32	2	observed	observed	JJ
cord-023873-fidpskcs	32	3	mortality	mortality	NN
cord-023873-fidpskcs	32	4	of	of	IN
cord-023873-fidpskcs	32	5	80	80	CD
cord-023873-fidpskcs	32	6	%	%	NN
cord-023873-fidpskcs	32	7	was	be	VBD
cord-023873-fidpskcs	32	8	much	much	RB
cord-023873-fidpskcs	32	9	higher	high	JJR
cord-023873-fidpskcs	32	10	than	than	IN
cord-023873-fidpskcs	32	11	the	the	DT
cord-023873-fidpskcs	32	12	predicted	predict	VBN
cord-023873-fidpskcs	32	13	mortality	mortality	NN
cord-023873-fidpskcs	32	14	as	as	IN
cord-023873-fidpskcs	32	15	per	per	IN
cord-023873-fidpskcs	32	16	SAPS	SAPS	NNP
cord-023873-fidpskcs	32	17	II	II	NNP
cord-023873-fidpskcs	32	18	score	score	NN
cord-023873-fidpskcs	32	19	(	(	-LRB-
cord-023873-fidpskcs	32	20	48	48	CD
cord-023873-fidpskcs	32	21	%	%	NN
cord-023873-fidpskcs	32	22	)	)	-RRB-
cord-023873-fidpskcs	32	23	[	[	-LRB-
cord-023873-fidpskcs	32	24	4	4	CD
cord-023873-fidpskcs	32	25	]	]	-RRB-
cord-023873-fidpskcs	32	26	.	.	.
cord-023873-fidpskcs	33	1	An	an	DT
cord-023873-fidpskcs	33	2	earlier	early	JJR
cord-023873-fidpskcs	33	3	study	study	NN
cord-023873-fidpskcs	33	4	looked	look	VBD
cord-023873-fidpskcs	33	5	for	for	IN
cord-023873-fidpskcs	33	6	unsuspected	unsuspected	JJ
cord-023873-fidpskcs	33	7	causes	cause	NNS
cord-023873-fidpskcs	33	8	of	of	IN
cord-023873-fidpskcs	33	9	death	death	NN
cord-023873-fidpskcs	33	10	in	in	IN
cord-023873-fidpskcs	33	11	the	the	DT
cord-023873-fidpskcs	33	12	same	same	JJ
cord-023873-fidpskcs	33	13	medical	medical	JJ
cord-023873-fidpskcs	33	14	ICU	ICU	NNP
cord-023873-fidpskcs	33	15	and	and	CC
cord-023873-fidpskcs	33	16	showed	show	VBD
cord-023873-fidpskcs	33	17	that	that	IN
cord-023873-fidpskcs	33	18	,	,	,
cord-023873-fidpskcs	33	19	out	out	IN
cord-023873-fidpskcs	33	20	of	of	IN
cord-023873-fidpskcs	33	21	100	100	CD
cord-023873-fidpskcs	33	22	autopsies	autopsy	NNS
cord-023873-fidpskcs	33	23	,	,	,
cord-023873-fidpskcs	33	24	there	there	EX
cord-023873-fidpskcs	33	25	were	be	VBD
cord-023873-fidpskcs	33	26	15	15	CD
cord-023873-fidpskcs	33	27	cases	case	NNS
cord-023873-fidpskcs	33	28	of	of	IN
cord-023873-fidpskcs	33	29	IA	IA	NNP
cord-023873-fidpskcs	33	30	,	,	,
cord-023873-fidpskcs	33	31	of	of	IN
cord-023873-fidpskcs	33	32	which	which	WDT
cord-023873-fidpskcs	33	33	5	5	CD
cord-023873-fidpskcs	33	34	were	be	VBD
cord-023873-fidpskcs	33	35	missed	miss	VBN
cord-023873-fidpskcs	33	36	pre	pre	JJ
cord-023873-fidpskcs	33	37	-	-	JJ
cord-023873-fidpskcs	33	38	mortem	mortem	JJ
cord-023873-fidpskcs	33	39	[	[	-LRB-
cord-023873-fidpskcs	33	40	3	3	CD
cord-023873-fidpskcs	33	41	]	]	-RRB-
cord-023873-fidpskcs	33	42	.	.	.
cord-023873-fidpskcs	34	1	During	during	IN
cord-023873-fidpskcs	34	2	a	a	DT
cord-023873-fidpskcs	34	3	6-year	6-year	JJ
cord-023873-fidpskcs	34	4	period	period	NN
cord-023873-fidpskcs	34	5	,	,	,
cord-023873-fidpskcs	34	6	Cornillet	Cornillet	NNP
cord-023873-fidpskcs	34	7	et	et	NNP
cord-023873-fidpskcs	34	8	al	al	NNP
cord-023873-fidpskcs	34	9	.	.	NNP
cord-023873-fidpskcs	34	10	found	find	VBD
cord-023873-fidpskcs	34	11	a	a	DT
cord-023873-fidpskcs	34	12	mean	mean	JJ
cord-023873-fidpskcs	34	13	number	number	NN
cord-023873-fidpskcs	34	14	of	of	IN
cord-023873-fidpskcs	34	15	15	15	CD
cord-023873-fidpskcs	34	16	patients	patient	NNS
cord-023873-fidpskcs	34	17	per	per	IN
cord-023873-fidpskcs	34	18	year	year	NN
cord-023873-fidpskcs	34	19	diagnosed	diagnose	VBN
cord-023873-fidpskcs	34	20	with	with	IN
cord-023873-fidpskcs	34	21	IA	IA	NNP
cord-023873-fidpskcs	34	22	;	;	:
cord-023873-fidpskcs	34	23	approximately	approximately	RB
cord-023873-fidpskcs	34	24	half	half	NN
cord-023873-fidpskcs	34	25	of	of	IN
cord-023873-fidpskcs	34	26	them	-PRON-	PRP
cord-023873-fidpskcs	34	27	were	be	VBD
cord-023873-fidpskcs	34	28	in	in	IN
cord-023873-fidpskcs	34	29	the	the	DT
cord-023873-fidpskcs	34	30	ICU	ICU	NNP
cord-023873-fidpskcs	34	31	[	[	-LRB-
cord-023873-fidpskcs	34	32	9	9	CD
cord-023873-fidpskcs	34	33	]	]	-RRB-
cord-023873-fidpskcs	34	34	.	.	.
cord-023873-fidpskcs	35	1	These	these	DT
cord-023873-fidpskcs	35	2	inter	inter	JJ
cord-023873-fidpskcs	35	3	-	-	JJ
cord-023873-fidpskcs	35	4	centre	centre	JJ
cord-023873-fidpskcs	35	5	differences	difference	NNS
cord-023873-fidpskcs	35	6	can	can	MD
cord-023873-fidpskcs	35	7	be	be	VB
cord-023873-fidpskcs	35	8	explained	explain	VBN
cord-023873-fidpskcs	35	9	by	by	IN
cord-023873-fidpskcs	35	10	differences	difference	NNS
cord-023873-fidpskcs	35	11	in	in	IN
cord-023873-fidpskcs	35	12	underlying	underlying	JJ
cord-023873-fidpskcs	35	13	patient	patient	NN
cord-023873-fidpskcs	35	14	characteristics	characteristic	NNS
cord-023873-fidpskcs	35	15	,	,	,
cord-023873-fidpskcs	35	16	case	case	NN
cord-023873-fidpskcs	35	17	mix	mix	NN
cord-023873-fidpskcs	35	18	and	and	CC
cord-023873-fidpskcs	35	19	different	different	JJ
cord-023873-fidpskcs	35	20	autopsy	autopsy	JJ
cord-023873-fidpskcs	35	21	policies	policy	NNS
cord-023873-fidpskcs	35	22	.	.	.
cord-023873-fidpskcs	36	1	In	in	IN
cord-023873-fidpskcs	36	2	a	a	DT
cord-023873-fidpskcs	36	3	recent	recent	JJ
cord-023873-fidpskcs	36	4	study	study	NN
cord-023873-fidpskcs	36	5	published	publish	VBN
cord-023873-fidpskcs	36	6	by	by	IN
cord-023873-fidpskcs	36	7	our	-PRON-	PRP$
cord-023873-fidpskcs	36	8	group	group	NN
cord-023873-fidpskcs	36	9	[	[	-LRB-
cord-023873-fidpskcs	36	10	10	10	CD
cord-023873-fidpskcs	36	11	]	]	-RRB-
cord-023873-fidpskcs	36	12	,	,	,
cord-023873-fidpskcs	36	13	patients	patient	NNS
cord-023873-fidpskcs	36	14	with	with	IN
cord-023873-fidpskcs	36	15	fever	fever	NN
cord-023873-fidpskcs	36	16	new	new	JJ
cord-023873-fidpskcs	36	17	lung	lung	NN
cord-023873-fidpskcs	36	18	infiltrates	infiltrate	NNS
cord-023873-fidpskcs	36	19	were	be	VBD
cord-023873-fidpskcs	36	20	screened	screen	VBN
cord-023873-fidpskcs	36	21	for	for	IN
cord-023873-fidpskcs	36	22	IA	IA	NNP
cord-023873-fidpskcs	36	23	using	use	VBG
cord-023873-fidpskcs	36	24	galactomannan	galactomannan	NNP
cord-023873-fidpskcs	36	25	testing	testing	NN
cord-023873-fidpskcs	36	26	in	in	IN
cord-023873-fidpskcs	36	27	bronchoalveolar	bronchoalveolar	NNP
cord-023873-fidpskcs	36	28	(	(	-LRB-
cord-023873-fidpskcs	36	29	BAL	BAL	NNP
cord-023873-fidpskcs	36	30	)	)	-RRB-
cord-023873-fidpskcs	36	31	fluid	fluid	NN
cord-023873-fidpskcs	36	32	.	.	.
cord-023873-fidpskcs	37	1	From	from	IN
cord-023873-fidpskcs	37	2	a	a	DT
cord-023873-fidpskcs	37	3	total	total	NN
cord-023873-fidpskcs	37	4	of	of	IN
cord-023873-fidpskcs	37	5	1,109	1,109	CD
cord-023873-fidpskcs	37	6	patients	patient	NNS
cord-023873-fidpskcs	37	7	admitted	admit	VBN
cord-023873-fidpskcs	37	8	to	to	IN
cord-023873-fidpskcs	37	9	the	the	DT
cord-023873-fidpskcs	37	10	ICU	ICU	NNP
cord-023873-fidpskcs	37	11	,	,	,
cord-023873-fidpskcs	37	12	110	110	CD
cord-023873-fidpskcs	37	13	patients	patient	NNS
cord-023873-fidpskcs	37	14	fulfilled	fulfil	VBD
cord-023873-fidpskcs	37	15	the	the	DT
cord-023873-fidpskcs	37	16	entrance	entrance	NN
cord-023873-fidpskcs	37	17	criteria	criterion	NNS
cord-023873-fidpskcs	37	18	and	and	CC
cord-023873-fidpskcs	37	19	were	be	VBD
cord-023873-fidpskcs	37	20	evaluated	evaluate	VBN
cord-023873-fidpskcs	37	21	.	.	.
cord-023873-fidpskcs	38	1	Most	Most	JJS
cord-023873-fidpskcs	38	2	patients	patient	NNS
cord-023873-fidpskcs	38	3	had	have	VBD
cord-023873-fidpskcs	38	4	non	non	JJ
cord-023873-fidpskcs	38	5	-	-	JJ
cord-023873-fidpskcs	38	6	haematological	haematological	JJ
cord-023873-fidpskcs	38	7	diseases	disease	NNS
cord-023873-fidpskcs	38	8	(	(	-LRB-
cord-023873-fidpskcs	38	9	67	67	CD
cord-023873-fidpskcs	38	10	%	%	NN
cord-023873-fidpskcs	38	11	)	)	-RRB-
cord-023873-fidpskcs	38	12	,	,	,
cord-023873-fidpskcs	38	13	including	include	VBG
cord-023873-fidpskcs	38	14	liver	liver	NN
cord-023873-fidpskcs	38	15	cirrhosis	cirrhosis	NN
cord-023873-fidpskcs	38	16	(	(	-LRB-
cord-023873-fidpskcs	38	17	21	21	CD
cord-023873-fidpskcs	38	18	%	%	NN
cord-023873-fidpskcs	38	19	)	)	-RRB-
cord-023873-fidpskcs	38	20	,	,	,
cord-023873-fidpskcs	38	21	COPD	COPD	NNP
cord-023873-fidpskcs	38	22	(	(	-LRB-
cord-023873-fidpskcs	38	23	14	14	CD
cord-023873-fidpskcs	38	24	%	%	NN
cord-023873-fidpskcs	38	25	)	)	-RRB-
cord-023873-fidpskcs	38	26	and	and	CC
cord-023873-fidpskcs	38	27	other	other	JJ
cord-023873-fidpskcs	38	28	systemic	systemic	JJ
cord-023873-fidpskcs	38	29	conditions	condition	NNS
cord-023873-fidpskcs	38	30	(	(	-LRB-
cord-023873-fidpskcs	38	31	15	15	CD
cord-023873-fidpskcs	38	32	%	%	NN
cord-023873-fidpskcs	38	33	)	)	-RRB-
cord-023873-fidpskcs	38	34	.	.	.
cord-023873-fidpskcs	39	1	The	the	DT
cord-023873-fidpskcs	39	2	incidence	incidence	NN
cord-023873-fidpskcs	39	3	of	of	IN
cord-023873-fidpskcs	39	4	proven	prove	VBN
cord-023873-fidpskcs	39	5	IA	IA	NNP
cord-023873-fidpskcs	39	6	in	in	IN
cord-023873-fidpskcs	39	7	this	this	DT
cord-023873-fidpskcs	39	8	population	population	NN
cord-023873-fidpskcs	39	9	was	be	VBD
cord-023873-fidpskcs	39	10	surprisingly	surprisingly	RB
cord-023873-fidpskcs	39	11	high	high	JJ
cord-023873-fidpskcs	39	12	at	at	IN
cord-023873-fidpskcs	39	13	23.6	23.6	CD
cord-023873-fidpskcs	39	14	%	%	NN
cord-023873-fidpskcs	39	15	,	,	,
cord-023873-fidpskcs	39	16	which	which	WDT
cord-023873-fidpskcs	39	17	might	may	MD
cord-023873-fidpskcs	39	18	have	have	VB
cord-023873-fidpskcs	39	19	been	be	VBN
cord-023873-fidpskcs	39	20	associated	associate	VBN
cord-023873-fidpskcs	39	21	with	with	IN
cord-023873-fidpskcs	39	22	the	the	DT
cord-023873-fidpskcs	39	23	high	high	JJ
cord-023873-fidpskcs	39	24	frequency	frequency	NN
cord-023873-fidpskcs	39	25	of	of	IN
cord-023873-fidpskcs	39	26	autopsy	autopsy	JJ
cord-023873-fidpskcs	39	27	(	(	-LRB-
cord-023873-fidpskcs	39	28	95	95	CD
cord-023873-fidpskcs	39	29	%	%	NN
cord-023873-fidpskcs	39	30	of	of	IN
cord-023873-fidpskcs	39	31	fatalities	fatality	NNS
cord-023873-fidpskcs	39	32	)	)	-RRB-
cord-023873-fidpskcs	39	33	,	,	,
cord-023873-fidpskcs	39	34	as	as	RB
cord-023873-fidpskcs	39	35	well	well	RB
cord-023873-fidpskcs	39	36	as	as	IN
cord-023873-fidpskcs	39	37	the	the	DT
cord-023873-fidpskcs	39	38	use	use	NN
cord-023873-fidpskcs	39	39	of	of	IN
cord-023873-fidpskcs	39	40	a	a	DT
cord-023873-fidpskcs	39	41	sensitive	sensitive	JJ
cord-023873-fidpskcs	39	42	diagnostic	diagnostic	JJ
cord-023873-fidpskcs	39	43	tool	tool	NN
cord-023873-fidpskcs	39	44	(	(	-LRB-
cord-023873-fidpskcs	39	45	more	more	JJR
cord-023873-fidpskcs	39	46	comments	comment	NNS
cord-023873-fidpskcs	39	47	about	about	IN
cord-023873-fidpskcs	39	48	galactomannan	galactomannan	NNP
cord-023873-fidpskcs	39	49	testing	testing	NN
cord-023873-fidpskcs	39	50	are	be	VBP
cord-023873-fidpskcs	39	51	presented	present	VBN
cord-023873-fidpskcs	39	52	below	below	RB
cord-023873-fidpskcs	39	53	)	)	-RRB-
cord-023873-fidpskcs	39	54	.	.	.
cord-023873-fidpskcs	40	1	As	as	IN
cord-023873-fidpskcs	40	2	this	this	DT
cord-023873-fidpskcs	40	3	was	be	VBD
cord-023873-fidpskcs	40	4	a	a	DT
cord-023873-fidpskcs	40	5	single	single	JJ
cord-023873-fidpskcs	40	6	-	-	HYPH
cord-023873-fidpskcs	40	7	centre	centre	NN
cord-023873-fidpskcs	40	8	study	study	NN
cord-023873-fidpskcs	40	9	,	,	,
cord-023873-fidpskcs	40	10	the	the	DT
cord-023873-fidpskcs	40	11	presence	presence	NN
cord-023873-fidpskcs	40	12	of	of	IN
cord-023873-fidpskcs	40	13	an	an	DT
cord-023873-fidpskcs	40	14	outbreak	outbreak	NN
cord-023873-fidpskcs	40	15	is	be	VBZ
cord-023873-fidpskcs	40	16	also	also	RB
cord-023873-fidpskcs	40	17	a	a	DT
cord-023873-fidpskcs	40	18	possibility	possibility	NN
cord-023873-fidpskcs	40	19	.	.	.
cord-023873-fidpskcs	41	1	2	2	LS
cord-023873-fidpskcs	42	1	Who	who	WP
cord-023873-fidpskcs	42	2	is	be	VBZ
cord-023873-fidpskcs	42	3	at	at	IN
cord-023873-fidpskcs	42	4	Risk	risk	NN
cord-023873-fidpskcs	42	5	for	for	IN
cord-023873-fidpskcs	42	6	Developing	develop	VBG
cord-023873-fidpskcs	42	7	IA	IA	NNP
cord-023873-fidpskcs	42	8	in	in	IN
cord-023873-fidpskcs	42	9	the	the	DT
cord-023873-fidpskcs	42	10	ICU	ICU	NNP
cord-023873-fidpskcs	42	11	?	?	.
cord-023873-fidpskcs	43	1	Over	over	IN
cord-023873-fidpskcs	43	2	the	the	DT
cord-023873-fidpskcs	43	3	past	past	JJ
cord-023873-fidpskcs	43	4	two	two	CD
cord-023873-fidpskcs	43	5	decades	decade	NNS
cord-023873-fidpskcs	43	6	,	,	,
cord-023873-fidpskcs	43	7	IA	IA	NNP
cord-023873-fidpskcs	43	8	has	have	VBZ
cord-023873-fidpskcs	43	9	emerged	emerge	VBN
cord-023873-fidpskcs	43	10	as	as	IN
cord-023873-fidpskcs	43	11	a	a	DT
cord-023873-fidpskcs	43	12	life	life	NN
cord-023873-fidpskcs	43	13	threatening	threaten	VBG
cord-023873-fidpskcs	43	14	fungal	fungal	JJ
cord-023873-fidpskcs	43	15	infection	infection	NN
cord-023873-fidpskcs	43	16	in	in	IN
cord-023873-fidpskcs	43	17	patients	patient	NNS
cord-023873-fidpskcs	43	18	with	with	IN
cord-023873-fidpskcs	43	19	haematological	haematological	JJ
cord-023873-fidpskcs	43	20	diseases	disease	NNS
cord-023873-fidpskcs	43	21	.	.	.
cord-023873-fidpskcs	44	1	Although	although	IN
cord-023873-fidpskcs	44	2	many	many	JJ
cord-023873-fidpskcs	44	3	of	of	IN
cord-023873-fidpskcs	44	4	these	these	DT
cord-023873-fidpskcs	44	5	infected	infect	VBN
cord-023873-fidpskcs	44	6	patients	patient	NNS
cord-023873-fidpskcs	44	7	will	will	MD
cord-023873-fidpskcs	44	8	eventually	eventually	RB
cord-023873-fidpskcs	44	9	be	be	VB
cord-023873-fidpskcs	44	10	admitted	admit	VBN
cord-023873-fidpskcs	44	11	to	to	IN
cord-023873-fidpskcs	44	12	the	the	DT
cord-023873-fidpskcs	44	13	ICU	ICU	NNP
cord-023873-fidpskcs	44	14	for	for	IN
cord-023873-fidpskcs	44	15	advanced	advanced	JJ
cord-023873-fidpskcs	44	16	supportive	supportive	JJ
cord-023873-fidpskcs	44	17	care	care	NN
cord-023873-fidpskcs	44	18	,	,	,
cord-023873-fidpskcs	44	19	it	-PRON-	PRP
cord-023873-fidpskcs	44	20	seems	seem	VBZ
cord-023873-fidpskcs	44	21	that	that	IN
cord-023873-fidpskcs	44	22	IA	IA	NNP
cord-023873-fidpskcs	44	23	has	have	VBZ
cord-023873-fidpskcs	44	24	also	also	RB
cord-023873-fidpskcs	44	25	gained	gain	VBN
cord-023873-fidpskcs	44	26	a	a	DT
cord-023873-fidpskcs	44	27	foothold	foothold	NN
cord-023873-fidpskcs	44	28	in	in	IN
cord-023873-fidpskcs	44	29	less	less	RBR
cord-023873-fidpskcs	44	30	severely	severely	RB
cord-023873-fidpskcs	44	31	compromised	compromise	VBN
cord-023873-fidpskcs	44	32	ICU	ICU	NNP
cord-023873-fidpskcs	44	33	patients	patient	NNS
cord-023873-fidpskcs	44	34	[	[	-LRB-
cord-023873-fidpskcs	44	35	7	7	CD
cord-023873-fidpskcs	44	36	]	]	-RRB-
cord-023873-fidpskcs	44	37	.	.	.
cord-023873-fidpskcs	45	1	So	so	RB
cord-023873-fidpskcs	45	2	,	,	,
cord-023873-fidpskcs	45	3	can	can	MD
cord-023873-fidpskcs	45	4	a	a	DT
cord-023873-fidpskcs	45	5	threshold	threshold	NN
cord-023873-fidpskcs	45	6	of	of	IN
cord-023873-fidpskcs	45	7	immunosuppression	immunosuppression	NN
cord-023873-fidpskcs	45	8	needed	need	VBN
cord-023873-fidpskcs	45	9	for	for	IN
cord-023873-fidpskcs	45	10	the	the	DT
cord-023873-fidpskcs	45	11	development	development	NN
cord-023873-fidpskcs	45	12	of	of	IN
cord-023873-fidpskcs	45	13	IA	IA	NNP
cord-023873-fidpskcs	45	14	be	be	VB
cord-023873-fidpskcs	45	15	defined	define	VBN
cord-023873-fidpskcs	45	16	?	?	.
cord-023873-fidpskcs	46	1	We	-PRON-	PRP
cord-023873-fidpskcs	46	2	grouped	group	VBD
cord-023873-fidpskcs	46	3	the	the	DT
cord-023873-fidpskcs	46	4	risk	risk	NN
cord-023873-fidpskcs	46	5	factors	factor	NNS
cord-023873-fidpskcs	46	6	for	for	IN
cord-023873-fidpskcs	46	7	IA	IA	NNP
cord-023873-fidpskcs	46	8	in	in	IN
cord-023873-fidpskcs	46	9	the	the	DT
cord-023873-fidpskcs	46	10	ICU	ICU	NNP
cord-023873-fidpskcs	46	11	are	be	VBP
cord-023873-fidpskcs	46	12	into	into	IN
cord-023873-fidpskcs	46	13	3	3	CD
cord-023873-fidpskcs	46	14	categories	category	NNS
cord-023873-fidpskcs	46	15	(	(	-LRB-
cord-023873-fidpskcs	46	16	high	high	JJ
cord-023873-fidpskcs	46	17	,	,	,
cord-023873-fidpskcs	46	18	intermediate	intermediate	JJ
cord-023873-fidpskcs	46	19	,	,	,
cord-023873-fidpskcs	46	20	low	low	JJ
cord-023873-fidpskcs	46	21	)	)	-RRB-
cord-023873-fidpskcs	47	1	(	(	-LRB-
cord-023873-fidpskcs	47	2	Table	table	NN
cord-023873-fidpskcs	47	3	2	2	CD
cord-023873-fidpskcs	47	4	)	)	-RRB-
cord-023873-fidpskcs	47	5	.	.	.
cord-023873-fidpskcs	48	1	Various	various	JJ
cord-023873-fidpskcs	48	2	factors	factor	NNS
cord-023873-fidpskcs	48	3	adversely	adversely	RB
cord-023873-fidpskcs	48	4	affect	affect	VBP
cord-023873-fidpskcs	48	5	the	the	DT
cord-023873-fidpskcs	48	6	defence	defence	NN
cord-023873-fidpskcs	48	7	systems	system	NNS
cord-023873-fidpskcs	48	8	of	of	IN
cord-023873-fidpskcs	48	9	previously	previously	RB
cord-023873-fidpskcs	48	10	healthy	healthy	JJ
cord-023873-fidpskcs	48	11	individuals	individual	NNS
cord-023873-fidpskcs	48	12	,	,	,
cord-023873-fidpskcs	48	13	including	include	VBG
cord-023873-fidpskcs	48	14	the	the	DT
cord-023873-fidpskcs	48	15	prolonged	prolong	VBN
cord-023873-fidpskcs	48	16	use	use	NN
cord-023873-fidpskcs	48	17	of	of	IN
cord-023873-fidpskcs	48	18	antibiotics	antibiotic	NNS
cord-023873-fidpskcs	48	19	,	,	,
cord-023873-fidpskcs	48	20	the	the	DT
cord-023873-fidpskcs	48	21	use	use	NN
cord-023873-fidpskcs	48	22	of	of	IN
cord-023873-fidpskcs	48	23	central	central	JJ
cord-023873-fidpskcs	48	24	venous	venous	JJ
cord-023873-fidpskcs	48	25	catheters	catheter	NNS
cord-023873-fidpskcs	48	26	and/or	and/or	CC
cord-023873-fidpskcs	48	27	mechanical	mechanical	JJ
cord-023873-fidpskcs	48	28	ventilation	ventilation	NN
cord-023873-fidpskcs	48	29	.	.	.
cord-023873-fidpskcs	49	1	Although	although	IN
cord-023873-fidpskcs	49	2	these	these	DT
cord-023873-fidpskcs	49	3	factors	factor	NNS
cord-023873-fidpskcs	49	4	are	be	VBP
cord-023873-fidpskcs	49	5	present	present	JJ
cord-023873-fidpskcs	49	6	in	in	IN
cord-023873-fidpskcs	49	7	most	most	JJS
cord-023873-fidpskcs	49	8	ICU	ICU	NNP
cord-023873-fidpskcs	49	9	patients	patient	NNS
cord-023873-fidpskcs	49	10	,	,	,
cord-023873-fidpskcs	49	11	many	many	JJ
cord-023873-fidpskcs	49	12	of	of	IN
cord-023873-fidpskcs	49	13	them	-PRON-	PRP
cord-023873-fidpskcs	49	14	do	do	VBP
cord-023873-fidpskcs	49	15	not	not	RB
cord-023873-fidpskcs	49	16	develop	develop	VB
cord-023873-fidpskcs	49	17	IA	IA	NNP
cord-023873-fidpskcs	49	18	.	.	.
cord-023873-fidpskcs	50	1	One	one	CD
cord-023873-fidpskcs	50	2	of	of	IN
cord-023873-fidpskcs	50	3	the	the	DT
cord-023873-fidpskcs	50	4	intriguing	intriguing	JJ
cord-023873-fidpskcs	50	5	hypotheses	hypothesis	NNS
cord-023873-fidpskcs	50	6	for	for	IN
cord-023873-fidpskcs	50	7	immunosuppression	immunosuppression	NN
cord-023873-fidpskcs	50	8	in	in	IN
cord-023873-fidpskcs	50	9	the	the	DT
cord-023873-fidpskcs	50	10	apparently	apparently	RB
cord-023873-fidpskcs	50	11	immunocompetent	immunocompetent	JJ
cord-023873-fidpskcs	50	12	patient	patient	NN
cord-023873-fidpskcs	50	13	with	with	IN
cord-023873-fidpskcs	50	14	multiple	multiple	JJ
cord-023873-fidpskcs	50	15	organ	organ	NN
cord-023873-fidpskcs	50	16	dysfunctions	dysfunction	NNS
cord-023873-fidpskcs	50	17	is	be	VBZ
cord-023873-fidpskcs	50	18	related	relate	VBN
cord-023873-fidpskcs	50	19	to	to	IN
cord-023873-fidpskcs	50	20	the	the	DT
cord-023873-fidpskcs	50	21	biphasic	biphasic	JJ
cord-023873-fidpskcs	50	22	response	response	NN
cord-023873-fidpskcs	50	23	to	to	IN
cord-023873-fidpskcs	50	24	sepsis	sepsis	NN
cord-023873-fidpskcs	50	25	.	.	.
cord-023873-fidpskcs	51	1	The	the	DT
cord-023873-fidpskcs	51	2	initial	initial	JJ
cord-023873-fidpskcs	51	3	hyperinflammatory	hyperinflammatory	NN
cord-023873-fidpskcs	51	4	phase	phase	NN
cord-023873-fidpskcs	51	5	is	be	VBZ
cord-023873-fidpskcs	51	6	followed	follow	VBN
cord-023873-fidpskcs	51	7	by	by	IN
cord-023873-fidpskcs	51	8	relative	relative	JJ
cord-023873-fidpskcs	51	9	immunoparalysis	immunoparalysis	NN
cord-023873-fidpskcs	51	10	[	[	-LRB-
cord-023873-fidpskcs	51	11	11	11	CD
cord-023873-fidpskcs	51	12	]	]	-RRB-
cord-023873-fidpskcs	51	13	.	.	.
cord-023873-fidpskcs	52	1	This	this	DT
cord-023873-fidpskcs	52	2	latter	latter	JJ
cord-023873-fidpskcs	52	3	process	process	NN
cord-023873-fidpskcs	52	4	is	be	VBZ
cord-023873-fidpskcs	52	5	characterized	characterize	VBN
cord-023873-fidpskcs	52	6	by	by	IN
cord-023873-fidpskcs	52	7	neutrophil	neutrophil	NN
cord-023873-fidpskcs	52	8	deactivation	deactivation	NN
cord-023873-fidpskcs	52	9	and	and	CC
cord-023873-fidpskcs	52	10	may	may	MD
cord-023873-fidpskcs	52	11	put	put	VB
cord-023873-fidpskcs	52	12	the	the	DT
cord-023873-fidpskcs	52	13	patient	patient	NN
cord-023873-fidpskcs	52	14	at	at	IN
cord-023873-fidpskcs	52	15	risk	risk	NN
cord-023873-fidpskcs	52	16	for	for	IN
cord-023873-fidpskcs	52	17	developing	develop	VBG
cord-023873-fidpskcs	52	18	opportunistic	opportunistic	JJ
cord-023873-fidpskcs	52	19	infections	infection	NNS
cord-023873-fidpskcs	52	20	such	such	JJ
cord-023873-fidpskcs	52	21	as	as	IN
cord-023873-fidpskcs	52	22	IA	IA	NNP
cord-023873-fidpskcs	52	23	.	.	.
cord-023873-fidpskcs	53	1	Further	further	JJ
cord-023873-fidpskcs	53	2	epidemiological	epidemiological	JJ
cord-023873-fidpskcs	53	3	study	study	NN
cord-023873-fidpskcs	53	4	is	be	VBZ
cord-023873-fidpskcs	53	5	warranted	warrant	VBN
cord-023873-fidpskcs	53	6	to	to	TO
cord-023873-fidpskcs	53	7	better	better	RB
cord-023873-fidpskcs	53	8	delineate	delineate	VB
cord-023873-fidpskcs	53	9	this	this	DT
cord-023873-fidpskcs	53	10	phase	phase	NN
cord-023873-fidpskcs	53	11	of	of	IN
cord-023873-fidpskcs	53	12	immunoparalysis	immunoparalysis	NN
cord-023873-fidpskcs	53	13	.	.	.
cord-023873-fidpskcs	54	1	More	More	JJR
cord-023873-fidpskcs	54	2	detail	detail	NN
cord-023873-fidpskcs	54	3	on	on	IN
cord-023873-fidpskcs	54	4	the	the	DT
cord-023873-fidpskcs	54	5	interactions	interaction	NNS
cord-023873-fidpskcs	54	6	between	between	IN
cord-023873-fidpskcs	54	7	Aspergillus	aspergillus	NN
cord-023873-fidpskcs	54	8	and	and	CC
cord-023873-fidpskcs	54	9	the	the	DT
cord-023873-fidpskcs	54	10	immune	immune	JJ
cord-023873-fidpskcs	54	11	system	system	NN
cord-023873-fidpskcs	54	12	are	be	VBP
cord-023873-fidpskcs	54	13	presented	present	VBN
cord-023873-fidpskcs	54	14	in	in	IN
cord-023873-fidpskcs	54	15	the	the	DT
cord-023873-fidpskcs	54	16	chapter	chapter	NN
cord-023873-fidpskcs	54	17	by	by	IN
cord-023873-fidpskcs	54	18	Dr	Dr	NNP
cord-023873-fidpskcs	54	19	Romani	Romani	NNP
cord-023873-fidpskcs	54	20	.	.	.
cord-023873-fidpskcs	55	1	Patients	patient	NNS
cord-023873-fidpskcs	55	2	in	in	IN
cord-023873-fidpskcs	55	3	the	the	DT
cord-023873-fidpskcs	55	4	ICU	ICU	NNP
cord-023873-fidpskcs	55	5	(	(	-LRB-
cord-023873-fidpskcs	55	6	medical	medical	JJ
cord-023873-fidpskcs	55	7	and	and	CC
cord-023873-fidpskcs	55	8	surgical	surgical	JJ
cord-023873-fidpskcs	55	9	)	)	-RRB-
cord-023873-fidpskcs	55	10	are	be	VBP
cord-023873-fidpskcs	55	11	often	often	RB
cord-023873-fidpskcs	55	12	treated	treat	VBN
cord-023873-fidpskcs	55	13	with	with	IN
cord-023873-fidpskcs	55	14	steroids	steroid	NNS
cord-023873-fidpskcs	55	15	.	.	.
cord-023873-fidpskcs	56	1	Recent	recent	JJ
cord-023873-fidpskcs	56	2	work	work	NN
cord-023873-fidpskcs	56	3	concluded	conclude	VBD
cord-023873-fidpskcs	56	4	that	that	IN
cord-023873-fidpskcs	56	5	the	the	DT
cord-023873-fidpskcs	56	6	mortality	mortality	NN
cord-023873-fidpskcs	56	7	is	be	VBZ
cord-023873-fidpskcs	56	8	reduced	reduce	VBN
cord-023873-fidpskcs	56	9	if	if	IN
cord-023873-fidpskcs	56	10	septic	septic	JJ
cord-023873-fidpskcs	56	11	shock	shock	NN
cord-023873-fidpskcs	56	12	patients	patient	NNS
cord-023873-fidpskcs	56	13	with	with	IN
cord-023873-fidpskcs	56	14	adrenal	adrenal	JJ
cord-023873-fidpskcs	56	15	dysfunction	dysfunction	NN
cord-023873-fidpskcs	56	16	receive	receive	VBP
cord-023873-fidpskcs	56	17	hydrocortisone	hydrocortisone	NN
cord-023873-fidpskcs	56	18	for	for	IN
cord-023873-fidpskcs	56	19	a	a	DT
cord-023873-fidpskcs	56	20	7-day	7-day	JJ
cord-023873-fidpskcs	56	21	period	period	NN
cord-023873-fidpskcs	56	22	[	[	-LRB-
cord-023873-fidpskcs	56	23	12	12	CD
cord-023873-fidpskcs	56	24	]	]	-RRB-
cord-023873-fidpskcs	56	25	.	.	.
cord-023873-fidpskcs	57	1	In	in	IN
cord-023873-fidpskcs	57	2	vitro	vitro	FW
cord-023873-fidpskcs	57	3	,	,	,
cord-023873-fidpskcs	57	4	however	however	RB
cord-023873-fidpskcs	57	5	,	,	,
cord-023873-fidpskcs	57	6	pharmacological	pharmacological	JJ
cord-023873-fidpskcs	57	7	concentrations	concentration	NNS
cord-023873-fidpskcs	57	8	of	of	IN
cord-023873-fidpskcs	57	9	hydrocortisone	hydrocortisone	NN
cord-023873-fidpskcs	57	10	accelerate	accelerate	VBP
cord-023873-fidpskcs	57	11	the	the	DT
cord-023873-fidpskcs	57	12	growth	growth	NN
cord-023873-fidpskcs	57	13	of	of	IN
cord-023873-fidpskcs	57	14	Aspergillus	aspergillus	NN
cord-023873-fidpskcs	57	15	spp	spp	NNS
cord-023873-fidpskcs	57	16	.	.	.
cord-023873-fidpskcs	58	1	[	[	-LRB-
cord-023873-fidpskcs	58	2	13	13	CD
cord-023873-fidpskcs	58	3	]	]	-RRB-
cord-023873-fidpskcs	58	4	.	.	.
cord-023873-fidpskcs	59	1	Clearly	clearly	RB
cord-023873-fidpskcs	59	2	,	,	,
cord-023873-fidpskcs	59	3	high	high	JJ
cord-023873-fidpskcs	59	4	steroid	steroid	NN
cord-023873-fidpskcs	59	5	intake	intake	NN
cord-023873-fidpskcs	59	6	diminishes	diminish	VBZ
cord-023873-fidpskcs	59	7	both	both	DT
cord-023873-fidpskcs	59	8	lines	line	NNS
cord-023873-fidpskcs	59	9	of	of	IN
cord-023873-fidpskcs	59	10	cellular	cellular	JJ
cord-023873-fidpskcs	59	11	defence	defence	NN
cord-023873-fidpskcs	59	12	against	against	IN
cord-023873-fidpskcs	59	13	IA	IA	NNP
cord-023873-fidpskcs	59	14	(	(	-LRB-
cord-023873-fidpskcs	59	15	macrophages	macrophage	NNS
cord-023873-fidpskcs	59	16	and	and	CC
cord-023873-fidpskcs	59	17	neutrophils	neutrophil	NNS
cord-023873-fidpskcs	59	18	)	)	-RRB-
cord-023873-fidpskcs	59	19	.	.	.
cord-023873-fidpskcs	60	1	Palmer	Palmer	NNP
cord-023873-fidpskcs	60	2	reported	report	VBD
cord-023873-fidpskcs	60	3	that	that	IN
cord-023873-fidpskcs	60	4	the	the	DT
cord-023873-fidpskcs	60	5	threshold	threshold	NN
cord-023873-fidpskcs	60	6	steroid	steroid	JJ
cord-023873-fidpskcs	60	7	level	level	NN
cord-023873-fidpskcs	60	8	varies	vary	VBZ
cord-023873-fidpskcs	60	9	according	accord	VBG
cord-023873-fidpskcs	60	10	to	to	IN
cord-023873-fidpskcs	60	11	the	the	DT
cord-023873-fidpskcs	60	12	type	type	NN
cord-023873-fidpskcs	60	13	of	of	IN
cord-023873-fidpskcs	60	14	patients	patient	NNS
cord-023873-fidpskcs	60	15	and	and	CC
cord-023873-fidpskcs	60	16	emphasized	emphasize	VBD
cord-023873-fidpskcs	60	17	that	that	IN
cord-023873-fidpskcs	60	18	underlying	underlie	VBG
cord-023873-fidpskcs	60	19	lung	lung	NN
cord-023873-fidpskcs	60	20	disease	disease	NN
cord-023873-fidpskcs	60	21	is	be	VBZ
cord-023873-fidpskcs	60	22	a	a	DT
cord-023873-fidpskcs	60	23	risk	risk	NN
cord-023873-fidpskcs	60	24	factor	factor	NN
cord-023873-fidpskcs	60	25	for	for	IN
cord-023873-fidpskcs	60	26	IA	IA	NNP
cord-023873-fidpskcs	60	27	even	even	RB
cord-023873-fidpskcs	60	28	at	at	IN
cord-023873-fidpskcs	60	29	low	low	JJ
cord-023873-fidpskcs	60	30	doses	dose	NNS
cord-023873-fidpskcs	60	31	[	[	-LRB-
cord-023873-fidpskcs	60	32	14	14	CD
cord-023873-fidpskcs	60	33	]	]	-RRB-
cord-023873-fidpskcs	60	34	.	.	.
cord-023873-fidpskcs	61	1	Further	further	JJ
cord-023873-fidpskcs	61	2	study	study	NN
cord-023873-fidpskcs	61	3	is	be	VBZ
cord-023873-fidpskcs	61	4	needed	need	VBN
cord-023873-fidpskcs	61	5	to	to	TO
cord-023873-fidpskcs	61	6	investigate	investigate	VB
cord-023873-fidpskcs	61	7	whether	whether	IN
cord-023873-fidpskcs	61	8	the	the	DT
cord-023873-fidpskcs	61	9	7	7	CD
cord-023873-fidpskcs	61	10	day	day	NN
cord-023873-fidpskcs	61	11	course	course	NN
cord-023873-fidpskcs	61	12	of	of	IN
cord-023873-fidpskcs	61	13	hydrocortisone	hydrocortisone	NN
cord-023873-fidpskcs	61	14	at	at	IN
cord-023873-fidpskcs	61	15	200-mg	200-mg	CD
cord-023873-fidpskcs	61	16	/	/	SYM
cord-023873-fidpskcs	61	17	day	day	NN
cord-023873-fidpskcs	61	18	in	in	IN
cord-023873-fidpskcs	61	19	patients	patient	NNS
cord-023873-fidpskcs	61	20	with	with	IN
cord-023873-fidpskcs	61	21	septic	septic	JJ
cord-023873-fidpskcs	61	22	shock	shock	NN
cord-023873-fidpskcs	61	23	puts	put	VBZ
cord-023873-fidpskcs	61	24	them	-PRON-	PRP
cord-023873-fidpskcs	61	25	at	at	IN
cord-023873-fidpskcs	61	26	risk	risk	NN
cord-023873-fidpskcs	61	27	for	for	IN
cord-023873-fidpskcs	61	28	IA	IA	NNP
cord-023873-fidpskcs	61	29	,	,	,
cord-023873-fidpskcs	61	30	knowing	know	VBG
cord-023873-fidpskcs	61	31	that	that	IN
cord-023873-fidpskcs	61	32	recognition	recognition	NN
cord-023873-fidpskcs	61	33	of	of	IN
cord-023873-fidpskcs	61	34	fungal	fungal	JJ
cord-023873-fidpskcs	61	35	infection	infection	NN
cord-023873-fidpskcs	61	36	may	may	MD
cord-023873-fidpskcs	61	37	be	be	VB
cord-023873-fidpskcs	61	38	delayed	delay	VBN
cord-023873-fidpskcs	61	39	,	,	,
cord-023873-fidpskcs	61	40	since	since	IN
cord-023873-fidpskcs	61	41	the	the	DT
cord-023873-fidpskcs	61	42	anti	anti	JJ
cord-023873-fidpskcs	61	43	-	-	JJ
cord-023873-fidpskcs	61	44	inflammatory	inflammatory	JJ
cord-023873-fidpskcs	61	45	properties	property	NNS
cord-023873-fidpskcs	61	46	of	of	IN
cord-023873-fidpskcs	61	47	steroids	steroid	NNS
cord-023873-fidpskcs	61	48	blunt	blunt	VBP
cord-023873-fidpskcs	61	49	the	the	DT
cord-023873-fidpskcs	61	50	signs	sign	NNS
cord-023873-fidpskcs	61	51	of	of	IN
cord-023873-fidpskcs	61	52	infection	infection	NN
cord-023873-fidpskcs	61	53	.	.	.
cord-023873-fidpskcs	62	1	Two	two	CD
cord-023873-fidpskcs	62	2	at	at	IN
cord-023873-fidpskcs	62	3	-	-	HYPH
cord-023873-fidpskcs	62	4	risk	risk	NN
cord-023873-fidpskcs	62	5	groups	group	NNS
cord-023873-fidpskcs	62	6	not	not	RB
cord-023873-fidpskcs	62	7	included	include	VBN
cord-023873-fidpskcs	62	8	in	in	IN
cord-023873-fidpskcs	62	9	the	the	DT
cord-023873-fidpskcs	62	10	EORTC	EORTC	NNP
cord-023873-fidpskcs	62	11	/	/	SYM
cord-023873-fidpskcs	62	12	MSG	MSG	NNP
cord-023873-fidpskcs	62	13	definitions	definition	NNS
cord-023873-fidpskcs	62	14	stand	stand	VBP
cord-023873-fidpskcs	62	15	out	out	RP
cord-023873-fidpskcs	62	16	for	for	IN
cord-023873-fidpskcs	62	17	IA	IA	NNP
cord-023873-fidpskcs	62	18	,	,	,
cord-023873-fidpskcs	62	19	COPD	COPD	NNP
cord-023873-fidpskcs	62	20	and	and	CC
cord-023873-fidpskcs	62	21	cirrhosis	cirrhosis	NN
cord-023873-fidpskcs	62	22	patients	patient	NNS
cord-023873-fidpskcs	62	23	.	.	.
cord-023873-fidpskcs	63	1	Patients	patient	NNS
cord-023873-fidpskcs	63	2	with	with	IN
cord-023873-fidpskcs	63	3	COPD	COPD	NNP
cord-023873-fidpskcs	63	4	are	be	VBP
cord-023873-fidpskcs	63	5	an	an	DT
cord-023873-fidpskcs	63	6	increasingly	increasingly	RB
cord-023873-fidpskcs	63	7	recognized	recognize	VBN
cord-023873-fidpskcs	63	8	group	group	NN
cord-023873-fidpskcs	63	9	of	of	IN
cord-023873-fidpskcs	63	10	patients	patient	NNS
cord-023873-fidpskcs	63	11	at	at	IN
cord-023873-fidpskcs	63	12	risk	risk	NN
cord-023873-fidpskcs	63	13	for	for	IN
cord-023873-fidpskcs	63	14	developing	develop	VBG
cord-023873-fidpskcs	63	15	IA	IA	NNP
cord-023873-fidpskcs	63	16	and	and	CC
cord-023873-fidpskcs	63	17	in	in	IN
cord-023873-fidpskcs	63	18	some	some	DT
cord-023873-fidpskcs	63	19	institutions	institution	NNS
cord-023873-fidpskcs	63	20	outnumber	outnumber	VBP
cord-023873-fidpskcs	63	21	cases	case	NNS
cord-023873-fidpskcs	63	22	in	in	IN
cord-023873-fidpskcs	63	23	"	"	``
cord-023873-fidpskcs	63	24	classic	classic	JJ
cord-023873-fidpskcs	63	25	"	"	''
cord-023873-fidpskcs	63	26	patients	patient	NNS
cord-023873-fidpskcs	63	27	.	.	.
cord-023873-fidpskcs	64	1	Bulpa	Bulpa	NNP
cord-023873-fidpskcs	64	2	et	et	NNP
cord-023873-fidpskcs	64	3	al	al	NNP
cord-023873-fidpskcs	64	4	.	.	.
cord-023873-fidpskcs	64	5	analyzed	analyze	VBD
cord-023873-fidpskcs	64	6	a	a	DT
cord-023873-fidpskcs	64	7	group	group	NN
cord-023873-fidpskcs	64	8	of	of	IN
cord-023873-fidpskcs	64	9	16	16	CD
cord-023873-fidpskcs	64	10	COPD	COPD	NNP
cord-023873-fidpskcs	64	11	patients	patient	NNS
cord-023873-fidpskcs	64	12	with	with	IN
cord-023873-fidpskcs	64	13	proven	proven	JJ
cord-023873-fidpskcs	64	14	or	or	CC
cord-023873-fidpskcs	64	15	probable	probable	JJ
cord-023873-fidpskcs	64	16	IA	IA	NNP
cord-023873-fidpskcs	64	17	requiring	require	VBG
cord-023873-fidpskcs	64	18	ICU	ICU	NNP
cord-023873-fidpskcs	64	19	admission	admission	NN
cord-023873-fidpskcs	64	20	.	.	.
cord-023873-fidpskcs	65	1	All	all	DT
cord-023873-fidpskcs	65	2	patients	patient	NNS
cord-023873-fidpskcs	65	3	were	be	VBD
cord-023873-fidpskcs	65	4	on	on	IN
cord-023873-fidpskcs	65	5	steroid	steroid	NN
cord-023873-fidpskcs	65	6	treatment	treatment	NN
cord-023873-fidpskcs	65	7	.	.	.
cord-023873-fidpskcs	66	1	The	the	DT
cord-023873-fidpskcs	66	2	outcome	outcome	NN
cord-023873-fidpskcs	66	3	was	be	VBD
cord-023873-fidpskcs	66	4	invariably	invariably	RB
cord-023873-fidpskcs	66	5	poor	poor	JJ
cord-023873-fidpskcs	66	6	[	[	-LRB-
cord-023873-fidpskcs	66	7	15	15	CD
cord-023873-fidpskcs	66	8	]	]	-RRB-
cord-023873-fidpskcs	66	9	.	.	.
cord-023873-fidpskcs	67	1	This	this	DT
cord-023873-fidpskcs	67	2	is	be	VBZ
cord-023873-fidpskcs	67	3	in	in	IN
cord-023873-fidpskcs	67	4	accordance	accordance	NN
cord-023873-fidpskcs	67	5	with	with	IN
cord-023873-fidpskcs	67	6	the	the	DT
cord-023873-fidpskcs	67	7	report	report	NN
cord-023873-fidpskcs	67	8	of	of	IN
cord-023873-fidpskcs	67	9	Rello	Rello	NNP
cord-023873-fidpskcs	67	10	et	et	NNP
cord-023873-fidpskcs	67	11	al	al	NNP
cord-023873-fidpskcs	67	12	.	.	NNP
cord-023873-fidpskcs	67	13	,	,	,
cord-023873-fidpskcs	67	14	who	who	WP
cord-023873-fidpskcs	67	15	describes	describe	VBZ
cord-023873-fidpskcs	67	16	another	another	DT
cord-023873-fidpskcs	67	17	8	8	CD
cord-023873-fidpskcs	67	18	COPD	COPD	NNP
cord-023873-fidpskcs	67	19	patients	patient	NNS
cord-023873-fidpskcs	67	20	with	with	IN
cord-023873-fidpskcs	67	21	IA	IA	NNP
cord-023873-fidpskcs	67	22	and	and	CC
cord-023873-fidpskcs	67	23	universally	universally	RB
cord-023873-fidpskcs	67	24	fatal	fatal	JJ
cord-023873-fidpskcs	67	25	outcome	outcome	NN
cord-023873-fidpskcs	67	26	[	[	-LRB-
cord-023873-fidpskcs	67	27	16	16	CD
cord-023873-fidpskcs	67	28	]	]	-RRB-
cord-023873-fidpskcs	67	29	.	.	.
cord-023873-fidpskcs	68	1	Guinea	Guinea	NNP
cord-023873-fidpskcs	68	2	et	et	NNP
cord-023873-fidpskcs	68	3	al	al	NNP
cord-023873-fidpskcs	68	4	.	.	.
cord-023873-fidpskcs	69	1	from	from	IN
cord-023873-fidpskcs	69	2	Madrid	Madrid	NNP
cord-023873-fidpskcs	69	3	recently	recently	RB
cord-023873-fidpskcs	69	4	presented	present	VBD
cord-023873-fidpskcs	69	5	results	result	NNS
cord-023873-fidpskcs	69	6	from	from	IN
cord-023873-fidpskcs	69	7	a	a	DT
cord-023873-fidpskcs	69	8	large	large	JJ
cord-023873-fidpskcs	69	9	series	series	NN
cord-023873-fidpskcs	69	10	of	of	IN
cord-023873-fidpskcs	69	11	IA	IA	NNP
cord-023873-fidpskcs	69	12	cases	case	NNS
cord-023873-fidpskcs	69	13	in	in	IN
cord-023873-fidpskcs	69	14	association	association	NN
cord-023873-fidpskcs	69	15	with	with	IN
cord-023873-fidpskcs	69	16	COPD	COPD	NNP
cord-023873-fidpskcs	69	17	(	(	-LRB-
cord-023873-fidpskcs	69	18	n	n	NN
cord-023873-fidpskcs	69	19	=	=	SYM
cord-023873-fidpskcs	69	20	57	57	CD
cord-023873-fidpskcs	69	21	)	)	-RRB-
cord-023873-fidpskcs	69	22	[	[	-LRB-
cord-023873-fidpskcs	69	23	17	17	CD
cord-023873-fidpskcs	69	24	]	]	-RRB-
cord-023873-fidpskcs	69	25	.	.	.
cord-023873-fidpskcs	70	1	Steroids	steroid	NNS
cord-023873-fidpskcs	70	2	were	be	VBD
cord-023873-fidpskcs	70	3	identified	identify	VBN
cord-023873-fidpskcs	70	4	as	as	IN
cord-023873-fidpskcs	70	5	a	a	DT
cord-023873-fidpskcs	70	6	risk	risk	NN
cord-023873-fidpskcs	70	7	factor	factor	NN
cord-023873-fidpskcs	70	8	in	in	IN
cord-023873-fidpskcs	70	9	98	98	CD
cord-023873-fidpskcs	70	10	%	%	NN
cord-023873-fidpskcs	70	11	of	of	IN
cord-023873-fidpskcs	70	12	patients	patient	NNS
cord-023873-fidpskcs	70	13	,	,	,
cord-023873-fidpskcs	70	14	with	with	IN
cord-023873-fidpskcs	70	15	74	74	CD
cord-023873-fidpskcs	70	16	%	%	NN
cord-023873-fidpskcs	70	17	of	of	IN
cord-023873-fidpskcs	70	18	patients	patient	NNS
cord-023873-fidpskcs	70	19	having	have	VBG
cord-023873-fidpskcs	70	20	received	receive	VBN
cord-023873-fidpskcs	70	21	total	total	JJ
cord-023873-fidpskcs	70	22	doses	dose	NNS
cord-023873-fidpskcs	70	23	of	of	IN
cord-023873-fidpskcs	70	24	>	>	XX
cord-023873-fidpskcs	70	25	700	700	CD
cord-023873-fidpskcs	70	26	mg	mg	NN
cord-023873-fidpskcs	70	27	.	.	.
cord-023873-fidpskcs	71	1	Most	Most	JJS
cord-023873-fidpskcs	71	2	cases	case	NNS
cord-023873-fidpskcs	71	3	of	of	IN
cord-023873-fidpskcs	71	4	IA	IA	NNP
cord-023873-fidpskcs	71	5	in	in	IN
cord-023873-fidpskcs	71	6	COPD	COPD	NNP
cord-023873-fidpskcs	71	7	patients	patient	NNS
cord-023873-fidpskcs	71	8	had	have	VBD
cord-023873-fidpskcs	71	9	only	only	RB
cord-023873-fidpskcs	71	10	lung	lung	NN
cord-023873-fidpskcs	71	11	involvement	involvement	NN
cord-023873-fidpskcs	71	12	,	,	,
cord-023873-fidpskcs	71	13	but	but	CC
cord-023873-fidpskcs	71	14	2	2	CD
cord-023873-fidpskcs	71	15	patients	patient	NNS
cord-023873-fidpskcs	71	16	also	also	RB
cord-023873-fidpskcs	71	17	had	have	VBD
cord-023873-fidpskcs	71	18	probable	probable	JJ
cord-023873-fidpskcs	71	19	brain	brain	NN
cord-023873-fidpskcs	71	20	involvement	involvement	NN
cord-023873-fidpskcs	71	21	.	.	.
cord-023873-fidpskcs	72	1	Data	datum	NNS
cord-023873-fidpskcs	72	2	from	from	IN
cord-023873-fidpskcs	72	3	the	the	DT
cord-023873-fidpskcs	72	4	same	same	JJ
cord-023873-fidpskcs	72	5	group	group	NN
cord-023873-fidpskcs	72	6	also	also	RB
cord-023873-fidpskcs	72	7	revealed	reveal	VBD
cord-023873-fidpskcs	72	8	that	that	IN
cord-023873-fidpskcs	72	9	COPD	COPD	NNP
cord-023873-fidpskcs	72	10	became	become	VBD
cord-023873-fidpskcs	72	11	the	the	DT
cord-023873-fidpskcs	72	12	leading	lead	VBG
cord-023873-fidpskcs	72	13	underlying	underlie	VBG
cord-023873-fidpskcs	72	14	disease	disease	NN
cord-023873-fidpskcs	72	15	associated	associate	VBN
cord-023873-fidpskcs	72	16	with	with	IN
cord-023873-fidpskcs	72	17	IA	IA	NNP
cord-023873-fidpskcs	72	18	(	(	-LRB-
cord-023873-fidpskcs	72	19	52.4	52.4	CD
cord-023873-fidpskcs	72	20	%	%	NN
cord-023873-fidpskcs	72	21	of	of	IN
cord-023873-fidpskcs	72	22	cases	case	NNS
cord-023873-fidpskcs	72	23	)	)	-RRB-
cord-023873-fidpskcs	72	24	,	,	,
cord-023873-fidpskcs	72	25	far	far	RB
cord-023873-fidpskcs	72	26	more	more	RBR
cord-023873-fidpskcs	72	27	frequent	frequent	JJ
cord-023873-fidpskcs	72	28	than	than	IN
cord-023873-fidpskcs	72	29	classical	classical	JJ
cord-023873-fidpskcs	72	30	conditions	condition	NNS
cord-023873-fidpskcs	72	31	such	such	JJ
cord-023873-fidpskcs	72	32	as	as	IN
cord-023873-fidpskcs	72	33	haematological	haematological	JJ
cord-023873-fidpskcs	72	34	malignancies	malignancy	NNS
cord-023873-fidpskcs	72	35	(	(	-LRB-
cord-023873-fidpskcs	72	36	15.2	15.2	CD
cord-023873-fidpskcs	72	37	%	%	NN
cord-023873-fidpskcs	72	38	)	)	-RRB-
cord-023873-fidpskcs	72	39	[	[	-LRB-
cord-023873-fidpskcs	72	40	18	18	CD
cord-023873-fidpskcs	72	41	]	]	-RRB-
cord-023873-fidpskcs	72	42	.	.	.
cord-023873-fidpskcs	73	1	Hepatic	hepatic	JJ
cord-023873-fidpskcs	73	2	failure	failure	NN
cord-023873-fidpskcs	73	3	is	be	VBZ
cord-023873-fidpskcs	73	4	generally	generally	RB
cord-023873-fidpskcs	73	5	not	not	RB
cord-023873-fidpskcs	73	6	recognized	recognize	VBN
cord-023873-fidpskcs	73	7	as	as	IN
cord-023873-fidpskcs	73	8	a	a	DT
cord-023873-fidpskcs	73	9	risk	risk	NN
cord-023873-fidpskcs	73	10	factor	factor	NN
cord-023873-fidpskcs	73	11	for	for	IN
cord-023873-fidpskcs	73	12	IA	IA	NNP
cord-023873-fidpskcs	73	13	.	.	.
cord-023873-fidpskcs	74	1	A	a	DT
cord-023873-fidpskcs	74	2	literature	literature	NN
cord-023873-fidpskcs	74	3	review	review	NN
cord-023873-fidpskcs	74	4	revealed	reveal	VBD
cord-023873-fidpskcs	74	5	that	that	IN
cord-023873-fidpskcs	74	6	5	5	CD
cord-023873-fidpskcs	74	7	of	of	IN
cord-023873-fidpskcs	74	8	14	14	CD
cord-023873-fidpskcs	74	9	previously	previously	RB
cord-023873-fidpskcs	74	10	reported	report	VBN
cord-023873-fidpskcs	74	11	cases	case	NNS
cord-023873-fidpskcs	74	12	of	of	IN
cord-023873-fidpskcs	74	13	IA	IA	NNP
cord-023873-fidpskcs	74	14	in	in	IN
cord-023873-fidpskcs	74	15	seemingly	seemingly	RB
cord-023873-fidpskcs	74	16	immunocompetent	immunocompetent	JJ
cord-023873-fidpskcs	74	17	hosts	host	NNS
cord-023873-fidpskcs	74	18	were	be	VBD
cord-023873-fidpskcs	74	19	associated	associate	VBN
cord-023873-fidpskcs	74	20	with	with	IN
cord-023873-fidpskcs	74	21	liver	liver	NN
cord-023873-fidpskcs	74	22	disease	disease	NN
cord-023873-fidpskcs	74	23	[	[	-LRB-
cord-023873-fidpskcs	74	24	19	19	CD
cord-023873-fidpskcs	74	25	]	]	-RRB-
cord-023873-fidpskcs	74	26	.	.	.
cord-023873-fidpskcs	75	1	Our	-PRON-	PRP$
cord-023873-fidpskcs	75	2	study	study	NN
cord-023873-fidpskcs	75	3	revealed	reveal	VBD
cord-023873-fidpskcs	75	4	3	3	CD
cord-023873-fidpskcs	75	5	fatal	fatal	JJ
cord-023873-fidpskcs	75	6	cases	case	NNS
cord-023873-fidpskcs	75	7	of	of	IN
cord-023873-fidpskcs	75	8	IA	IA	NNP
cord-023873-fidpskcs	75	9	[	[	-LRB-
cord-023873-fidpskcs	75	10	4	4	CD
cord-023873-fidpskcs	75	11	]	]	-RRB-
cord-023873-fidpskcs	75	12	.	.	.
cord-023873-fidpskcs	76	1	Patients	patient	NNS
cord-023873-fidpskcs	76	2	with	with	IN
cord-023873-fidpskcs	76	3	cirrhosis	cirrhosi	NNS
cord-023873-fidpskcs	76	4	have	have	VBP
cord-023873-fidpskcs	76	5	depressed	depress	VBN
cord-023873-fidpskcs	76	6	phagocytosis	phagocytosis	NN
cord-023873-fidpskcs	76	7	,	,	,
cord-023873-fidpskcs	76	8	which	which	WDT
cord-023873-fidpskcs	76	9	may	may	MD
cord-023873-fidpskcs	76	10	increase	increase	VB
cord-023873-fidpskcs	76	11	their	-PRON-	PRP$
cord-023873-fidpskcs	76	12	risk	risk	NN
cord-023873-fidpskcs	76	13	for	for	IN
cord-023873-fidpskcs	76	14	severe	severe	JJ
cord-023873-fidpskcs	76	15	infections	infection	NNS
cord-023873-fidpskcs	76	16	.	.	.
cord-023873-fidpskcs	77	1	It	-PRON-	PRP
cord-023873-fidpskcs	77	2	is	be	VBZ
cord-023873-fidpskcs	77	3	expected	expect	VBN
cord-023873-fidpskcs	77	4	that	that	IN
cord-023873-fidpskcs	77	5	new	new	JJ
cord-023873-fidpskcs	77	6	risk	risk	NN
cord-023873-fidpskcs	77	7	categories	category	NNS
cord-023873-fidpskcs	77	8	of	of	IN
cord-023873-fidpskcs	77	9	IA	IA	NNP
cord-023873-fidpskcs	77	10	will	will	MD
cord-023873-fidpskcs	77	11	come	come	VB
cord-023873-fidpskcs	77	12	up	up	RP
cord-023873-fidpskcs	77	13	as	as	IN
cord-023873-fidpskcs	77	14	new	new	JJ
cord-023873-fidpskcs	77	15	immunosuppressive	immunosuppressive	JJ
cord-023873-fidpskcs	77	16	agents	agent	NNS
cord-023873-fidpskcs	77	17	are	be	VBP
cord-023873-fidpskcs	77	18	made	make	VBN
cord-023873-fidpskcs	77	19	available	available	JJ
cord-023873-fidpskcs	77	20	such	such	JJ
cord-023873-fidpskcs	77	21	as	as	IN
cord-023873-fidpskcs	77	22	alemtuzumab	alemtuzumab	NNP
cord-023873-fidpskcs	77	23	and	and	CC
cord-023873-fidpskcs	77	24	etanercept	etanercept	NNP
cord-023873-fidpskcs	77	25	(	(	-LRB-
cord-023873-fidpskcs	77	26	TNF	TNF	NNP
cord-023873-fidpskcs	77	27	-	-	HYPH
cord-023873-fidpskcs	77	28	α	α	NNP
cord-023873-fidpskcs	77	29	blocker	blocker	NN
cord-023873-fidpskcs	77	30	)	)	-RRB-
cord-023873-fidpskcs	77	31	[	[	-LRB-
cord-023873-fidpskcs	77	32	20	20	CD
cord-023873-fidpskcs	77	33	]	]	-RRB-
cord-023873-fidpskcs	77	34	.	.	.
cord-023873-fidpskcs	78	1	There	there	EX
cord-023873-fidpskcs	78	2	are	be	VBP
cord-023873-fidpskcs	78	3	numerous	numerous	JJ
cord-023873-fidpskcs	78	4	sources	source	NNS
cord-023873-fidpskcs	78	5	of	of	IN
cord-023873-fidpskcs	78	6	Aspergillus	aspergillus	NN
cord-023873-fidpskcs	78	7	species	specie	NNS
cord-023873-fidpskcs	78	8	for	for	IN
cord-023873-fidpskcs	78	9	patients	patient	NNS
cord-023873-fidpskcs	78	10	in	in	IN
cord-023873-fidpskcs	78	11	the	the	DT
cord-023873-fidpskcs	78	12	ICU	ICU	NNP
cord-023873-fidpskcs	78	13	[	[	-LRB-
cord-023873-fidpskcs	78	14	21	21	CD
cord-023873-fidpskcs	78	15	,	,	,
cord-023873-fidpskcs	78	16	22	22	CD
cord-023873-fidpskcs	78	17	]	]	-RRB-
cord-023873-fidpskcs	78	18	.	.	.
cord-023873-fidpskcs	79	1	It	-PRON-	PRP
cord-023873-fidpskcs	79	2	is	be	VBZ
cord-023873-fidpskcs	79	3	believed	believe	VBN
cord-023873-fidpskcs	79	4	that	that	IN
cord-023873-fidpskcs	79	5	the	the	DT
cord-023873-fidpskcs	79	6	primary	primary	JJ
cord-023873-fidpskcs	79	7	ecological	ecological	JJ
cord-023873-fidpskcs	79	8	niche	niche	NN
cord-023873-fidpskcs	79	9	is	be	VBZ
cord-023873-fidpskcs	79	10	decomposing	decompose	VBG
cord-023873-fidpskcs	79	11	material	material	NN
cord-023873-fidpskcs	79	12	.	.	.
cord-023873-fidpskcs	80	1	However	however	RB
cord-023873-fidpskcs	80	2	,	,	,
cord-023873-fidpskcs	80	3	aerosolised	aerosolise	VBN
cord-023873-fidpskcs	80	4	spores	spore	NNS
cord-023873-fidpskcs	80	5	may	may	MD
cord-023873-fidpskcs	80	6	become	become	VB
cord-023873-fidpskcs	80	7	a	a	DT
cord-023873-fidpskcs	80	8	potential	potential	JJ
cord-023873-fidpskcs	80	9	source	source	NN
cord-023873-fidpskcs	80	10	of	of	IN
cord-023873-fidpskcs	80	11	infection	infection	NN
cord-023873-fidpskcs	80	12	through	through	IN
cord-023873-fidpskcs	80	13	improperly	improperly	RB
cord-023873-fidpskcs	80	14	cleaned	clean	VBN
cord-023873-fidpskcs	80	15	ventilation	ventilation	NN
cord-023873-fidpskcs	80	16	systems	system	NNS
cord-023873-fidpskcs	80	17	,	,	,
cord-023873-fidpskcs	80	18	water	water	NN
cord-023873-fidpskcs	80	19	systems	system	NNS
cord-023873-fidpskcs	80	20	or	or	CC
cord-023873-fidpskcs	80	21	even	even	RB
cord-023873-fidpskcs	80	22	computer	computer	NN
cord-023873-fidpskcs	80	23	consoles	console	NNS
cord-023873-fidpskcs	80	24	.	.	.
cord-023873-fidpskcs	81	1	The	the	DT
cord-023873-fidpskcs	81	2	use	use	NN
cord-023873-fidpskcs	81	3	of	of	IN
cord-023873-fidpskcs	81	4	High	High	NNP
cord-023873-fidpskcs	81	5	Efficiency	Efficiency	NNP
cord-023873-fidpskcs	81	6	Particulate	Particulate	NNP
cord-023873-fidpskcs	81	7	Air	Air	NNP
cord-023873-fidpskcs	81	8	(	(	-LRB-
cord-023873-fidpskcs	81	9	HEPA	HEPA	NNP
cord-023873-fidpskcs	81	10	)	)	-RRB-
cord-023873-fidpskcs	81	11	filtration	filtration	NN
cord-023873-fidpskcs	81	12	reduces	reduce	VBZ
cord-023873-fidpskcs	81	13	the	the	DT
cord-023873-fidpskcs	81	14	risk	risk	NN
cord-023873-fidpskcs	81	15	of	of	IN
cord-023873-fidpskcs	81	16	IA	IA	NNP
cord-023873-fidpskcs	81	17	but	but	CC
cord-023873-fidpskcs	81	18	does	do	VBZ
cord-023873-fidpskcs	81	19	not	not	RB
cord-023873-fidpskcs	81	20	reduce	reduce	VB
cord-023873-fidpskcs	81	21	it	-PRON-	PRP
cord-023873-fidpskcs	81	22	to	to	IN
cord-023873-fidpskcs	81	23	zero	zero	CD
cord-023873-fidpskcs	81	24	,	,	,
cord-023873-fidpskcs	81	25	probably	probably	RB
cord-023873-fidpskcs	81	26	partly	partly	RB
cord-023873-fidpskcs	81	27	because	because	IN
cord-023873-fidpskcs	81	28	patients	patient	NNS
cord-023873-fidpskcs	81	29	may	may	MD
cord-023873-fidpskcs	81	30	be	be	VB
cord-023873-fidpskcs	81	31	colonised	colonise	VBN
cord-023873-fidpskcs	81	32	before	before	IN
cord-023873-fidpskcs	81	33	admission	admission	NN
cord-023873-fidpskcs	81	34	to	to	IN
cord-023873-fidpskcs	81	35	the	the	DT
cord-023873-fidpskcs	81	36	ICU	ICU	NNP
cord-023873-fidpskcs	81	37	,	,	,
cord-023873-fidpskcs	81	38	partly	partly	RB
cord-023873-fidpskcs	81	39	because	because	IN
cord-023873-fidpskcs	81	40	of	of	IN
cord-023873-fidpskcs	81	41	breaks	break	NNS
cord-023873-fidpskcs	81	42	in	in	IN
cord-023873-fidpskcs	81	43	airflow	airflow	NN
cord-023873-fidpskcs	81	44	.	.	.
cord-023873-fidpskcs	82	1	Pittet	Pittet	NNP
cord-023873-fidpskcs	82	2	described	describe	VBD
cord-023873-fidpskcs	82	3	two	two	CD
cord-023873-fidpskcs	82	4	patients	patient	NNS
cord-023873-fidpskcs	82	5	who	who	WP
cord-023873-fidpskcs	82	6	developed	develop	VBD
cord-023873-fidpskcs	82	7	fatal	fatal	JJ
cord-023873-fidpskcs	82	8	IA	IA	NNP
cord-023873-fidpskcs	82	9	in	in	IN
cord-023873-fidpskcs	82	10	the	the	DT
cord-023873-fidpskcs	82	11	ICU	ICU	NNP
cord-023873-fidpskcs	82	12	.	.	.
cord-023873-fidpskcs	83	1	In	in	IN
cord-023873-fidpskcs	83	2	retrospect	retrospect	JJ
cord-023873-fidpskcs	83	3	,	,	,
cord-023873-fidpskcs	83	4	high	high	JJ
cord-023873-fidpskcs	83	5	concentrations	concentration	NNS
cord-023873-fidpskcs	83	6	of	of	IN
cord-023873-fidpskcs	83	7	airborne	airborne	JJ
cord-023873-fidpskcs	83	8	Aspergillus	aspergillus	NN
cord-023873-fidpskcs	83	9	spores	spore	NNS
cord-023873-fidpskcs	83	10	could	could	MD
cord-023873-fidpskcs	83	11	be	be	VB
cord-023873-fidpskcs	83	12	found	find	VBN
cord-023873-fidpskcs	83	13	,	,	,
cord-023873-fidpskcs	83	14	closely	closely	RB
cord-023873-fidpskcs	83	15	related	relate	VBN
cord-023873-fidpskcs	83	16	to	to	IN
cord-023873-fidpskcs	83	17	air	air	NN
cord-023873-fidpskcs	83	18	filter	filter	NN
cord-023873-fidpskcs	83	19	change	change	NN
cord-023873-fidpskcs	83	20	in	in	IN
cord-023873-fidpskcs	83	21	the	the	DT
cord-023873-fidpskcs	83	22	ICU	ICU	NNP
cord-023873-fidpskcs	83	23	[	[	-LRB-
cord-023873-fidpskcs	83	24	23	23	CD
cord-023873-fidpskcs	83	25	]	]	-RRB-
cord-023873-fidpskcs	83	26	.	.	.
cord-023873-fidpskcs	84	1	Besides	besides	IN
cord-023873-fidpskcs	84	2	the	the	DT
cord-023873-fidpskcs	84	3	airborne	airborne	JJ
cord-023873-fidpskcs	84	4	route	route	NN
cord-023873-fidpskcs	84	5	,	,	,
cord-023873-fidpskcs	84	6	contaminated	contaminated	JJ
cord-023873-fidpskcs	84	7	water	water	NN
cord-023873-fidpskcs	84	8	has	have	VBZ
cord-023873-fidpskcs	84	9	been	be	VBN
cord-023873-fidpskcs	84	10	implicated	implicate	VBN
cord-023873-fidpskcs	84	11	as	as	IN
cord-023873-fidpskcs	84	12	a	a	DT
cord-023873-fidpskcs	84	13	source	source	NN
cord-023873-fidpskcs	84	14	of	of	IN
cord-023873-fidpskcs	84	15	infection	infection	NN
cord-023873-fidpskcs	84	16	[	[	-LRB-
cord-023873-fidpskcs	84	17	24	24	CD
cord-023873-fidpskcs	84	18	]	]	-RRB-
cord-023873-fidpskcs	84	19	.	.	.
cord-023873-fidpskcs	85	1	A	a	DT
cord-023873-fidpskcs	85	2	study	study	NN
cord-023873-fidpskcs	85	3	of	of	IN
cord-023873-fidpskcs	85	4	ventilators	ventilator	NNS
cord-023873-fidpskcs	85	5	as	as	IN
cord-023873-fidpskcs	85	6	a	a	DT
cord-023873-fidpskcs	85	7	source	source	NN
cord-023873-fidpskcs	85	8	of	of	IN
cord-023873-fidpskcs	85	9	infection	infection	NN
cord-023873-fidpskcs	85	10	has	have	VBZ
cord-023873-fidpskcs	85	11	not	not	RB
cord-023873-fidpskcs	85	12	been	be	VBN
cord-023873-fidpskcs	85	13	undertaken	undertake	VBN
cord-023873-fidpskcs	85	14	.	.	.
cord-023873-fidpskcs	86	1	Of	of	IN
cord-023873-fidpskcs	86	2	note	note	NN
cord-023873-fidpskcs	86	3	,	,	,
cord-023873-fidpskcs	86	4	the	the	DT
cord-023873-fidpskcs	86	5	development	development	NN
cord-023873-fidpskcs	86	6	of	of	IN
cord-023873-fidpskcs	86	7	IA	IA	NNP
cord-023873-fidpskcs	86	8	is	be	VBZ
cord-023873-fidpskcs	86	9	depends	depend	VBZ
cord-023873-fidpskcs	86	10	on	on	IN
cord-023873-fidpskcs	86	11	an	an	DT
cord-023873-fidpskcs	86	12	interplay	interplay	NN
cord-023873-fidpskcs	86	13	between	between	IN
cord-023873-fidpskcs	86	14	the	the	DT
cord-023873-fidpskcs	86	15	inoculating	inoculate	VBG
cord-023873-fidpskcs	86	16	dose	dose	NN
cord-023873-fidpskcs	86	17	,	,	,
cord-023873-fidpskcs	86	18	the	the	DT
cord-023873-fidpskcs	86	19	ability	ability	NN
cord-023873-fidpskcs	86	20	of	of	IN
cord-023873-fidpskcs	86	21	the	the	DT
cord-023873-fidpskcs	86	22	host	host	NN
cord-023873-fidpskcs	86	23	to	to	TO
cord-023873-fidpskcs	86	24	resist	resist	VB
cord-023873-fidpskcs	86	25	infection	infection	NN
cord-023873-fidpskcs	86	26	(	(	-LRB-
cord-023873-fidpskcs	86	27	which	which	WDT
cord-023873-fidpskcs	86	28	also	also	RB
cord-023873-fidpskcs	86	29	depends	depend	VBZ
cord-023873-fidpskcs	86	30	on	on	IN
cord-023873-fidpskcs	86	31	the	the	DT
cord-023873-fidpskcs	86	32	lung	lung	NN
cord-023873-fidpskcs	86	33	architecture	architecture	NN
cord-023873-fidpskcs	86	34	)	)	-RRB-
cord-023873-fidpskcs	86	35	and	and	CC
cord-023873-fidpskcs	86	36	the	the	DT
cord-023873-fidpskcs	86	37	virulence	virulence	NN
cord-023873-fidpskcs	86	38	of	of	IN
cord-023873-fidpskcs	86	39	the	the	DT
cord-023873-fidpskcs	86	40	infecting	infect	VBG
cord-023873-fidpskcs	86	41	organism	organism	NN
cord-023873-fidpskcs	86	42	.	.	.
cord-023873-fidpskcs	87	1	The	the	DT
cord-023873-fidpskcs	87	2	concept	concept	NN
cord-023873-fidpskcs	87	3	that	that	IN
cord-023873-fidpskcs	87	4	increasing	increase	VBG
cord-023873-fidpskcs	87	5	fungal	fungal	JJ
cord-023873-fidpskcs	87	6	burden	burden	NN
cord-023873-fidpskcs	87	7	due	due	JJ
cord-023873-fidpskcs	87	8	to	to	IN
cord-023873-fidpskcs	87	9	specific	specific	JJ
cord-023873-fidpskcs	87	10	ICU	ICU	NNP
cord-023873-fidpskcs	87	11	treatments	treatment	NNS
cord-023873-fidpskcs	87	12	for	for	IN
cord-023873-fidpskcs	87	13	other	other	JJ
cord-023873-fidpskcs	87	14	diseases	disease	NNS
cord-023873-fidpskcs	87	15	than	than	IN
cord-023873-fidpskcs	87	16	IA	IA	NNP
cord-023873-fidpskcs	88	1	(	(	-LRB-
cord-023873-fidpskcs	88	2	e.g.	e.g.	IN
cord-023873-fidpskcs	88	3	steroids	steroid	NNS
cord-023873-fidpskcs	88	4	for	for	IN
cord-023873-fidpskcs	88	5	septic	septic	JJ
cord-023873-fidpskcs	88	6	shock	shock	NN
cord-023873-fidpskcs	88	7	)	)	-RRB-
cord-023873-fidpskcs	88	8	parallels	parallel	VBZ
cord-023873-fidpskcs	88	9	the	the	DT
cord-023873-fidpskcs	88	10	progression	progression	NN
cord-023873-fidpskcs	88	11	from	from	IN
cord-023873-fidpskcs	88	12	subclinical	subclinical	JJ
cord-023873-fidpskcs	88	13	to	to	IN
cord-023873-fidpskcs	88	14	clinical	clinical	JJ
cord-023873-fidpskcs	88	15	aspergillosis	aspergillosis	NN
cord-023873-fidpskcs	88	16	,	,	,
cord-023873-fidpskcs	88	17	needs	need	VBZ
cord-023873-fidpskcs	88	18	to	to	TO
cord-023873-fidpskcs	88	19	be	be	VB
cord-023873-fidpskcs	88	20	explored	explore	VBN
cord-023873-fidpskcs	88	21	with	with	IN
cord-023873-fidpskcs	88	22	more	more	RBR
cord-023873-fidpskcs	88	23	sensitive	sensitive	JJ
cord-023873-fidpskcs	88	24	markers	marker	NNS
cord-023873-fidpskcs	88	25	(	(	-LRB-
cord-023873-fidpskcs	88	26	e.g.	e.g.	RB
cord-023873-fidpskcs	88	27	PCR	PCR	NNP
cord-023873-fidpskcs	88	28	)	)	-RRB-
cord-023873-fidpskcs	88	29	.	.	.
cord-023873-fidpskcs	89	1	PCR	PCR	NNP
cord-023873-fidpskcs	89	2	in	in	IN
cord-023873-fidpskcs	89	3	respiratory	respiratory	JJ
cord-023873-fidpskcs	89	4	secretions	secretion	NNS
cord-023873-fidpskcs	89	5	as	as	IN
cord-023873-fidpskcs	89	6	a	a	DT
cord-023873-fidpskcs	89	7	modality	modality	NN
cord-023873-fidpskcs	89	8	for	for	IN
cord-023873-fidpskcs	89	9	surveillance	surveillance	NN
cord-023873-fidpskcs	89	10	is	be	VBZ
cord-023873-fidpskcs	89	11	an	an	DT
cord-023873-fidpskcs	89	12	interesting	interesting	JJ
cord-023873-fidpskcs	89	13	topic	topic	NN
cord-023873-fidpskcs	89	14	for	for	IN
cord-023873-fidpskcs	89	15	research	research	NN
cord-023873-fidpskcs	89	16	.	.	.
cord-023873-fidpskcs	90	1	Generally	generally	RB
cord-023873-fidpskcs	90	2	speaking	speak	VBG
cord-023873-fidpskcs	90	3	,	,	,
cord-023873-fidpskcs	90	4	there	there	EX
cord-023873-fidpskcs	90	5	are	be	VBP
cord-023873-fidpskcs	90	6	types	type	NNS
cord-023873-fidpskcs	90	7	of	of	IN
cord-023873-fidpskcs	90	8	pulmonary	pulmonary	JJ
cord-023873-fidpskcs	90	9	interactions	interaction	NNS
cord-023873-fidpskcs	90	10	between	between	IN
cord-023873-fidpskcs	90	11	Aspergillus	aspergillus	NN
cord-023873-fidpskcs	90	12	species	specie	NNS
cord-023873-fidpskcs	90	13	and	and	CC
cord-023873-fidpskcs	90	14	humans	human	NNS
cord-023873-fidpskcs	90	15	.	.	.
cord-023873-fidpskcs	91	1	The	the	DT
cord-023873-fidpskcs	91	2	most	most	RBS
cord-023873-fidpskcs	91	3	frequent	frequent	JJ
cord-023873-fidpskcs	91	4	interaction	interaction	NN
cord-023873-fidpskcs	91	5	is	be	VBZ
cord-023873-fidpskcs	91	6	colonisation	colonisation	NN
cord-023873-fidpskcs	91	7	of	of	IN
cord-023873-fidpskcs	91	8	the	the	DT
cord-023873-fidpskcs	91	9	airways	airways	NNPS
cord-023873-fidpskcs	91	10	.	.	.
cord-023873-fidpskcs	92	1	This	this	DT
cord-023873-fidpskcs	92	2	can	can	MD
cord-023873-fidpskcs	92	3	be	be	VB
cord-023873-fidpskcs	92	4	present	present	JJ
cord-023873-fidpskcs	92	5	in	in	IN
cord-023873-fidpskcs	92	6	patients	patient	NNS
cord-023873-fidpskcs	92	7	with	with	IN
cord-023873-fidpskcs	92	8	defective	defective	JJ
cord-023873-fidpskcs	92	9	mucociliary	mucociliary	JJ
cord-023873-fidpskcs	92	10	clearance	clearance	NN
cord-023873-fidpskcs	92	11	and	and	CC
cord-023873-fidpskcs	92	12	structural	structural	JJ
cord-023873-fidpskcs	92	13	changes	change	NNS
cord-023873-fidpskcs	92	14	in	in	IN
cord-023873-fidpskcs	92	15	the	the	DT
cord-023873-fidpskcs	92	16	bronchial	bronchial	JJ
cord-023873-fidpskcs	92	17	wall	wall	NN
cord-023873-fidpskcs	92	18	.	.	.
cord-023873-fidpskcs	93	1	These	these	DT
cord-023873-fidpskcs	93	2	changes	change	NNS
cord-023873-fidpskcs	93	3	are	be	VBP
cord-023873-fidpskcs	93	4	present	present	JJ
cord-023873-fidpskcs	93	5	in	in	IN
cord-023873-fidpskcs	93	6	almost	almost	RB
cord-023873-fidpskcs	93	7	every	every	DT
cord-023873-fidpskcs	93	8	mechanically	mechanically	RB
cord-023873-fidpskcs	93	9	ventilated	ventilate	VBN
cord-023873-fidpskcs	93	10	patient	patient	NN
cord-023873-fidpskcs	93	11	,	,	,
cord-023873-fidpskcs	93	12	making	make	VBG
cord-023873-fidpskcs	93	13	them	-PRON-	PRP
cord-023873-fidpskcs	93	14	particularly	particularly	RB
cord-023873-fidpskcs	93	15	susceptible	susceptible	JJ
cord-023873-fidpskcs	93	16	to	to	IN
cord-023873-fidpskcs	93	17	colonisation	colonisation	NN
cord-023873-fidpskcs	93	18	.	.	.
cord-023873-fidpskcs	94	1	IA	IA	NNP
cord-023873-fidpskcs	94	2	will	will	MD
cord-023873-fidpskcs	94	3	not	not	RB
cord-023873-fidpskcs	94	4	develop	develop	VB
cord-023873-fidpskcs	94	5	in	in	IN
cord-023873-fidpskcs	94	6	these	these	DT
cord-023873-fidpskcs	94	7	patients	patient	NNS
cord-023873-fidpskcs	94	8	unless	unless	IN
cord-023873-fidpskcs	94	9	a	a	DT
cord-023873-fidpskcs	94	10	critical	critical	JJ
cord-023873-fidpskcs	94	11	level	level	NN
cord-023873-fidpskcs	94	12	of	of	IN
cord-023873-fidpskcs	94	13	immunodeficiency	immunodeficiency	NN
cord-023873-fidpskcs	94	14	has	have	VBZ
cord-023873-fidpskcs	94	15	been	be	VBN
cord-023873-fidpskcs	94	16	reached	reach	VBN
cord-023873-fidpskcs	94	17	.	.	.
cord-023873-fidpskcs	95	1	The	the	DT
cord-023873-fidpskcs	95	2	second	second	JJ
cord-023873-fidpskcs	95	3	type	type	NN
cord-023873-fidpskcs	95	4	of	of	IN
cord-023873-fidpskcs	95	5	interaction	interaction	NN
cord-023873-fidpskcs	95	6	is	be	VBZ
cord-023873-fidpskcs	95	7	allergic	allergic	JJ
cord-023873-fidpskcs	95	8	in	in	IN
cord-023873-fidpskcs	95	9	nature	nature	NN
cord-023873-fidpskcs	95	10	and	and	CC
cord-023873-fidpskcs	95	11	is	be	VBZ
cord-023873-fidpskcs	95	12	beyond	beyond	IN
cord-023873-fidpskcs	95	13	the	the	DT
cord-023873-fidpskcs	95	14	scope	scope	NN
cord-023873-fidpskcs	95	15	of	of	IN
cord-023873-fidpskcs	95	16	this	this	DT
cord-023873-fidpskcs	95	17	review	review	NN
cord-023873-fidpskcs	95	18	(	(	-LRB-
cord-023873-fidpskcs	95	19	these	these	DT
cord-023873-fidpskcs	95	20	are	be	VBP
cord-023873-fidpskcs	95	21	discussed	discuss	VBN
cord-023873-fidpskcs	95	22	in	in	IN
cord-023873-fidpskcs	95	23	other	other	JJ
cord-023873-fidpskcs	95	24	chapter	chapter	NN
cord-023873-fidpskcs	95	25	in	in	IN
cord-023873-fidpskcs	95	26	this	this	DT
cord-023873-fidpskcs	95	27	book	book	NN
cord-023873-fidpskcs	95	28	)	)	-RRB-
cord-023873-fidpskcs	95	29	.	.	.
cord-023873-fidpskcs	96	1	The	the	DT
cord-023873-fidpskcs	96	2	most	most	RBS
cord-023873-fidpskcs	96	3	relevant	relevant	JJ
cord-023873-fidpskcs	96	4	form	form	NN
cord-023873-fidpskcs	96	5	of	of	IN
cord-023873-fidpskcs	96	6	interaction	interaction	NN
cord-023873-fidpskcs	96	7	for	for	IN
cord-023873-fidpskcs	96	8	ICU	ICU	NNP
cord-023873-fidpskcs	96	9	physicians	physician	NNS
cord-023873-fidpskcs	96	10	is	be	VBZ
cord-023873-fidpskcs	96	11	the	the	DT
cord-023873-fidpskcs	96	12	invasive	invasive	JJ
cord-023873-fidpskcs	96	13	disease	disease	NN
cord-023873-fidpskcs	96	14	that	that	WDT
cord-023873-fidpskcs	96	15	develops	develop	VBZ
cord-023873-fidpskcs	96	16	in	in	IN
cord-023873-fidpskcs	96	17	persons	person	NNS
cord-023873-fidpskcs	96	18	with	with	IN
cord-023873-fidpskcs	96	19	impaired	impaired	JJ
cord-023873-fidpskcs	96	20	immunity	immunity	NN
cord-023873-fidpskcs	96	21	.	.	.
cord-023873-fidpskcs	97	1	The	the	DT
cord-023873-fidpskcs	97	2	aggressive	aggressive	JJ
cord-023873-fidpskcs	97	3	angioinvasive	angioinvasive	JJ
cord-023873-fidpskcs	97	4	form	form	NN
cord-023873-fidpskcs	97	5	is	be	VBZ
cord-023873-fidpskcs	97	6	frequently	frequently	RB
cord-023873-fidpskcs	97	7	encountered	encounter	VBN
cord-023873-fidpskcs	97	8	in	in	IN
cord-023873-fidpskcs	97	9	neutropenic	neutropenic	JJ
cord-023873-fidpskcs	97	10	patients	patient	NNS
cord-023873-fidpskcs	97	11	,	,	,
cord-023873-fidpskcs	97	12	whereas	whereas	IN
cord-023873-fidpskcs	97	13	cavitating	cavitating	JJ
cord-023873-fidpskcs	97	14	infiltrates	infiltrate	NNS
cord-023873-fidpskcs	97	15	are	be	VBP
cord-023873-fidpskcs	97	16	observed	observe	VBN
cord-023873-fidpskcs	97	17	most	most	RBS
cord-023873-fidpskcs	97	18	frequently	frequently	RB
cord-023873-fidpskcs	97	19	in	in	IN
cord-023873-fidpskcs	97	20	patients	patient	NNS
cord-023873-fidpskcs	97	21	on	on	IN
cord-023873-fidpskcs	97	22	steroids	steroid	NNS
cord-023873-fidpskcs	97	23	,	,	,
cord-023873-fidpskcs	97	24	patients	patient	NNS
cord-023873-fidpskcs	97	25	with	with	IN
cord-023873-fidpskcs	97	26	COPD	COPD	NNP
cord-023873-fidpskcs	97	27	,	,	,
cord-023873-fidpskcs	97	28	cirrhosis	cirrhosis	NN
cord-023873-fidpskcs	97	29	,	,	,
cord-023873-fidpskcs	97	30	and	and	CC
cord-023873-fidpskcs	97	31	solid	solid	JJ
cord-023873-fidpskcs	97	32	organ	organ	NN
cord-023873-fidpskcs	97	33	transplant	transplant	NN
cord-023873-fidpskcs	97	34	recipients	recipient	NNS
cord-023873-fidpskcs	97	35	.	.	.
cord-023873-fidpskcs	98	1	Other	other	JJ
cord-023873-fidpskcs	98	2	more	more	JJR
cord-023873-fidpskcs	98	3	rare	rare	JJ
cord-023873-fidpskcs	98	4	presentations	presentation	NNS
cord-023873-fidpskcs	98	5	include	include	VBP
cord-023873-fidpskcs	98	6	endocarditis	endocarditis	NN
cord-023873-fidpskcs	98	7	,	,	,
cord-023873-fidpskcs	98	8	wound	wound	NN
cord-023873-fidpskcs	98	9	infections	infection	NNS
cord-023873-fidpskcs	98	10	,	,	,
cord-023873-fidpskcs	98	11	mediastinitis	mediastinitis	NNP
cord-023873-fidpskcs	98	12	(	(	-LRB-
cord-023873-fidpskcs	98	13	post	post	JJ
cord-023873-fidpskcs	98	14	-	-	JJ
cord-023873-fidpskcs	98	15	cardiac	cardiac	JJ
cord-023873-fidpskcs	98	16	surgery	surgery	NN
cord-023873-fidpskcs	98	17	)	)	-RRB-
cord-023873-fidpskcs	98	18	,	,	,
cord-023873-fidpskcs	98	19	infection	infection	NN
cord-023873-fidpskcs	98	20	of	of	IN
cord-023873-fidpskcs	98	21	vascular	vascular	JJ
cord-023873-fidpskcs	98	22	grafts	graft	NNS
cord-023873-fidpskcs	98	23	,	,	,
cord-023873-fidpskcs	98	24	and	and	CC
cord-023873-fidpskcs	98	25	osteomyelitis	osteomyelitis	NN
cord-023873-fidpskcs	98	26	.	.	.
cord-023873-fidpskcs	99	1	These	these	DT
cord-023873-fidpskcs	99	2	are	be	VBP
cord-023873-fidpskcs	99	3	occasionally	occasionally	RB
cord-023873-fidpskcs	99	4	a	a	DT
cord-023873-fidpskcs	99	5	problem	problem	NN
cord-023873-fidpskcs	99	6	in	in	IN
cord-023873-fidpskcs	99	7	immunocompromised	immunocompromised	JJ
cord-023873-fidpskcs	99	8	patients	patient	NNS
cord-023873-fidpskcs	99	9	and	and	CC
cord-023873-fidpskcs	99	10	may	may	MD
cord-023873-fidpskcs	99	11	occur	occur	VB
cord-023873-fidpskcs	99	12	as	as	IN
cord-023873-fidpskcs	99	13	outbreaks	outbreak	NNS
cord-023873-fidpskcs	99	14	.	.	.
cord-023873-fidpskcs	100	1	Infection	infection	NN
cord-023873-fidpskcs	100	2	of	of	IN
cord-023873-fidpskcs	100	3	the	the	DT
cord-023873-fidpskcs	100	4	central	central	JJ
cord-023873-fidpskcs	100	5	nervous	nervous	JJ
cord-023873-fidpskcs	100	6	system	system	NN
cord-023873-fidpskcs	100	7	is	be	VBZ
cord-023873-fidpskcs	100	8	frequently	frequently	RB
cord-023873-fidpskcs	100	9	an	an	DT
cord-023873-fidpskcs	100	10	ominous	ominous	JJ
cord-023873-fidpskcs	100	11	sign	sign	NN
cord-023873-fidpskcs	100	12	and	and	CC
cord-023873-fidpskcs	100	13	may	may	MD
cord-023873-fidpskcs	100	14	arise	arise	VB
cord-023873-fidpskcs	100	15	from	from	IN
cord-023873-fidpskcs	100	16	haematogenous	haematogenous	JJ
cord-023873-fidpskcs	100	17	seeding	seeding	NN
cord-023873-fidpskcs	100	18	(	(	-LRB-
cord-023873-fidpskcs	100	19	in	in	IN
cord-023873-fidpskcs	100	20	which	which	WDT
cord-023873-fidpskcs	100	21	the	the	DT
cord-023873-fidpskcs	100	22	lung	lung	NN
cord-023873-fidpskcs	100	23	is	be	VBZ
cord-023873-fidpskcs	100	24	the	the	DT
cord-023873-fidpskcs	100	25	most	most	RBS
cord-023873-fidpskcs	100	26	common	common	JJ
cord-023873-fidpskcs	100	27	primary	primary	JJ
cord-023873-fidpskcs	100	28	site	site	NN
cord-023873-fidpskcs	100	29	)	)	-RRB-
cord-023873-fidpskcs	100	30	or	or	CC
cord-023873-fidpskcs	100	31	spread	spread	VBD
cord-023873-fidpskcs	100	32	from	from	IN
cord-023873-fidpskcs	100	33	the	the	DT
cord-023873-fidpskcs	100	34	sinuses	sinus	NNS
cord-023873-fidpskcs	100	35	or	or	CC
cord-023873-fidpskcs	100	36	following	follow	VBG
cord-023873-fidpskcs	100	37	neurosurgery	neurosurgery	NNP
cord-023873-fidpskcs	100	38	.	.	.
cord-023873-fidpskcs	101	1	The	the	DT
cord-023873-fidpskcs	101	2	pathogenesis	pathogenesis	NN
cord-023873-fidpskcs	101	3	of	of	IN
cord-023873-fidpskcs	101	4	IA	IA	NNP
cord-023873-fidpskcs	101	5	in	in	IN
cord-023873-fidpskcs	101	6	steroid	steroid	NN
cord-023873-fidpskcs	101	7	-	-	HYPH
cord-023873-fidpskcs	101	8	immunosuppressed	immunosuppressed	JJ
cord-023873-fidpskcs	101	9	patients	patient	NNS
cord-023873-fidpskcs	101	10	differs	differ	VBZ
cord-023873-fidpskcs	101	11	greatly	greatly	RB
cord-023873-fidpskcs	101	12	from	from	IN
cord-023873-fidpskcs	101	13	that	that	DT
cord-023873-fidpskcs	101	14	in	in	IN
cord-023873-fidpskcs	101	15	neutropenic	neutropenic	JJ
cord-023873-fidpskcs	101	16	patients	patient	NNS
cord-023873-fidpskcs	101	17	.	.	.
cord-023873-fidpskcs	102	1	Data	datum	NNS
cord-023873-fidpskcs	102	2	demonstrate	demonstrate	VBP
cord-023873-fidpskcs	102	3	that	that	IN
cord-023873-fidpskcs	102	4	the	the	DT
cord-023873-fidpskcs	102	5	pathological	pathological	JJ
cord-023873-fidpskcs	102	6	lesions	lesion	NNS
cord-023873-fidpskcs	102	7	are	be	VBP
cord-023873-fidpskcs	102	8	often	often	RB
cord-023873-fidpskcs	102	9	widespread	widespread	JJ
cord-023873-fidpskcs	102	10	and	and	CC
cord-023873-fidpskcs	102	11	that	that	DT
cord-023873-fidpskcs	102	12	death	death	NN
cord-023873-fidpskcs	102	13	is	be	VBZ
cord-023873-fidpskcs	102	14	related	relate	VBN
cord-023873-fidpskcs	102	15	to	to	IN
cord-023873-fidpskcs	102	16	a	a	DT
cord-023873-fidpskcs	102	17	high	high	JJ
cord-023873-fidpskcs	102	18	fungal	fungal	NN
cord-023873-fidpskcs	102	19	burden	burden	NN
cord-023873-fidpskcs	102	20	in	in	IN
cord-023873-fidpskcs	102	21	neutropenic	neutropenic	JJ
cord-023873-fidpskcs	102	22	animals	animal	NNS
cord-023873-fidpskcs	102	23	,	,	,
cord-023873-fidpskcs	102	24	while	while	IN
cord-023873-fidpskcs	102	25	the	the	DT
cord-023873-fidpskcs	102	26	pathogenesis	pathogenesis	NN
cord-023873-fidpskcs	102	27	in	in	IN
cord-023873-fidpskcs	102	28	non	non	JJ
cord-023873-fidpskcs	102	29	-	-	JJ
cord-023873-fidpskcs	102	30	neutropenic	neutropenic	JJ
cord-023873-fidpskcs	102	31	,	,	,
cord-023873-fidpskcs	102	32	steroid	steroid	NN
cord-023873-fidpskcs	102	33	-	-	HYPH
cord-023873-fidpskcs	102	34	treated	treat	VBN
cord-023873-fidpskcs	102	35	animals	animal	NNS
cord-023873-fidpskcs	102	36	is	be	VBZ
cord-023873-fidpskcs	102	37	driven	drive	VBN
cord-023873-fidpskcs	102	38	by	by	IN
cord-023873-fidpskcs	102	39	an	an	DT
cord-023873-fidpskcs	102	40	adverse	adverse	JJ
cord-023873-fidpskcs	102	41	inflammatory	inflammatory	JJ
cord-023873-fidpskcs	102	42	host	host	NN
cord-023873-fidpskcs	102	43	response	response	NN
cord-023873-fidpskcs	102	44	,	,	,
cord-023873-fidpskcs	102	45	frequently	frequently	RB
cord-023873-fidpskcs	102	46	confined	confine	VBN
cord-023873-fidpskcs	102	47	to	to	IN
cord-023873-fidpskcs	102	48	the	the	DT
cord-023873-fidpskcs	102	49	lungs	lung	NNS
cord-023873-fidpskcs	102	50	,	,	,
cord-023873-fidpskcs	102	51	with	with	IN
cord-023873-fidpskcs	102	52	a	a	DT
cord-023873-fidpskcs	102	53	low	low	JJ
cord-023873-fidpskcs	102	54	fungal	fungal	JJ
cord-023873-fidpskcs	102	55	burden	burden	NN
cord-023873-fidpskcs	102	56	in	in	IN
cord-023873-fidpskcs	102	57	the	the	DT
cord-023873-fidpskcs	102	58	lung	lung	NN
cord-023873-fidpskcs	102	59	parenchyma	parenchyma	NN
cord-023873-fidpskcs	102	60	and	and	CC
cord-023873-fidpskcs	102	61	other	other	JJ
cord-023873-fidpskcs	102	62	organs	organ	NNS
cord-023873-fidpskcs	102	63	[	[	-LRB-
cord-023873-fidpskcs	102	64	25	25	CD
cord-023873-fidpskcs	102	65	,	,	,
cord-023873-fidpskcs	102	66	26	26	CD
cord-023873-fidpskcs	102	67	]	]	-RRB-
cord-023873-fidpskcs	102	68	.	.	.
cord-023873-fidpskcs	103	1	The	the	DT
cord-023873-fidpskcs	103	2	reader	reader	NN
cord-023873-fidpskcs	103	3	is	be	VBZ
cord-023873-fidpskcs	103	4	referred	refer	VBN
cord-023873-fidpskcs	103	5	to	to	IN
cord-023873-fidpskcs	103	6	the	the	DT
cord-023873-fidpskcs	103	7	chapter	chapter	NN
cord-023873-fidpskcs	103	8	by	by	IN
cord-023873-fidpskcs	103	9	Drs	Drs	NNP
cord-023873-fidpskcs	103	10	Ben	Ben	NNP
cord-023873-fidpskcs	103	11	-	-	HYPH
cord-023873-fidpskcs	103	12	Ami	Ami	NNP
cord-023873-fidpskcs	103	13	and	and	CC
cord-023873-fidpskcs	103	14	Kontoyiannis	Kontoyiannis	NNP
cord-023873-fidpskcs	103	15	for	for	IN
cord-023873-fidpskcs	103	16	more	more	JJR
cord-023873-fidpskcs	103	17	detail	detail	NN
cord-023873-fidpskcs	103	18	on	on	IN
cord-023873-fidpskcs	103	19	the	the	DT
cord-023873-fidpskcs	103	20	pathogenesis	pathogenesis	NN
cord-023873-fidpskcs	103	21	of	of	IN
cord-023873-fidpskcs	103	22	IA	IA	NNP
cord-023873-fidpskcs	103	23	.	.	.
cord-023873-fidpskcs	104	1	Clinical	clinical	JJ
cord-023873-fidpskcs	104	2	signs	sign	NNS
cord-023873-fidpskcs	104	3	are	be	VBP
cord-023873-fidpskcs	104	4	usually	usually	RB
cord-023873-fidpskcs	104	5	non	non	JJ
cord-023873-fidpskcs	104	6	-	-	JJ
cord-023873-fidpskcs	104	7	specific	specific	JJ
cord-023873-fidpskcs	104	8	and	and	CC
cord-023873-fidpskcs	104	9	do	do	VBP
cord-023873-fidpskcs	104	10	not	not	RB
cord-023873-fidpskcs	104	11	necessarily	necessarily	RB
cord-023873-fidpskcs	104	12	differ	differ	VB
cord-023873-fidpskcs	104	13	from	from	IN
cord-023873-fidpskcs	104	14	other	other	JJ
cord-023873-fidpskcs	104	15	causes	cause	NNS
cord-023873-fidpskcs	104	16	of	of	IN
cord-023873-fidpskcs	104	17	nosocomial	nosocomial	JJ
cord-023873-fidpskcs	104	18	pneumonia	pneumonia	NN
cord-023873-fidpskcs	104	19	.	.	.
cord-023873-fidpskcs	105	1	In	in	IN
cord-023873-fidpskcs	105	2	addition	addition	NN
cord-023873-fidpskcs	105	3	,	,	,
cord-023873-fidpskcs	105	4	critically	critically	RB
cord-023873-fidpskcs	105	5	ill	ill	JJ
cord-023873-fidpskcs	105	6	patients	patient	NNS
cord-023873-fidpskcs	105	7	with	with	IN
cord-023873-fidpskcs	105	8	prolonged	prolonged	JJ
cord-023873-fidpskcs	105	9	stays	stay	NNS
cord-023873-fidpskcs	105	10	in	in	IN
cord-023873-fidpskcs	105	11	the	the	DT
cord-023873-fidpskcs	105	12	ICU	ICU	NNP
cord-023873-fidpskcs	105	13	often	often	RB
cord-023873-fidpskcs	105	14	develop	develop	VBP
cord-023873-fidpskcs	105	15	pulmonary	pulmonary	JJ
cord-023873-fidpskcs	105	16	infiltrates	infiltrate	NNS
cord-023873-fidpskcs	105	17	,	,	,
cord-023873-fidpskcs	105	18	atelectasis	atelectasis	NN
cord-023873-fidpskcs	105	19	and/or	and/or	CC
cord-023873-fidpskcs	105	20	acute	acute	JJ
cord-023873-fidpskcs	105	21	respiratory	respiratory	JJ
cord-023873-fidpskcs	105	22	distress	distress	NN
cord-023873-fidpskcs	105	23	syndrome	syndrome	NN
cord-023873-fidpskcs	105	24	(	(	-LRB-
cord-023873-fidpskcs	105	25	ARDS	ARDS	NNP
cord-023873-fidpskcs	105	26	)	)	-RRB-
cord-023873-fidpskcs	105	27	,	,	,
cord-023873-fidpskcs	105	28	whereas	whereas	IN
cord-023873-fidpskcs	105	29	patients	patient	NNS
cord-023873-fidpskcs	105	30	with	with	IN
cord-023873-fidpskcs	105	31	prior	prior	JJ
cord-023873-fidpskcs	105	32	lung	lung	NN
cord-023873-fidpskcs	105	33	disease	disease	NN
cord-023873-fidpskcs	105	34	(	(	-LRB-
cord-023873-fidpskcs	105	35	e.g.	e.g.	RB
cord-023873-fidpskcs	105	36	COPD	COPD	NNP
cord-023873-fidpskcs	105	37	)	)	-RRB-
cord-023873-fidpskcs	105	38	may	may	MD
cord-023873-fidpskcs	105	39	present	present	VB
cord-023873-fidpskcs	105	40	with	with	IN
cord-023873-fidpskcs	105	41	pre	pre	JJ
cord-023873-fidpskcs	105	42	-	-	JJ
cord-023873-fidpskcs	105	43	existing	existing	JJ
cord-023873-fidpskcs	105	44	cavities	cavity	NNS
cord-023873-fidpskcs	105	45	on	on	IN
cord-023873-fidpskcs	105	46	conventional	conventional	JJ
cord-023873-fidpskcs	105	47	chest	chest	NN
cord-023873-fidpskcs	105	48	radiographs	radiograph	NNS
cord-023873-fidpskcs	105	49	(	(	-LRB-
cord-023873-fidpskcs	105	50	Fig	fig	NN
cord-023873-fidpskcs	105	51	.	.	.
cord-023873-fidpskcs	105	52	1	1	CD
cord-023873-fidpskcs	105	53	)	)	-RRB-
cord-023873-fidpskcs	105	54	.	.	.
cord-023873-fidpskcs	106	1	Fig	fig	NN
cord-023873-fidpskcs	106	2	.	.	.
cord-023873-fidpskcs	106	3	1	1	CD
cord-023873-fidpskcs	107	1	Chest	chest	NN
cord-023873-fidpskcs	107	2	X	x	NN
cord-023873-fidpskcs	107	3	-	-	NN
cord-023873-fidpskcs	107	4	ray	ray	NN
cord-023873-fidpskcs	107	5	from	from	IN
cord-023873-fidpskcs	107	6	a	a	DT
cord-023873-fidpskcs	107	7	COPD	COPD	NNP
cord-023873-fidpskcs	107	8	patient	patient	NN
cord-023873-fidpskcs	107	9	on	on	IN
cord-023873-fidpskcs	107	10	steroids	steroid	NNS
cord-023873-fidpskcs	107	11	,	,	,
cord-023873-fidpskcs	107	12	admitted	admit	VBN
cord-023873-fidpskcs	107	13	to	to	IN
cord-023873-fidpskcs	107	14	the	the	DT
cord-023873-fidpskcs	107	15	ICU	ICU	NNP
cord-023873-fidpskcs	107	16	because	because	IN
cord-023873-fidpskcs	107	17	of	of	IN
cord-023873-fidpskcs	107	18	an	an	DT
cord-023873-fidpskcs	107	19	exacerbation	exacerbation	NN
cord-023873-fidpskcs	107	20	with	with	IN
cord-023873-fidpskcs	107	21	respiratory	respiratory	JJ
cord-023873-fidpskcs	107	22	failure	failure	NN
cord-023873-fidpskcs	107	23	.	.	.
cord-023873-fidpskcs	108	1	Patchy	patchy	JJ
cord-023873-fidpskcs	108	2	,	,	,
cord-023873-fidpskcs	108	3	hazy	hazy	JJ
cord-023873-fidpskcs	108	4	infiltrates	infiltrate	VBZ
cord-023873-fidpskcs	108	5	with	with	IN
cord-023873-fidpskcs	108	6	predominantly	predominantly	RB
cord-023873-fidpskcs	108	7	a	a	DT
cord-023873-fidpskcs	108	8	peripheral	peripheral	JJ
cord-023873-fidpskcs	108	9	localisation	localisation	NN
cord-023873-fidpskcs	108	10	and	and	CC
cord-023873-fidpskcs	108	11	a	a	DT
cord-023873-fidpskcs	108	12	right	right	JJ
cord-023873-fidpskcs	108	13	sided	sided	JJ
cord-023873-fidpskcs	108	14	pleural	pleural	JJ
cord-023873-fidpskcs	108	15	effusion	effusion	NN
cord-023873-fidpskcs	108	16	were	be	VBD
cord-023873-fidpskcs	108	17	seen	see	VBN
cord-023873-fidpskcs	108	18	.	.	.
cord-023873-fidpskcs	109	1	BAL	bal	NN
cord-023873-fidpskcs	109	2	culture	culture	NN
cord-023873-fidpskcs	109	3	was	be	VBD
cord-023873-fidpskcs	109	4	positive	positive	JJ
cord-023873-fidpskcs	109	5	for	for	IN
cord-023873-fidpskcs	109	6	Haemophilus	haemophilus	JJ
cord-023873-fidpskcs	109	7	influenzae	influenzae	NN
cord-023873-fidpskcs	109	8	and	and	CC
cord-023873-fidpskcs	109	9	negative	negative	JJ
cord-023873-fidpskcs	109	10	for	for	IN
cord-023873-fidpskcs	109	11	fungi	fungus	NNS
cord-023873-fidpskcs	109	12	.	.	.
cord-023873-fidpskcs	110	1	Serum	serum	NN
cord-023873-fidpskcs	110	2	galactomannan	galactomannan	NNP
cord-023873-fidpskcs	110	3	was	be	VBD
cord-023873-fidpskcs	110	4	negative	negative	JJ
cord-023873-fidpskcs	110	5	but	but	CC
cord-023873-fidpskcs	110	6	showed	show	VBD
cord-023873-fidpskcs	110	7	a	a	DT
cord-023873-fidpskcs	110	8	value	value	NN
cord-023873-fidpskcs	110	9	of	of	IN
cord-023873-fidpskcs	110	10	2.6	2.6	CD
cord-023873-fidpskcs	110	11	ng	ng	NNP
cord-023873-fidpskcs	110	12	/	/	SYM
cord-023873-fidpskcs	110	13	ml	ml	XX
cord-023873-fidpskcs	110	14	in	in	IN
cord-023873-fidpskcs	110	15	the	the	DT
cord-023873-fidpskcs	110	16	BAL	bal	NN
cord-023873-fidpskcs	110	17	fluid	fluid	NN
cord-023873-fidpskcs	110	18	.	.	.
cord-023873-fidpskcs	111	1	Despite	despite	IN
cord-023873-fidpskcs	111	2	treatment	treatment	NN
cord-023873-fidpskcs	111	3	with	with	IN
cord-023873-fidpskcs	111	4	caspofungin	caspofungin	NNP
cord-023873-fidpskcs	111	5	(	(	-LRB-
cord-023873-fidpskcs	111	6	patient	patient	NN
cord-023873-fidpskcs	111	7	was	be	VBD
cord-023873-fidpskcs	111	8	in	in	IN
cord-023873-fidpskcs	111	9	renal	renal	JJ
cord-023873-fidpskcs	111	10	failure	failure	NN
cord-023873-fidpskcs	111	11	)	)	-RRB-
cord-023873-fidpskcs	111	12	,	,	,
cord-023873-fidpskcs	111	13	he	-PRON-	PRP
cord-023873-fidpskcs	111	14	died	die	VBD
cord-023873-fidpskcs	111	15	and	and	CC
cord-023873-fidpskcs	111	16	autopsy	autopsy	NN
cord-023873-fidpskcs	111	17	showed	show	VBD
cord-023873-fidpskcs	111	18	invasive	invasive	JJ
cord-023873-fidpskcs	111	19	aspergillosis	aspergillosis	NN
cord-023873-fidpskcs	111	20	,	,	,
cord-023873-fidpskcs	111	21	confined	confine	VBN
cord-023873-fidpskcs	111	22	to	to	IN
cord-023873-fidpskcs	111	23	the	the	DT
cord-023873-fidpskcs	111	24	lungs	lung	NNS
cord-023873-fidpskcs	111	25	Making	make	VBG
cord-023873-fidpskcs	111	26	a	a	DT
cord-023873-fidpskcs	111	27	timely	timely	JJ
cord-023873-fidpskcs	111	28	diagnosis	diagnosis	NN
cord-023873-fidpskcs	111	29	of	of	IN
cord-023873-fidpskcs	111	30	IA	IA	NNP
cord-023873-fidpskcs	111	31	in	in	IN
cord-023873-fidpskcs	111	32	the	the	DT
cord-023873-fidpskcs	111	33	ICU	ICU	NNP
cord-023873-fidpskcs	111	34	population	population	NN
cord-023873-fidpskcs	111	35	is	be	VBZ
cord-023873-fidpskcs	111	36	probably	probably	RB
cord-023873-fidpskcs	111	37	even	even	RB
cord-023873-fidpskcs	111	38	more	more	RBR
cord-023873-fidpskcs	111	39	challenging	challenging	JJ
cord-023873-fidpskcs	111	40	than	than	IN
cord-023873-fidpskcs	111	41	establishing	establish	VBG
cord-023873-fidpskcs	111	42	an	an	DT
cord-023873-fidpskcs	111	43	early	early	JJ
cord-023873-fidpskcs	111	44	diagnosis	diagnosis	NN
cord-023873-fidpskcs	111	45	in	in	IN
cord-023873-fidpskcs	111	46	patients	patient	NNS
cord-023873-fidpskcs	111	47	with	with	IN
cord-023873-fidpskcs	111	48	haematological	haematological	JJ
cord-023873-fidpskcs	111	49	disease	disease	NN
cord-023873-fidpskcs	111	50	,	,	,
cord-023873-fidpskcs	111	51	basically	basically	RB
cord-023873-fidpskcs	111	52	because	because	IN
cord-023873-fidpskcs	111	53	the	the	DT
cord-023873-fidpskcs	111	54	index	index	NN
cord-023873-fidpskcs	111	55	of	of	IN
cord-023873-fidpskcs	111	56	suspicion	suspicion	NN
cord-023873-fidpskcs	111	57	is	be	VBZ
cord-023873-fidpskcs	111	58	lower	low	JJR
cord-023873-fidpskcs	111	59	since	since	IN
cord-023873-fidpskcs	111	60	most	most	JJS
cord-023873-fidpskcs	111	61	patients	patient	NNS
cord-023873-fidpskcs	111	62	do	do	VBP
cord-023873-fidpskcs	111	63	not	not	RB
cord-023873-fidpskcs	111	64	belong	belong	VB
cord-023873-fidpskcs	111	65	to	to	IN
cord-023873-fidpskcs	111	66	one	one	CD
cord-023873-fidpskcs	111	67	of	of	IN
cord-023873-fidpskcs	111	68	the	the	DT
cord-023873-fidpskcs	111	69	well	well	RB
cord-023873-fidpskcs	111	70	-	-	HYPH
cord-023873-fidpskcs	111	71	established	establish	VBN
cord-023873-fidpskcs	111	72	risk	risk	NN
cord-023873-fidpskcs	111	73	groups	group	NNS
cord-023873-fidpskcs	111	74	.	.	.
cord-023873-fidpskcs	112	1	Moreover	moreover	RB
cord-023873-fidpskcs	112	2	,	,	,
cord-023873-fidpskcs	112	3	the	the	DT
cord-023873-fidpskcs	112	4	diagnostic	diagnostic	JJ
cord-023873-fidpskcs	112	5	tools	tool	NNS
cord-023873-fidpskcs	112	6	were	be	VBD
cord-023873-fidpskcs	112	7	mainly	mainly	RB
cord-023873-fidpskcs	112	8	developed	develop	VBN
cord-023873-fidpskcs	112	9	in	in	IN
cord-023873-fidpskcs	112	10	haematological	haematological	JJ
cord-023873-fidpskcs	112	11	patients	patient	NNS
cord-023873-fidpskcs	112	12	.	.	.
cord-023873-fidpskcs	113	1	In	in	IN
cord-023873-fidpskcs	113	2	general	general	JJ
cord-023873-fidpskcs	113	3	,	,	,
cord-023873-fidpskcs	113	4	the	the	DT
cord-023873-fidpskcs	113	5	diagnosis	diagnosis	NN
cord-023873-fidpskcs	113	6	is	be	VBZ
cord-023873-fidpskcs	113	7	based	base	VBN
cord-023873-fidpskcs	113	8	on	on	IN
cord-023873-fidpskcs	113	9	a	a	DT
cord-023873-fidpskcs	113	10	combination	combination	NN
cord-023873-fidpskcs	113	11	of	of	IN
cord-023873-fidpskcs	113	12	compatible	compatible	JJ
cord-023873-fidpskcs	113	13	clinical	clinical	JJ
cord-023873-fidpskcs	113	14	findings	finding	NNS
cord-023873-fidpskcs	113	15	,	,	,
cord-023873-fidpskcs	113	16	radiological	radiological	JJ
cord-023873-fidpskcs	113	17	abnormalities	abnormality	NNS
cord-023873-fidpskcs	113	18	,	,	,
cord-023873-fidpskcs	113	19	and	and	CC
cord-023873-fidpskcs	113	20	microbiological	microbiological	JJ
cord-023873-fidpskcs	113	21	confirmation	confirmation	NN
cord-023873-fidpskcs	113	22	or	or	CC
cord-023873-fidpskcs	113	23	on	on	IN
cord-023873-fidpskcs	113	24	the	the	DT
cord-023873-fidpskcs	113	25	histological	histological	JJ
cord-023873-fidpskcs	113	26	proof	proof	NN
cord-023873-fidpskcs	113	27	of	of	IN
cord-023873-fidpskcs	113	28	tissue	tissue	NN
cord-023873-fidpskcs	113	29	invasion	invasion	NN
cord-023873-fidpskcs	113	30	by	by	IN
cord-023873-fidpskcs	113	31	the	the	DT
cord-023873-fidpskcs	113	32	fungus	fungus	NN
cord-023873-fidpskcs	113	33	.	.	.
cord-023873-fidpskcs	114	1	Table	table	NN
cord-023873-fidpskcs	114	2	3	3	CD
cord-023873-fidpskcs	114	3	gives	give	VBZ
cord-023873-fidpskcs	114	4	an	an	DT
cord-023873-fidpskcs	114	5	overview	overview	NN
cord-023873-fidpskcs	114	6	of	of	IN
cord-023873-fidpskcs	114	7	the	the	DT
cord-023873-fidpskcs	114	8	available	available	JJ
cord-023873-fidpskcs	114	9	diagnostic	diagnostic	JJ
cord-023873-fidpskcs	114	10	tools	tool	NNS
cord-023873-fidpskcs	114	11	.	.	.
cord-023873-fidpskcs	115	1	Over	over	IN
cord-023873-fidpskcs	115	2	the	the	DT
cord-023873-fidpskcs	115	3	past	past	JJ
cord-023873-fidpskcs	115	4	few	few	JJ
cord-023873-fidpskcs	115	5	years	year	NNS
cord-023873-fidpskcs	115	6	,	,	,
cord-023873-fidpskcs	115	7	lung	lung	NN
cord-023873-fidpskcs	115	8	computed	compute	VBD
cord-023873-fidpskcs	115	9	tomography	tomography	NN
cord-023873-fidpskcs	115	10	(	(	-LRB-
cord-023873-fidpskcs	115	11	CT	CT	NNP
cord-023873-fidpskcs	115	12	)	)	-RRB-
cord-023873-fidpskcs	115	13	scan	scan	NN
cord-023873-fidpskcs	115	14	has	have	VBZ
cord-023873-fidpskcs	115	15	become	become	VBN
cord-023873-fidpskcs	115	16	one	one	CD
cord-023873-fidpskcs	115	17	of	of	IN
cord-023873-fidpskcs	115	18	the	the	DT
cord-023873-fidpskcs	115	19	most	most	RBS
cord-023873-fidpskcs	115	20	important	important	JJ
cord-023873-fidpskcs	115	21	tools	tool	NNS
cord-023873-fidpskcs	115	22	for	for	IN
cord-023873-fidpskcs	115	23	the	the	DT
cord-023873-fidpskcs	115	24	diagnosis	diagnosis	NN
cord-023873-fidpskcs	115	25	of	of	IN
cord-023873-fidpskcs	115	26	IA	IA	NNP
cord-023873-fidpskcs	115	27	[	[	-LRB-
cord-023873-fidpskcs	115	28	27	27	CD
cord-023873-fidpskcs	115	29	]	]	-RRB-
cord-023873-fidpskcs	115	30	.	.	.
cord-023873-fidpskcs	116	1	Virtually	virtually	RB
cord-023873-fidpskcs	116	2	diagnostic	diagnostic	JJ
cord-023873-fidpskcs	116	3	signs	sign	NNS
cord-023873-fidpskcs	116	4	for	for	IN
cord-023873-fidpskcs	116	5	angioinvasive	angioinvasive	JJ
cord-023873-fidpskcs	116	6	pulmonary	pulmonary	NNP
cord-023873-fidpskcs	116	7	mycosis	mycosis	NNP
cord-023873-fidpskcs	116	8	-not	-not	:
cord-023873-fidpskcs	116	9	only	only	RB
cord-023873-fidpskcs	116	10	due	due	IN
cord-023873-fidpskcs	116	11	to	to	IN
cord-023873-fidpskcs	116	12	aspergillosis	aspergillosis	NNP
cord-023873-fidpskcs	117	1	but	but	CC
cord-023873-fidpskcs	117	2	occasionally	occasionally	RB
cord-023873-fidpskcs	117	3	also	also	RB
cord-023873-fidpskcs	117	4	due	due	JJ
cord-023873-fidpskcs	117	5	to	to	IN
cord-023873-fidpskcs	117	6	zygomycosis	zygomycosis	NNP
cord-023873-fidpskcs	117	7	as	as	RB
cord-023873-fidpskcs	117	8	well	well	RB
cord-023873-fidpskcs	117	9	as	as	IN
cord-023873-fidpskcs	117	10	other	other	JJ
cord-023873-fidpskcs	117	11	vascular	vascular	JJ
cord-023873-fidpskcs	117	12	conditions	condition	NNS
cord-023873-fidpskcs	118	1	-include	-include	:
cord-023873-fidpskcs	118	2	single	single	JJ
cord-023873-fidpskcs	118	3	or	or	CC
cord-023873-fidpskcs	118	4	multiple	multiple	JJ
cord-023873-fidpskcs	118	5	small	small	JJ
cord-023873-fidpskcs	118	6	nodules	nodule	NNS
cord-023873-fidpskcs	118	7	with	with	IN
cord-023873-fidpskcs	118	8	a	a	DT
cord-023873-fidpskcs	118	9	"	"	``
cord-023873-fidpskcs	118	10	halo	halo	NN
cord-023873-fidpskcs	118	11	"	"	''
cord-023873-fidpskcs	118	12	sign	sign	NN
cord-023873-fidpskcs	118	13	.	.	.
cord-023873-fidpskcs	119	1	It	-PRON-	PRP
cord-023873-fidpskcs	119	2	should	should	MD
cord-023873-fidpskcs	119	3	be	be	VB
cord-023873-fidpskcs	119	4	recognized	recognize	VBN
cord-023873-fidpskcs	119	5	that	that	IN
cord-023873-fidpskcs	119	6	the	the	DT
cord-023873-fidpskcs	119	7	utility	utility	NN
cord-023873-fidpskcs	119	8	of	of	IN
cord-023873-fidpskcs	119	9	this	this	DT
cord-023873-fidpskcs	119	10	sign	sign	NN
cord-023873-fidpskcs	119	11	has	have	VBZ
cord-023873-fidpskcs	119	12	been	be	VBN
cord-023873-fidpskcs	119	13	evaluated	evaluate	VBN
cord-023873-fidpskcs	119	14	almost	almost	RB
cord-023873-fidpskcs	119	15	exclusively	exclusively	RB
cord-023873-fidpskcs	119	16	in	in	IN
cord-023873-fidpskcs	119	17	neutropenic	neutropenic	JJ
cord-023873-fidpskcs	119	18	patients	patient	NNS
cord-023873-fidpskcs	119	19	.	.	.
cord-023873-fidpskcs	120	1	In	in	IN
cord-023873-fidpskcs	120	2	other	other	JJ
cord-023873-fidpskcs	120	3	groups	group	NNS
cord-023873-fidpskcs	120	4	,	,	,
cord-023873-fidpskcs	120	5	including	include	VBG
cord-023873-fidpskcs	120	6	ICU	ICU	NNP
cord-023873-fidpskcs	120	7	patients	patient	NNS
cord-023873-fidpskcs	120	8	,	,	,
cord-023873-fidpskcs	120	9	similar	similar	JJ
cord-023873-fidpskcs	120	10	CT	CT	NNP
cord-023873-fidpskcs	120	11	-	-	HYPH
cord-023873-fidpskcs	120	12	findings	finding	NNS
cord-023873-fidpskcs	120	13	are	be	VBP
cord-023873-fidpskcs	120	14	frequently	frequently	RB
cord-023873-fidpskcs	120	15	absent	absent	JJ
cord-023873-fidpskcs	120	16	and	and	CC
cord-023873-fidpskcs	120	17	,	,	,
cord-023873-fidpskcs	120	18	if	if	IN
cord-023873-fidpskcs	120	19	present	present	JJ
cord-023873-fidpskcs	120	20	,	,	,
cord-023873-fidpskcs	120	21	are	be	VBP
cord-023873-fidpskcs	120	22	far	far	RB
cord-023873-fidpskcs	120	23	less	less	RBR
cord-023873-fidpskcs	120	24	specific	specific	JJ
cord-023873-fidpskcs	120	25	[	[	-LRB-
cord-023873-fidpskcs	120	26	4	4	CD
cord-023873-fidpskcs	120	27	]	]	-RRB-
cord-023873-fidpskcs	120	28	.	.	.
cord-023873-fidpskcs	121	1	Many	many	JJ
cord-023873-fidpskcs	121	2	ICU	ICU	NNP
cord-023873-fidpskcs	121	3	patients	patient	NNS
cord-023873-fidpskcs	121	4	have	have	VBP
cord-023873-fidpskcs	121	5	non	non	JJ
cord-023873-fidpskcs	121	6	-	-	JJ
cord-023873-fidpskcs	121	7	specific	specific	JJ
cord-023873-fidpskcs	121	8	interfering	interfere	VBG
cord-023873-fidpskcs	121	9	radiological	radiological	JJ
cord-023873-fidpskcs	121	10	abnormalities	abnormality	NNS
cord-023873-fidpskcs	121	11	due	due	JJ
cord-023873-fidpskcs	121	12	to	to	IN
cord-023873-fidpskcs	121	13	atelectasis	atelectasis	NN
cord-023873-fidpskcs	121	14	,	,	,
cord-023873-fidpskcs	121	15	or	or	CC
cord-023873-fidpskcs	121	16	ARDS	ARDS	NNP
cord-023873-fidpskcs	121	17	(	(	-LRB-
cord-023873-fidpskcs	121	18	Figs	Figs	NNP
cord-023873-fidpskcs	121	19	.	.	.
cord-023873-fidpskcs	121	20	2	2	CD
cord-023873-fidpskcs	121	21	,	,	,
cord-023873-fidpskcs	121	22	3	3	CD
cord-023873-fidpskcs	121	23	,	,	,
cord-023873-fidpskcs	121	24	and	and	CC
cord-023873-fidpskcs	121	25	4	4	CD
cord-023873-fidpskcs	121	26	)	)	-RRB-
cord-023873-fidpskcs	121	27	.	.	.
cord-023873-fidpskcs	122	1	A	a	DT
cord-023873-fidpskcs	122	2	positive	positive	JJ
cord-023873-fidpskcs	122	3	respiratory	respiratory	JJ
cord-023873-fidpskcs	122	4	specimen	specimen	NN
cord-023873-fidpskcs	122	5	by	by	IN
cord-023873-fidpskcs	122	6	culture	culture	NN
cord-023873-fidpskcs	122	7	or	or	CC
cord-023873-fidpskcs	122	8	by	by	IN
cord-023873-fidpskcs	122	9	direct	direct	JJ
cord-023873-fidpskcs	122	10	microscopic	microscopic	JJ
cord-023873-fidpskcs	122	11	examination	examination	NN
cord-023873-fidpskcs	122	12	is	be	VBZ
cord-023873-fidpskcs	122	13	present	present	JJ
cord-023873-fidpskcs	122	14	in	in	IN
cord-023873-fidpskcs	122	15	only	only	RB
cord-023873-fidpskcs	122	16	half	half	NN
cord-023873-fidpskcs	122	17	of	of	IN
cord-023873-fidpskcs	122	18	the	the	DT
cord-023873-fidpskcs	122	19	patients	patient	NNS
cord-023873-fidpskcs	122	20	with	with	IN
cord-023873-fidpskcs	122	21	IA	IA	NNP
cord-023873-fidpskcs	122	22	.	.	.
cord-023873-fidpskcs	123	1	The	the	DT
cord-023873-fidpskcs	123	2	predictive	predictive	JJ
cord-023873-fidpskcs	123	3	value	value	NN
cord-023873-fidpskcs	123	4	of	of	IN
cord-023873-fidpskcs	123	5	a	a	DT
cord-023873-fidpskcs	123	6	positive	positive	JJ
cord-023873-fidpskcs	123	7	culture	culture	NN
cord-023873-fidpskcs	123	8	depends	depend	VBZ
cord-023873-fidpskcs	123	9	largely	largely	RB
cord-023873-fidpskcs	123	10	on	on	IN
cord-023873-fidpskcs	123	11	the	the	DT
cord-023873-fidpskcs	123	12	immunocompromised	immunocompromised	JJ
cord-023873-fidpskcs	123	13	status	status	NN
cord-023873-fidpskcs	123	14	of	of	IN
cord-023873-fidpskcs	123	15	the	the	DT
cord-023873-fidpskcs	123	16	patient	patient	NN
cord-023873-fidpskcs	123	17	and	and	CC
cord-023873-fidpskcs	123	18	ranges	range	VBZ
cord-023873-fidpskcs	123	19	from	from	IN
cord-023873-fidpskcs	123	20	20	20	CD
cord-023873-fidpskcs	123	21	to	to	TO
cord-023873-fidpskcs	123	22	80	80	CD
cord-023873-fidpskcs	123	23	%	%	NN
cord-023873-fidpskcs	123	24	.	.	.
cord-023873-fidpskcs	124	1	Given	give	VBN
cord-023873-fidpskcs	124	2	the	the	DT
cord-023873-fidpskcs	124	3	ubiquitous	ubiquitous	JJ
cord-023873-fidpskcs	124	4	nature	nature	NN
cord-023873-fidpskcs	124	5	of	of	IN
cord-023873-fidpskcs	124	6	Aspergillus	aspergillus	NN
cord-023873-fidpskcs	124	7	spores	spore	NNS
cord-023873-fidpskcs	124	8	,	,	,
cord-023873-fidpskcs	124	9	differentiating	differentiate	VBG
cord-023873-fidpskcs	124	10	colonisation	colonisation	NN
cord-023873-fidpskcs	124	11	from	from	IN
cord-023873-fidpskcs	124	12	infection	infection	NN
cord-023873-fidpskcs	124	13	remains	remain	VBZ
cord-023873-fidpskcs	124	14	problematic	problematic	JJ
cord-023873-fidpskcs	124	15	.	.	.
cord-023873-fidpskcs	125	1	Two	two	CD
cord-023873-fidpskcs	125	2	studies	study	NNS
cord-023873-fidpskcs	125	3	have	have	VBP
cord-023873-fidpskcs	125	4	examined	examine	VBN
cord-023873-fidpskcs	125	5	the	the	DT
cord-023873-fidpskcs	125	6	significance	significance	NN
cord-023873-fidpskcs	125	7	of	of	IN
cord-023873-fidpskcs	125	8	isolation	isolation	NN
cord-023873-fidpskcs	125	9	of	of	IN
cord-023873-fidpskcs	125	10	Aspergillus	aspergillus	NN
cord-023873-fidpskcs	125	11	spp	spp	NNS
cord-023873-fidpskcs	125	12	.	.	.
cord-023873-fidpskcs	126	1	in	in	IN
cord-023873-fidpskcs	126	2	ICU	ICU	NNP
cord-023873-fidpskcs	126	3	patients	patient	NNS
cord-023873-fidpskcs	126	4	and	and	CC
cord-023873-fidpskcs	126	5	confirmed	confirm	VBD
cord-023873-fidpskcs	126	6	the	the	DT
cord-023873-fidpskcs	126	7	poor	poor	JJ
cord-023873-fidpskcs	126	8	positive	positive	JJ
cord-023873-fidpskcs	126	9	predictive	predictive	JJ
cord-023873-fidpskcs	126	10	values	value	NNS
cord-023873-fidpskcs	126	11	[	[	-LRB-
cord-023873-fidpskcs	126	12	7	7	CD
cord-023873-fidpskcs	126	13	,	,	,
cord-023873-fidpskcs	126	14	28	28	CD
cord-023873-fidpskcs	126	15	]	]	-RRB-
cord-023873-fidpskcs	126	16	.	.	.
cord-023873-fidpskcs	127	1	Therefore	therefore	RB
cord-023873-fidpskcs	127	2	,	,	,
cord-023873-fidpskcs	127	3	surveillance	surveillance	NN
cord-023873-fidpskcs	127	4	cultures	culture	NNS
cord-023873-fidpskcs	127	5	in	in	IN
cord-023873-fidpskcs	127	6	the	the	DT
cord-023873-fidpskcs	127	7	ICU	ICU	NNP
cord-023873-fidpskcs	127	8	will	will	MD
cord-023873-fidpskcs	127	9	add	add	VB
cord-023873-fidpskcs	127	10	little	little	JJ
cord-023873-fidpskcs	127	11	to	to	IN
cord-023873-fidpskcs	127	12	the	the	DT
cord-023873-fidpskcs	127	13	diagnosis	diagnosis	NN
cord-023873-fidpskcs	127	14	of	of	IN
cord-023873-fidpskcs	127	15	IA	IA	NNP
cord-023873-fidpskcs	127	16	.	.	.
cord-023873-fidpskcs	128	1	Serological	serological	JJ
cord-023873-fidpskcs	128	2	techniques	technique	NNS
cord-023873-fidpskcs	128	3	based	base	VBN
cord-023873-fidpskcs	128	4	on	on	IN
cord-023873-fidpskcs	128	5	the	the	DT
cord-023873-fidpskcs	128	6	detection	detection	NN
cord-023873-fidpskcs	128	7	of	of	IN
cord-023873-fidpskcs	128	8	circulating	circulate	VBG
cord-023873-fidpskcs	128	9	fungal	fungal	JJ
cord-023873-fidpskcs	128	10	cell	cell	NN
cord-023873-fidpskcs	128	11	wall	wall	NN
cord-023873-fidpskcs	128	12	components	component	NNS
cord-023873-fidpskcs	128	13	such	such	JJ
cord-023873-fidpskcs	128	14	as	as	IN
cord-023873-fidpskcs	128	15	galactomannan	galactomannan	NNP
cord-023873-fidpskcs	128	16	(	(	-LRB-
cord-023873-fidpskcs	128	17	GM	GM	NNP
cord-023873-fidpskcs	128	18	)	)	-RRB-
cord-023873-fidpskcs	128	19	or	or	CC
cord-023873-fidpskcs	128	20	β	β	NN
cord-023873-fidpskcs	128	21	-	-	HYPH
cord-023873-fidpskcs	128	22	D	d	NN
cord-023873-fidpskcs	128	23	-	-	HYPH
cord-023873-fidpskcs	128	24	glucan	glucan	NN
cord-023873-fidpskcs	128	25	and	and	CC
cord-023873-fidpskcs	128	26	detection	detection	NN
cord-023873-fidpskcs	128	27	of	of	IN
cord-023873-fidpskcs	128	28	circulating	circulate	VBG
cord-023873-fidpskcs	128	29	fungal	fungal	JJ
cord-023873-fidpskcs	128	30	DNA	dna	NN
cord-023873-fidpskcs	128	31	by	by	IN
cord-023873-fidpskcs	128	32	PCR	PCR	NNP
cord-023873-fidpskcs	128	33	techniques	technique	NNS
cord-023873-fidpskcs	128	34	hold	hold	VBP
cord-023873-fidpskcs	128	35	promise	promise	NN
cord-023873-fidpskcs	128	36	in	in	IN
cord-023873-fidpskcs	128	37	patients	patient	NNS
cord-023873-fidpskcs	128	38	with	with	IN
cord-023873-fidpskcs	128	39	haematological	haematological	JJ
cord-023873-fidpskcs	128	40	malignancy	malignancy	NN
cord-023873-fidpskcs	128	41	but	but	CC
cord-023873-fidpskcs	128	42	limited	limited	JJ
cord-023873-fidpskcs	128	43	data	datum	NNS
cord-023873-fidpskcs	128	44	exist	exist	VBP
cord-023873-fidpskcs	128	45	with	with	IN
cord-023873-fidpskcs	128	46	the	the	DT
cord-023873-fidpskcs	128	47	use	use	NN
cord-023873-fidpskcs	128	48	of	of	IN
cord-023873-fidpskcs	128	49	these	these	DT
cord-023873-fidpskcs	128	50	tests	test	NNS
cord-023873-fidpskcs	128	51	in	in	IN
cord-023873-fidpskcs	128	52	diagnosis	diagnosis	NN
cord-023873-fidpskcs	128	53	of	of	IN
cord-023873-fidpskcs	128	54	IA	IA	NNP
cord-023873-fidpskcs	128	55	in	in	IN
cord-023873-fidpskcs	128	56	the	the	DT
cord-023873-fidpskcs	128	57	ICU	ICU	NNP
cord-023873-fidpskcs	128	58	[	[	-LRB-
cord-023873-fidpskcs	128	59	10	10	CD
cord-023873-fidpskcs	128	60	]	]	-RRB-
cord-023873-fidpskcs	128	61	.	.	.
cord-023873-fidpskcs	129	1	Although	although	IN
cord-023873-fidpskcs	129	2	very	very	RB
cord-023873-fidpskcs	129	3	useful	useful	JJ
cord-023873-fidpskcs	129	4	in	in	IN
cord-023873-fidpskcs	129	5	the	the	DT
cord-023873-fidpskcs	129	6	haematological	haematological	JJ
cord-023873-fidpskcs	129	7	patient	patient	NN
cord-023873-fidpskcs	129	8	[	[	-LRB-
cord-023873-fidpskcs	129	9	29	29	CD
cord-023873-fidpskcs	129	10	]	]	-RRB-
cord-023873-fidpskcs	129	11	,	,	,
cord-023873-fidpskcs	129	12	serum	serum	NN
cord-023873-fidpskcs	129	13	GM	GM	NNP
cord-023873-fidpskcs	129	14	is	be	VBZ
cord-023873-fidpskcs	129	15	not	not	RB
cord-023873-fidpskcs	129	16	a	a	DT
cord-023873-fidpskcs	129	17	sensitive	sensitive	JJ
cord-023873-fidpskcs	129	18	marker	marker	NN
cord-023873-fidpskcs	129	19	for	for	IN
cord-023873-fidpskcs	129	20	IA	IA	NNP
cord-023873-fidpskcs	129	21	in	in	IN
cord-023873-fidpskcs	129	22	the	the	DT
cord-023873-fidpskcs	129	23	non	non	JJ
cord-023873-fidpskcs	129	24	-	-	JJ
cord-023873-fidpskcs	129	25	neutropenic	neutropenic	JJ
cord-023873-fidpskcs	129	26	individual	individual	NN
cord-023873-fidpskcs	129	27	,	,	,
cord-023873-fidpskcs	129	28	as	as	IN
cord-023873-fidpskcs	129	29	demonstrated	demonstrate	VBN
cord-023873-fidpskcs	129	30	in	in	IN
cord-023873-fidpskcs	129	31	lung	lung	NN
cord-023873-fidpskcs	129	32	and	and	CC
cord-023873-fidpskcs	129	33	liver	liver	NN
cord-023873-fidpskcs	129	34	transplant	transplant	NN
cord-023873-fidpskcs	129	35	recipients	recipient	NNS
cord-023873-fidpskcs	129	36	[	[	-LRB-
cord-023873-fidpskcs	129	37	30	30	CD
cord-023873-fidpskcs	129	38	,	,	,
cord-023873-fidpskcs	129	39	31	31	CD
cord-023873-fidpskcs	129	40	]	]	-RRB-
cord-023873-fidpskcs	129	41	.	.	.
cord-023873-fidpskcs	130	1	Viable	viable	JJ
cord-023873-fidpskcs	130	2	fungi	fungus	NNS
cord-023873-fidpskcs	130	3	could	could	MD
cord-023873-fidpskcs	130	4	endure	endure	VB
cord-023873-fidpskcs	130	5	in	in	IN
cord-023873-fidpskcs	130	6	the	the	DT
cord-023873-fidpskcs	130	7	lung	lung	NN
cord-023873-fidpskcs	130	8	tissue	tissue	NN
cord-023873-fidpskcs	130	9	(	(	-LRB-
cord-023873-fidpskcs	130	10	with	with	IN
cord-023873-fidpskcs	130	11	encapsulation	encapsulation	NN
cord-023873-fidpskcs	130	12	by	by	IN
cord-023873-fidpskcs	130	13	an	an	DT
cord-023873-fidpskcs	130	14	inflammatory	inflammatory	JJ
cord-023873-fidpskcs	130	15	process	process	NN
cord-023873-fidpskcs	130	16	)	)	-RRB-
cord-023873-fidpskcs	130	17	,	,	,
cord-023873-fidpskcs	130	18	while	while	IN
cord-023873-fidpskcs	130	19	circulating	circulate	VBG
cord-023873-fidpskcs	130	20	markers	marker	NNS
cord-023873-fidpskcs	130	21	remain	remain	VBP
cord-023873-fidpskcs	130	22	undetectable	undetectable	JJ
cord-023873-fidpskcs	130	23	because	because	IN
cord-023873-fidpskcs	130	24	of	of	IN
cord-023873-fidpskcs	130	25	clearance	clearance	NN
cord-023873-fidpskcs	130	26	by	by	IN
cord-023873-fidpskcs	130	27	circulating	circulate	VBG
cord-023873-fidpskcs	130	28	neutrophils	neutrophil	NNS
cord-023873-fidpskcs	130	29	.	.	.
cord-023873-fidpskcs	131	1	BAL	bal	NN
cord-023873-fidpskcs	131	2	fluid	fluid	NN
cord-023873-fidpskcs	131	3	could	could	MD
cord-023873-fidpskcs	131	4	be	be	VB
cord-023873-fidpskcs	131	5	a	a	DT
cord-023873-fidpskcs	131	6	better	well	JJR
cord-023873-fidpskcs	131	7	specimen	specimen	NN
cord-023873-fidpskcs	131	8	for	for	IN
cord-023873-fidpskcs	131	9	GM	GM	NNP
cord-023873-fidpskcs	131	10	detection	detection	NN
cord-023873-fidpskcs	131	11	as	as	IN
cord-023873-fidpskcs	131	12	recently	recently	RB
cord-023873-fidpskcs	131	13	was	be	VBD
cord-023873-fidpskcs	131	14	demonstrated	demonstrate	VBN
cord-023873-fidpskcs	131	15	in	in	IN
cord-023873-fidpskcs	131	16	a	a	DT
cord-023873-fidpskcs	131	17	prospective	prospective	JJ
cord-023873-fidpskcs	131	18	study	study	NN
cord-023873-fidpskcs	131	19	performed	perform	VBN
cord-023873-fidpskcs	131	20	in	in	IN
cord-023873-fidpskcs	131	21	a	a	DT
cord-023873-fidpskcs	131	22	medical	medical	JJ
cord-023873-fidpskcs	131	23	ICU	ICU	NNP
cord-023873-fidpskcs	131	24	in	in	IN
cord-023873-fidpskcs	131	25	a	a	DT
cord-023873-fidpskcs	131	26	tertiary	tertiary	JJ
cord-023873-fidpskcs	131	27	referral	referral	NN
cord-023873-fidpskcs	131	28	hospital	hospital	NN
cord-023873-fidpskcs	131	29	[	[	-LRB-
cord-023873-fidpskcs	131	30	10	10	CD
cord-023873-fidpskcs	131	31	]	]	-RRB-
cord-023873-fidpskcs	131	32	.	.	.
cord-023873-fidpskcs	132	1	This	this	DT
cord-023873-fidpskcs	132	2	is	be	VBZ
cord-023873-fidpskcs	132	3	reinforced	reinforce	VBN
cord-023873-fidpskcs	132	4	by	by	IN
cord-023873-fidpskcs	132	5	the	the	DT
cord-023873-fidpskcs	132	6	data	datum	NNS
cord-023873-fidpskcs	132	7	with	with	IN
cord-023873-fidpskcs	132	8	the	the	DT
cord-023873-fidpskcs	132	9	solid	solid	JJ
cord-023873-fidpskcs	132	10	organ	organ	NN
cord-023873-fidpskcs	132	11	transplant	transplant	NN
cord-023873-fidpskcs	132	12	population	population	NN
cord-023873-fidpskcs	132	13	[	[	-LRB-
cord-023873-fidpskcs	132	14	32	32	CD
cord-023873-fidpskcs	132	15	]	]	-RRB-
cord-023873-fidpskcs	132	16	[	[	-LRB-
cord-023873-fidpskcs	132	17	33	33	CD
cord-023873-fidpskcs	132	18	]	]	-RRB-
cord-023873-fidpskcs	132	19	[	[	-LRB-
cord-023873-fidpskcs	132	20	34	34	CD
cord-023873-fidpskcs	132	21	]	]	-RRB-
cord-023873-fidpskcs	132	22	.	.	.
cord-023873-fidpskcs	133	1	On	on	IN
cord-023873-fidpskcs	133	2	the	the	DT
cord-023873-fidpskcs	133	3	other	other	JJ
cord-023873-fidpskcs	133	4	hand	hand	NN
cord-023873-fidpskcs	133	5	,	,	,
cord-023873-fidpskcs	133	6	GM	GM	NNP
cord-023873-fidpskcs	133	7	testing	testing	NN
cord-023873-fidpskcs	133	8	in	in	IN
cord-023873-fidpskcs	133	9	BAL	bal	NN
cord-023873-fidpskcs	133	10	fluid	fluid	NN
cord-023873-fidpskcs	133	11	samples	sample	NNS
cord-023873-fidpskcs	133	12	seems	seem	VBZ
cord-023873-fidpskcs	133	13	very	very	RB
cord-023873-fidpskcs	133	14	promising	promising	JJ
cord-023873-fidpskcs	133	15	for	for	IN
cord-023873-fidpskcs	133	16	the	the	DT
cord-023873-fidpskcs	133	17	diagnosis	diagnosis	NN
cord-023873-fidpskcs	133	18	of	of	IN
cord-023873-fidpskcs	133	19	IA	IA	NNP
cord-023873-fidpskcs	133	20	in	in	IN
cord-023873-fidpskcs	133	21	non	non	JJ
cord-023873-fidpskcs	133	22	-	-	JJ
cord-023873-fidpskcs	133	23	neutropenic	neutropenic	JJ
cord-023873-fidpskcs	133	24	patients	patient	NNS
cord-023873-fidpskcs	133	25	[	[	-LRB-
cord-023873-fidpskcs	133	26	10	10	CD
cord-023873-fidpskcs	133	27	,	,	,
cord-023873-fidpskcs	133	28	35	35	CD
cord-023873-fidpskcs	133	29	]	]	-RRB-
cord-023873-fidpskcs	133	30	.	.	.
cord-023873-fidpskcs	134	1	Results	result	NNS
cord-023873-fidpskcs	134	2	from	from	IN
cord-023873-fidpskcs	134	3	a	a	DT
cord-023873-fidpskcs	134	4	single	single	JJ
cord-023873-fidpskcs	134	5	ICU	ICU	NNP
cord-023873-fidpskcs	134	6	showed	show	VBD
cord-023873-fidpskcs	134	7	that	that	IN
cord-023873-fidpskcs	134	8	test	test	NN
cord-023873-fidpskcs	134	9	sensitivity	sensitivity	NN
cord-023873-fidpskcs	134	10	and	and	CC
cord-023873-fidpskcs	134	11	specificity	specificity	NN
cord-023873-fidpskcs	134	12	were	be	VBD
cord-023873-fidpskcs	134	13	88	88	CD
cord-023873-fidpskcs	134	14	and	and	CC
cord-023873-fidpskcs	134	15	87	87	CD
cord-023873-fidpskcs	134	16	%	%	NN
cord-023873-fidpskcs	134	17	,	,	,
cord-023873-fidpskcs	134	18	respectively	respectively	RB
cord-023873-fidpskcs	134	19	using	use	VBG
cord-023873-fidpskcs	134	20	a	a	DT
cord-023873-fidpskcs	134	21	cut	cut	NN
cord-023873-fidpskcs	134	22	-	-	HYPH
cord-023873-fidpskcs	134	23	off	off	NN
cord-023873-fidpskcs	134	24	of	of	IN
cord-023873-fidpskcs	134	25	0.5	0.5	CD
cord-023873-fidpskcs	134	26	for	for	IN
cord-023873-fidpskcs	134	27	BAL	bal	NN
cord-023873-fidpskcs	134	28	testing	testing	NN
cord-023873-fidpskcs	134	29	.	.	.
cord-023873-fidpskcs	135	1	In	in	IN
cord-023873-fidpskcs	135	2	contrast	contrast	NN
cord-023873-fidpskcs	135	3	,	,	,
cord-023873-fidpskcs	135	4	the	the	DT
cord-023873-fidpskcs	135	5	sensitivity	sensitivity	NN
cord-023873-fidpskcs	135	6	of	of	IN
cord-023873-fidpskcs	135	7	serum	serum	NN
cord-023873-fidpskcs	135	8	GM	GM	NNP
cord-023873-fidpskcs	135	9	was	be	VBD
cord-023873-fidpskcs	135	10	42	42	CD
cord-023873-fidpskcs	135	11	%	%	NN
cord-023873-fidpskcs	135	12	only	only	RB
cord-023873-fidpskcs	135	13	.	.	.
cord-023873-fidpskcs	136	1	A	a	DT
cord-023873-fidpskcs	136	2	bit	bit	NN
cord-023873-fidpskcs	136	3	of	of	IN
cord-023873-fidpskcs	136	4	caution	caution	NN
cord-023873-fidpskcs	136	5	,	,	,
cord-023873-fidpskcs	136	6	however	however	RB
cord-023873-fidpskcs	136	7	,	,	,
cord-023873-fidpskcs	136	8	is	be	VBZ
cord-023873-fidpskcs	136	9	required	require	VBN
cord-023873-fidpskcs	136	10	with	with	IN
cord-023873-fidpskcs	136	11	this	this	DT
cord-023873-fidpskcs	136	12	,	,	,
cord-023873-fidpskcs	136	13	since	since	IN
cord-023873-fidpskcs	136	14	the	the	DT
cord-023873-fidpskcs	136	15	best	good	JJS
cord-023873-fidpskcs	136	16	cut	cut	NN
cord-023873-fidpskcs	136	17	-	-	HYPH
cord-023873-fidpskcs	136	18	off	off	NN
cord-023873-fidpskcs	136	19	for	for	IN
cord-023873-fidpskcs	136	20	GM	GM	NNP
cord-023873-fidpskcs	136	21	testing	testing	NN
cord-023873-fidpskcs	136	22	in	in	IN
cord-023873-fidpskcs	136	23	BAL	BAL	NNP
cord-023873-fidpskcs	136	24	[	[	-LRB-
cord-023873-fidpskcs	136	25	36	36	CD
cord-023873-fidpskcs	136	26	]	]	-RRB-
cord-023873-fidpskcs	136	27	.	.	.
cord-023873-fidpskcs	137	1	Accordingly	accordingly	RB
cord-023873-fidpskcs	137	2	,	,	,
cord-023873-fidpskcs	137	3	many	many	JJ
cord-023873-fidpskcs	137	4	studies	study	NNS
cord-023873-fidpskcs	137	5	have	have	VBP
cord-023873-fidpskcs	137	6	shown	show	VBN
cord-023873-fidpskcs	137	7	that	that	IN
cord-023873-fidpskcs	137	8	testing	test	VBG
cord-023873-fidpskcs	137	9	GM	GM	NNP
cord-023873-fidpskcs	137	10	in	in	IN
cord-023873-fidpskcs	137	11	BAL	bal	NN
cord-023873-fidpskcs	137	12	fluid	fluid	NN
cord-023873-fidpskcs	137	13	samples	sample	NNS
cord-023873-fidpskcs	137	14	result	result	VBP
cord-023873-fidpskcs	137	15	in	in	IN
cord-023873-fidpskcs	137	16	higher	high	JJR
cord-023873-fidpskcs	137	17	optical	optical	JJ
cord-023873-fidpskcs	137	18	densities	density	NNS
cord-023873-fidpskcs	137	19	than	than	IN
cord-023873-fidpskcs	137	20	testing	test	VBG
cord-023873-fidpskcs	137	21	sera	sera	NNP
cord-023873-fidpskcs	137	22	[	[	-LRB-
cord-023873-fidpskcs	137	23	33	33	CD
cord-023873-fidpskcs	137	24	,	,	,
cord-023873-fidpskcs	137	25	37	37	CD
cord-023873-fidpskcs	137	26	]	]	-RRB-
cord-023873-fidpskcs	137	27	.	.	.
cord-023873-fidpskcs	138	1	In	in	IN
cord-023873-fidpskcs	138	2	a	a	DT
cord-023873-fidpskcs	138	3	study	study	NN
cord-023873-fidpskcs	138	4	with	with	IN
cord-023873-fidpskcs	138	5	non	non	JJ
cord-023873-fidpskcs	138	6	-	-	JJ
cord-023873-fidpskcs	138	7	immunocompromised	immunocompromised	JJ
cord-023873-fidpskcs	138	8	patients	patient	NNS
cord-023873-fidpskcs	138	9	,	,	,
cord-023873-fidpskcs	138	10	all	all	DT
cord-023873-fidpskcs	138	11	cases	case	NNS
cord-023873-fidpskcs	138	12	of	of	IN
cord-023873-fidpskcs	138	13	IA	IA	NNP
cord-023873-fidpskcs	138	14	were	be	VBD
cord-023873-fidpskcs	138	15	associated	associate	VBN
cord-023873-fidpskcs	138	16	with	with	IN
cord-023873-fidpskcs	138	17	GM	GM	NNP
cord-023873-fidpskcs	138	18	optical	optical	JJ
cord-023873-fidpskcs	138	19	densities	density	NNS
cord-023873-fidpskcs	138	20	of	of	IN
cord-023873-fidpskcs	138	21	≥	≥	CD
cord-023873-fidpskcs	138	22	1.18	1.18	CD
cord-023873-fidpskcs	138	23	in	in	IN
cord-023873-fidpskcs	138	24	the	the	DT
cord-023873-fidpskcs	138	25	BAL	bal	NN
cord-023873-fidpskcs	138	26	[	[	-LRB-
cord-023873-fidpskcs	138	27	34	34	CD
cord-023873-fidpskcs	138	28	]	]	-RRB-
cord-023873-fidpskcs	138	29	.	.	.
cord-023873-fidpskcs	139	1	A	a	DT
cord-023873-fidpskcs	139	2	higher	high	JJR
cord-023873-fidpskcs	139	3	cut	cut	VBN
cord-023873-fidpskcs	139	4	-	-	HYPH
cord-023873-fidpskcs	139	5	off	off	RP
cord-023873-fidpskcs	139	6	value	value	NN
cord-023873-fidpskcs	139	7	for	for	IN
cord-023873-fidpskcs	139	8	BAL	BAL	NNP
cord-023873-fidpskcs	139	9	has	have	VBZ
cord-023873-fidpskcs	139	10	also	also	RB
cord-023873-fidpskcs	139	11	been	be	VBN
cord-023873-fidpskcs	139	12	suggested	suggest	VBN
cord-023873-fidpskcs	139	13	by	by	IN
cord-023873-fidpskcs	139	14	other	other	JJ
cord-023873-fidpskcs	139	15	authors	author	NNS
cord-023873-fidpskcs	139	16	,	,	,
cord-023873-fidpskcs	139	17	in	in	IN
cord-023873-fidpskcs	139	18	comparison	comparison	NN
cord-023873-fidpskcs	139	19	to	to	IN
cord-023873-fidpskcs	139	20	sera	sera	NNP
cord-023873-fidpskcs	139	21	[	[	-LRB-
cord-023873-fidpskcs	139	22	32	32	CD
cord-023873-fidpskcs	139	23	,	,	,
cord-023873-fidpskcs	139	24	33	33	CD
cord-023873-fidpskcs	139	25	]	]	-RRB-
cord-023873-fidpskcs	139	26	.	.	.
cord-023873-fidpskcs	140	1	False	false	JJ
cord-023873-fidpskcs	140	2	-	-	HYPH
cord-023873-fidpskcs	140	3	positive	positive	JJ
cord-023873-fidpskcs	140	4	results	result	NNS
cord-023873-fidpskcs	140	5	have	have	VBP
cord-023873-fidpskcs	140	6	been	be	VBN
cord-023873-fidpskcs	140	7	observed	observe	VBN
cord-023873-fidpskcs	140	8	when	when	WRB
cord-023873-fidpskcs	140	9	BAL	BAL	NNP
cord-023873-fidpskcs	140	10	is	be	VBZ
cord-023873-fidpskcs	140	11	tested	test	VBN
cord-023873-fidpskcs	140	12	for	for	IN
cord-023873-fidpskcs	140	13	GM	GM	NNP
cord-023873-fidpskcs	140	14	in	in	IN
cord-023873-fidpskcs	140	15	patients	patient	NNS
cord-023873-fidpskcs	140	16	colonised	colonise	VBN
cord-023873-fidpskcs	140	17	with	with	IN
cord-023873-fidpskcs	140	18	Aspergillus	aspergillus	NN
cord-023873-fidpskcs	140	19	species	specie	NNS
cord-023873-fidpskcs	140	20	,	,	,
cord-023873-fidpskcs	140	21	particularly	particularly	RB
cord-023873-fidpskcs	140	22	lung	lung	NN
cord-023873-fidpskcs	140	23	transplant	transplant	NN
cord-023873-fidpskcs	140	24	recipients	recipient	NNS
cord-023873-fidpskcs	140	25	[	[	-LRB-
cord-023873-fidpskcs	140	26	32	32	CD
cord-023873-fidpskcs	140	27	]	]	-RRB-
cord-023873-fidpskcs	140	28	(	(	-LRB-
cord-023873-fidpskcs	140	29	Dr.	Dr.	NNP
cord-023873-fidpskcs	140	30	Pasqualotto	Pasqualotto	NNP
cord-023873-fidpskcs	140	31	,	,	,
cord-023873-fidpskcs	140	32	unpublished	unpublished	JJ
cord-023873-fidpskcs	140	33	data	datum	NNS
cord-023873-fidpskcs	140	34	)	)	-RRB-
cord-023873-fidpskcs	140	35	.	.	.
cord-023873-fidpskcs	141	1	Although	although	IN
cord-023873-fidpskcs	141	2	attractive	attractive	JJ
cord-023873-fidpskcs	141	3	,	,	,
cord-023873-fidpskcs	141	4	other	other	JJ
cord-023873-fidpskcs	141	5	modern	modern	JJ
cord-023873-fidpskcs	141	6	diagnostic	diagnostic	JJ
cord-023873-fidpskcs	141	7	tests	test	NNS
cord-023873-fidpskcs	141	8	have	have	VBP
cord-023873-fidpskcs	141	9	not	not	RB
cord-023873-fidpskcs	141	10	been	be	VBN
cord-023873-fidpskcs	141	11	systematically	systematically	RB
cord-023873-fidpskcs	141	12	evaluated	evaluate	VBN
cord-023873-fidpskcs	141	13	for	for	IN
cord-023873-fidpskcs	141	14	the	the	DT
cord-023873-fidpskcs	141	15	diagnosis	diagnosis	NN
cord-023873-fidpskcs	141	16	of	of	IN
cord-023873-fidpskcs	141	17	IA	IA	NNP
cord-023873-fidpskcs	141	18	in	in	IN
cord-023873-fidpskcs	141	19	ICU	ICU	NNP
cord-023873-fidpskcs	141	20	patients	patient	NNS
cord-023873-fidpskcs	141	21	.	.	.
cord-023873-fidpskcs	142	1	The	the	DT
cord-023873-fidpskcs	142	2	use	use	NN
cord-023873-fidpskcs	142	3	of	of	IN
cord-023873-fidpskcs	142	4	β	β	NN
cord-023873-fidpskcs	142	5	-	-	HYPH
cord-023873-fidpskcs	142	6	D	d	JJ
cord-023873-fidpskcs	142	7	-	-	HYPH
cord-023873-fidpskcs	142	8	glucan	glucan	JJ
cord-023873-fidpskcs	142	9	detection	detection	NN
cord-023873-fidpskcs	142	10	in	in	IN
cord-023873-fidpskcs	142	11	ICU	ICU	NNP
cord-023873-fidpskcs	142	12	is	be	VBZ
cord-023873-fidpskcs	142	13	hampered	hamper	VBN
cord-023873-fidpskcs	142	14	by	by	IN
cord-023873-fidpskcs	142	15	false	false	JJ
cord-023873-fidpskcs	142	16	-	-	HYPH
cord-023873-fidpskcs	142	17	positive	positive	JJ
cord-023873-fidpskcs	142	18	readings	reading	NNS
cord-023873-fidpskcs	142	19	(	(	-LRB-
cord-023873-fidpskcs	142	20	use	use	NN
cord-023873-fidpskcs	142	21	of	of	IN
cord-023873-fidpskcs	142	22	albumin	albumin	NN
cord-023873-fidpskcs	142	23	,	,	,
cord-023873-fidpskcs	142	24	wound	wound	VB
cord-023873-fidpskcs	142	25	gauze	gauze	NN
cord-023873-fidpskcs	142	26	,	,	,
cord-023873-fidpskcs	142	27	hemodialysis	hemodialysis	NN
cord-023873-fidpskcs	142	28	and	and	CC
cord-023873-fidpskcs	142	29	bacterial	bacterial	JJ
cord-023873-fidpskcs	142	30	infections	infection	NNS
cord-023873-fidpskcs	142	31	)	)	-RRB-
cord-023873-fidpskcs	142	32	[	[	-LRB-
cord-023873-fidpskcs	142	33	38	38	CD
cord-023873-fidpskcs	142	34	]	]	-RRB-
cord-023873-fidpskcs	142	35	.	.	.
cord-023873-fidpskcs	143	1	Galactomannan	Galactomannan	NNP
cord-023873-fidpskcs	143	2	gives	give	VBZ
cord-023873-fidpskcs	143	3	less	less	JJR
cord-023873-fidpskcs	143	4	falsepositive	falsepositive	JJ
cord-023873-fidpskcs	143	5	results	result	NNS
cord-023873-fidpskcs	143	6	,	,	,
cord-023873-fidpskcs	143	7	although	although	IN
cord-023873-fidpskcs	143	8	the	the	DT
cord-023873-fidpskcs	143	9	presence	presence	NN
cord-023873-fidpskcs	143	10	of	of	IN
cord-023873-fidpskcs	143	11	β	β	NN
cord-023873-fidpskcs	143	12	-	-	HYPH
cord-023873-fidpskcs	143	13	lactam	lactam	NNP
cord-023873-fidpskcs	143	14	antibiotics	antibiotic	NNS
cord-023873-fidpskcs	143	15	such	such	JJ
cord-023873-fidpskcs	143	16	as	as	IN
cord-023873-fidpskcs	143	17	piperacillintazobactam	piperacillintazobactam	NNP
cord-023873-fidpskcs	143	18	may	may	MD
cord-023873-fidpskcs	143	19	pose	pose	VB
cord-023873-fidpskcs	143	20	also	also	RB
cord-023873-fidpskcs	143	21	a	a	DT
cord-023873-fidpskcs	143	22	problem	problem	NN
cord-023873-fidpskcs	143	23	[	[	-LRB-
cord-023873-fidpskcs	143	24	39	39	CD
cord-023873-fidpskcs	143	25	]	]	-RRB-
cord-023873-fidpskcs	143	26	.	.	.
cord-023873-fidpskcs	144	1	The	the	DT
cord-023873-fidpskcs	144	2	impact	impact	NN
cord-023873-fidpskcs	144	3	of	of	IN
cord-023873-fidpskcs	144	4	piperacillin	piperacillin	NNP
cord-023873-fidpskcs	144	5	-	-	HYPH
cord-023873-fidpskcs	144	6	tazobactam	tazobactam	NNP
cord-023873-fidpskcs	144	7	is	be	VBZ
cord-023873-fidpskcs	144	8	probably	probably	RB
cord-023873-fidpskcs	144	9	reduced	reduce	VBN
cord-023873-fidpskcs	144	10	if	if	IN
cord-023873-fidpskcs	144	11	GM	GM	NNP
cord-023873-fidpskcs	144	12	is	be	VBZ
cord-023873-fidpskcs	144	13	tested	test	VBN
cord-023873-fidpskcs	144	14	in	in	IN
cord-023873-fidpskcs	144	15	the	the	DT
cord-023873-fidpskcs	144	16	BAL	bal	NN
cord-023873-fidpskcs	144	17	fluid	fluid	NN
cord-023873-fidpskcs	144	18	instead	instead	RB
cord-023873-fidpskcs	144	19	of	of	IN
cord-023873-fidpskcs	144	20	sera	sera	NNP
cord-023873-fidpskcs	144	21	,	,	,
cord-023873-fidpskcs	144	22	since	since	IN
cord-023873-fidpskcs	144	23	the	the	DT
cord-023873-fidpskcs	144	24	epithelial	epithelial	JJ
cord-023873-fidpskcs	144	25	Fig	Fig	NNP
cord-023873-fidpskcs	144	26	.	.	.
cord-023873-fidpskcs	145	1	3	3	LS
cord-023873-fidpskcs	146	1	Chest	chest	NN
cord-023873-fidpskcs	146	2	X	x	NN
cord-023873-fidpskcs	146	3	-	-	NN
cord-023873-fidpskcs	146	4	ray	ray	NN
cord-023873-fidpskcs	146	5	and	and	CC
cord-023873-fidpskcs	146	6	CT	CT	NNP
cord-023873-fidpskcs	146	7	scan	scan	NN
cord-023873-fidpskcs	146	8	from	from	IN
cord-023873-fidpskcs	146	9	a	a	DT
cord-023873-fidpskcs	146	10	patient	patient	NN
cord-023873-fidpskcs	146	11	on	on	IN
cord-023873-fidpskcs	146	12	high	high	JJ
cord-023873-fidpskcs	146	13	dose	dose	NN
cord-023873-fidpskcs	146	14	steroids	steroid	NNS
cord-023873-fidpskcs	146	15	because	because	IN
cord-023873-fidpskcs	146	16	of	of	IN
cord-023873-fidpskcs	146	17	graft	graft	NN
cord-023873-fidpskcs	146	18	-	-	HYPH
cord-023873-fidpskcs	146	19	versus	versus	IN
cord-023873-fidpskcs	146	20	-	-	HYPH
cord-023873-fidpskcs	146	21	host	host	NN
cord-023873-fidpskcs	146	22	disease	disease	NN
cord-023873-fidpskcs	146	23	4	4	CD
cord-023873-fidpskcs	146	24	months	month	NNS
cord-023873-fidpskcs	146	25	after	after	IN
cord-023873-fidpskcs	146	26	haematological	haematological	JJ
cord-023873-fidpskcs	146	27	stem	stem	NN
cord-023873-fidpskcs	146	28	cell	cell	NN
cord-023873-fidpskcs	146	29	transplantation	transplantation	NN
cord-023873-fidpskcs	146	30	for	for	IN
cord-023873-fidpskcs	146	31	acute	acute	JJ
cord-023873-fidpskcs	146	32	myeloid	myeloid	JJ
cord-023873-fidpskcs	146	33	leukaemia	leukaemia	NN
cord-023873-fidpskcs	146	34	.	.	.
cord-023873-fidpskcs	147	1	Chest	chest	NN
cord-023873-fidpskcs	147	2	X	x	NN
cord-023873-fidpskcs	147	3	-	-	NN
cord-023873-fidpskcs	147	4	ray	ray	NN
cord-023873-fidpskcs	147	5	reveals	reveal	VBZ
cord-023873-fidpskcs	147	6	a	a	DT
cord-023873-fidpskcs	147	7	right	right	RB
cord-023873-fidpskcs	147	8	-	-	HYPH
cord-023873-fidpskcs	147	9	sided	sided	JJ
cord-023873-fidpskcs	147	10	pleural	pleural	JJ
cord-023873-fidpskcs	147	11	effusion	effusion	NN
cord-023873-fidpskcs	147	12	and	and	CC
cord-023873-fidpskcs	147	13	adjacent	adjacent	JJ
cord-023873-fidpskcs	147	14	lung	lung	NN
cord-023873-fidpskcs	147	15	infiltrate	infiltrate	NN
cord-023873-fidpskcs	147	16	.	.	.
cord-023873-fidpskcs	148	1	CT	CT	NNP
cord-023873-fidpskcs	148	2	scan	scan	NNP
cord-023873-fidpskcs	148	3	confirms	confirm	VBZ
cord-023873-fidpskcs	148	4	a	a	DT
cord-023873-fidpskcs	148	5	right	right	JJ
cord-023873-fidpskcs	148	6	sided	sided	JJ
cord-023873-fidpskcs	148	7	complicated	complicated	JJ
cord-023873-fidpskcs	148	8	parapneumonic	parapneumonic	JJ
cord-023873-fidpskcs	148	9	effusion	effusion	NN
cord-023873-fidpskcs	148	10	,	,	,
cord-023873-fidpskcs	148	11	a	a	DT
cord-023873-fidpskcs	148	12	mass	mass	NN
cord-023873-fidpskcs	148	13	filled	fill	VBN
cord-023873-fidpskcs	148	14	partially	partially	RB
cord-023873-fidpskcs	148	15	with	with	IN
cord-023873-fidpskcs	148	16	air	air	NN
cord-023873-fidpskcs	148	17	between	between	IN
cord-023873-fidpskcs	148	18	the	the	DT
cord-023873-fidpskcs	148	19	4th	4th	JJ
cord-023873-fidpskcs	148	20	and	and	CC
cord-023873-fidpskcs	148	21	5th	5th	JJ
cord-023873-fidpskcs	148	22	rib	rib	NN
cord-023873-fidpskcs	148	23	(	(	-LRB-
cord-023873-fidpskcs	148	24	with	with	IN
cord-023873-fidpskcs	148	25	partial	partial	JJ
cord-023873-fidpskcs	148	26	destruction	destruction	NN
cord-023873-fidpskcs	148	27	of	of	IN
cord-023873-fidpskcs	148	28	the	the	DT
cord-023873-fidpskcs	148	29	bone	bone	NN
cord-023873-fidpskcs	148	30	)	)	-RRB-
cord-023873-fidpskcs	148	31	and	and	CC
cord-023873-fidpskcs	148	32	a	a	DT
cord-023873-fidpskcs	148	33	wedge	wedge	NN
cord-023873-fidpskcs	148	34	-	-	HYPH
cord-023873-fidpskcs	148	35	shaped	shape	VBN
cord-023873-fidpskcs	148	36	infiltrate	infiltrate	NN
cord-023873-fidpskcs	148	37	on	on	IN
cord-023873-fidpskcs	148	38	the	the	DT
cord-023873-fidpskcs	148	39	left	left	JJ
cord-023873-fidpskcs	148	40	side	side	NN
cord-023873-fidpskcs	148	41	.	.	.
cord-023873-fidpskcs	149	1	In	in	IN
cord-023873-fidpskcs	149	2	the	the	DT
cord-023873-fidpskcs	149	3	culture	culture	NN
cord-023873-fidpskcs	149	4	specimen	specimen	NN
cord-023873-fidpskcs	149	5	of	of	IN
cord-023873-fidpskcs	149	6	the	the	DT
cord-023873-fidpskcs	149	7	pleural	pleural	JJ
cord-023873-fidpskcs	149	8	fluid	fluid	NN
cord-023873-fidpskcs	149	9	grew	grow	VBD
cord-023873-fidpskcs	149	10	Aspergillus	Aspergillus	NNP
cord-023873-fidpskcs	149	11	fumigatus	fumigatus	NN
cord-023873-fidpskcs	149	12	.	.	.
cord-023873-fidpskcs	150	1	Findings	finding	NNS
cord-023873-fidpskcs	150	2	are	be	VBP
cord-023873-fidpskcs	150	3	compatible	compatible	JJ
cord-023873-fidpskcs	150	4	with	with	IN
cord-023873-fidpskcs	150	5	a	a	DT
cord-023873-fidpskcs	150	6	bronchopleural	bronchopleural	JJ
cord-023873-fidpskcs	150	7	fistula	fistula	NN
cord-023873-fidpskcs	150	8	,	,	,
cord-023873-fidpskcs	150	9	secondary	secondary	JJ
cord-023873-fidpskcs	150	10	to	to	TO
cord-023873-fidpskcs	150	11	rupture	rupture	VB
cord-023873-fidpskcs	150	12	of	of	IN
cord-023873-fidpskcs	150	13	a	a	DT
cord-023873-fidpskcs	150	14	cavitating	cavitating	JJ
cord-023873-fidpskcs	150	15	infiltrate	infiltrate	NN
cord-023873-fidpskcs	150	16	and	and	CC
cord-023873-fidpskcs	150	17	adjacent	adjacent	JJ
cord-023873-fidpskcs	150	18	bone	bone	NN
cord-023873-fidpskcs	150	19	destruction	destruction	NN
cord-023873-fidpskcs	151	1	Fig	Fig	NNP
cord-023873-fidpskcs	151	2	.	.	.
cord-023873-fidpskcs	152	1	4	4	LS
cord-023873-fidpskcs	153	1	Chest	chest	NN
cord-023873-fidpskcs	153	2	X	x	NN
cord-023873-fidpskcs	153	3	-	-	NN
cord-023873-fidpskcs	153	4	ray	ray	NN
cord-023873-fidpskcs	153	5	and	and	CC
cord-023873-fidpskcs	153	6	CT	CT	NNP
cord-023873-fidpskcs	153	7	scan	scan	NN
cord-023873-fidpskcs	154	1	2	2	CD
cord-023873-fidpskcs	154	2	months	month	NNS
cord-023873-fidpskcs	154	3	post	post	VBP
cord-023873-fidpskcs	154	4	kidney	kidney	NN
cord-023873-fidpskcs	154	5	transplantion	transplantion	NN
cord-023873-fidpskcs	154	6	for	for	IN
cord-023873-fidpskcs	154	7	end	end	JJ
cord-023873-fidpskcs	154	8	stage	stage	NN
cord-023873-fidpskcs	154	9	diabetes	diabetes	NN
cord-023873-fidpskcs	154	10	.	.	.
cord-023873-fidpskcs	155	1	Bilateral	bilateral	JJ
cord-023873-fidpskcs	155	2	lower	low	JJR
cord-023873-fidpskcs	155	3	lobe	lobe	NN
cord-023873-fidpskcs	155	4	cavities	cavity	NNS
cord-023873-fidpskcs	155	5	with	with	IN
cord-023873-fidpskcs	155	6	adjacent	adjacent	JJ
cord-023873-fidpskcs	155	7	pleural	pleural	JJ
cord-023873-fidpskcs	155	8	effusion	effusion	NN
cord-023873-fidpskcs	155	9	on	on	IN
cord-023873-fidpskcs	155	10	the	the	DT
cord-023873-fidpskcs	155	11	right	right	JJ
cord-023873-fidpskcs	155	12	side	side	NN
cord-023873-fidpskcs	155	13	are	be	VBP
cord-023873-fidpskcs	155	14	seen	see	VBN
cord-023873-fidpskcs	155	15	.	.	.
cord-023873-fidpskcs	156	1	Transbronchial	Transbronchial	NNP
cord-023873-fidpskcs	156	2	biopsy	biopsy	NN
cord-023873-fidpskcs	156	3	revealed	reveal	VBD
cord-023873-fidpskcs	156	4	Aspergillus	Aspergillus	NNP
cord-023873-fidpskcs	156	5	fumigatus	fumigatus	NN
cord-023873-fidpskcs	156	6	.	.	.
cord-023873-fidpskcs	157	1	Serum	serum	NN
cord-023873-fidpskcs	157	2	and	and	CC
cord-023873-fidpskcs	157	3	BAL	BAL	NNP
cord-023873-fidpskcs	157	4	galactomannan	galactomannan	NNP
cord-023873-fidpskcs	157	5	was	be	VBD
cord-023873-fidpskcs	157	6	0.1	0.1	CD
cord-023873-fidpskcs	157	7	and	and	CC
cord-023873-fidpskcs	157	8	5.7	5.7	CD
cord-023873-fidpskcs	157	9	ng	ng	NN
cord-023873-fidpskcs	157	10	/	/	SYM
cord-023873-fidpskcs	157	11	ml	ml	NNS
cord-023873-fidpskcs	157	12	,	,	,
cord-023873-fidpskcs	157	13	respectively	respectively	RB
cord-023873-fidpskcs	157	14	.	.	.
cord-023873-fidpskcs	158	1	Despite	despite	IN
cord-023873-fidpskcs	158	2	antifungal	antifungal	JJ
cord-023873-fidpskcs	158	3	treatment	treatment	NN
cord-023873-fidpskcs	158	4	,	,	,
cord-023873-fidpskcs	158	5	patient	patient	NN
cord-023873-fidpskcs	158	6	died	die	VBD
cord-023873-fidpskcs	158	7	of	of	IN
cord-023873-fidpskcs	158	8	proven	prove	VBN
cord-023873-fidpskcs	158	9	Aspergillus	aspergillus	NN
cord-023873-fidpskcs	158	10	endocarditis	endocarditis	NN
cord-023873-fidpskcs	158	11	of	of	IN
cord-023873-fidpskcs	158	12	the	the	DT
cord-023873-fidpskcs	158	13	tricuspid	tricuspid	NN
cord-023873-fidpskcs	158	14	valve	valve	NN
cord-023873-fidpskcs	158	15	lining	line	VBG
cord-023873-fidpskcs	158	16	fluid	fluid	JJ
cord-023873-fidpskcs	158	17	concentration	concentration	NN
cord-023873-fidpskcs	158	18	of	of	IN
cord-023873-fidpskcs	158	19	piperacillin	piperacillin	NN
cord-023873-fidpskcs	158	20	is	be	VBZ
cord-023873-fidpskcs	158	21	about	about	IN
cord-023873-fidpskcs	158	22	half	half	NN
cord-023873-fidpskcs	158	23	of	of	IN
cord-023873-fidpskcs	158	24	the	the	DT
cord-023873-fidpskcs	158	25	serum	serum	NN
cord-023873-fidpskcs	158	26	steady	steady	JJ
cord-023873-fidpskcs	158	27	state	state	NN
cord-023873-fidpskcs	158	28	concentrations	concentration	NNS
cord-023873-fidpskcs	158	29	[	[	-LRB-
cord-023873-fidpskcs	158	30	40	40	CD
cord-023873-fidpskcs	158	31	]	]	-RRB-
cord-023873-fidpskcs	158	32	.	.	.
cord-023873-fidpskcs	159	1	Thus	thus	RB
cord-023873-fidpskcs	159	2	far	far	RB
cord-023873-fidpskcs	159	3	,	,	,
cord-023873-fidpskcs	159	4	no	no	DT
cord-023873-fidpskcs	159	5	prospective	prospective	JJ
cord-023873-fidpskcs	159	6	data	datum	NNS
cord-023873-fidpskcs	159	7	on	on	IN
cord-023873-fidpskcs	159	8	PCR	PCR	NNP
cord-023873-fidpskcs	159	9	detection	detection	NN
cord-023873-fidpskcs	159	10	are	be	VBP
cord-023873-fidpskcs	159	11	available	available	JJ
cord-023873-fidpskcs	159	12	in	in	IN
cord-023873-fidpskcs	159	13	ICU	ICU	NNP
cord-023873-fidpskcs	159	14	patients	patient	NNS
cord-023873-fidpskcs	159	15	,	,	,
cord-023873-fidpskcs	159	16	and	and	CC
cord-023873-fidpskcs	159	17	the	the	DT
cord-023873-fidpskcs	159	18	usefulness	usefulness	NN
cord-023873-fidpskcs	159	19	of	of	IN
cord-023873-fidpskcs	159	20	combining	combine	VBG
cord-023873-fidpskcs	159	21	different	different	JJ
cord-023873-fidpskcs	159	22	diagnostic	diagnostic	JJ
cord-023873-fidpskcs	159	23	test	test	NN
cord-023873-fidpskcs	159	24	in	in	IN
cord-023873-fidpskcs	159	25	these	these	DT
cord-023873-fidpskcs	159	26	patients	patient	NNS
cord-023873-fidpskcs	159	27	is	be	VBZ
cord-023873-fidpskcs	159	28	also	also	RB
cord-023873-fidpskcs	159	29	unknown	unknown	JJ
cord-023873-fidpskcs	159	30	.	.	.
cord-023873-fidpskcs	160	1	6	6	CD
cord-023873-fidpskcs	160	2	Antifungals	Antifungals	NNPS
cord-023873-fidpskcs	160	3	for	for	IN
cord-023873-fidpskcs	160	4	the	the	DT
cord-023873-fidpskcs	160	5	Treatment	Treatment	NNP
cord-023873-fidpskcs	160	6	of	of	IN
cord-023873-fidpskcs	160	7	IA	IA	NNP
cord-023873-fidpskcs	160	8	in	in	IN
cord-023873-fidpskcs	160	9	the	the	DT
cord-023873-fidpskcs	160	10	ICU	ICU	NNP
cord-023873-fidpskcs	160	11	Treatment	Treatment	NNP
cord-023873-fidpskcs	160	12	options	option	NNS
cord-023873-fidpskcs	160	13	for	for	IN
cord-023873-fidpskcs	160	14	IA	IA	NNP
cord-023873-fidpskcs	160	15	are	be	VBP
cord-023873-fidpskcs	160	16	reviewed	review	VBN
cord-023873-fidpskcs	160	17	in	in	IN
cord-023873-fidpskcs	160	18	the	the	DT
cord-023873-fidpskcs	160	19	chapter	chapter	NN
cord-023873-fidpskcs	160	20	by	by	IN
cord-023873-fidpskcs	160	21	Dr	Dr	NNP
cord-023873-fidpskcs	160	22	Marr	Marr	NNP
cord-023873-fidpskcs	160	23	.	.	.
cord-023873-fidpskcs	161	1	In	in	IN
cord-023873-fidpskcs	161	2	summary	summary	NN
cord-023873-fidpskcs	161	3	,	,	,
cord-023873-fidpskcs	161	4	amphotericin	amphotericin	NNP
cord-023873-fidpskcs	161	5	B	B	NNP
cord-023873-fidpskcs	161	6	deoxycholate	deoxycholate	NN
cord-023873-fidpskcs	161	7	was	be	VBD
cord-023873-fidpskcs	161	8	the	the	DT
cord-023873-fidpskcs	161	9	mainstay	mainstay	NN
cord-023873-fidpskcs	161	10	for	for	IN
cord-023873-fidpskcs	161	11	the	the	DT
cord-023873-fidpskcs	161	12	treatment	treatment	NN
cord-023873-fidpskcs	161	13	of	of	IN
cord-023873-fidpskcs	161	14	IA	IA	NNP
cord-023873-fidpskcs	161	15	for	for	IN
cord-023873-fidpskcs	161	16	a	a	DT
cord-023873-fidpskcs	161	17	long	long	JJ
cord-023873-fidpskcs	161	18	time	time	NN
cord-023873-fidpskcs	161	19	.	.	.
cord-023873-fidpskcs	162	1	However	however	RB
cord-023873-fidpskcs	162	2	,	,	,
cord-023873-fidpskcs	162	3	this	this	DT
cord-023873-fidpskcs	162	4	formulation	formulation	NN
cord-023873-fidpskcs	162	5	is	be	VBZ
cord-023873-fidpskcs	162	6	infamous	infamous	JJ
cord-023873-fidpskcs	162	7	for	for	IN
cord-023873-fidpskcs	162	8	the	the	DT
cord-023873-fidpskcs	162	9	occurrence	occurrence	NN
cord-023873-fidpskcs	162	10	of	of	IN
cord-023873-fidpskcs	162	11	serious	serious	JJ
cord-023873-fidpskcs	162	12	side	side	NN
cord-023873-fidpskcs	162	13	effects	effect	NNS
cord-023873-fidpskcs	162	14	(	(	-LRB-
cord-023873-fidpskcs	162	15	e.g.	e.g.	RB
cord-023873-fidpskcs	162	16	,	,	,
cord-023873-fidpskcs	162	17	nephrotoxicity	nephrotoxicity	NN
cord-023873-fidpskcs	162	18	,	,	,
cord-023873-fidpskcs	162	19	hypokalemia	hypokalemia	NN
cord-023873-fidpskcs	162	20	,	,	,
cord-023873-fidpskcs	162	21	and	and	CC
cord-023873-fidpskcs	162	22	infusion	infusion	NN
cord-023873-fidpskcs	162	23	-	-	HYPH
cord-023873-fidpskcs	162	24	related	relate	VBN
cord-023873-fidpskcs	162	25	reactions	reaction	NNS
cord-023873-fidpskcs	162	26	)	)	-RRB-
cord-023873-fidpskcs	162	27	.	.	.
cord-023873-fidpskcs	163	1	These	these	DT
cord-023873-fidpskcs	163	2	events	event	NNS
cord-023873-fidpskcs	163	3	often	often	RB
cord-023873-fidpskcs	163	4	result	result	VBP
cord-023873-fidpskcs	163	5	in	in	IN
cord-023873-fidpskcs	163	6	the	the	DT
cord-023873-fidpskcs	163	7	use	use	NN
cord-023873-fidpskcs	163	8	of	of	IN
cord-023873-fidpskcs	163	9	suboptimal	suboptimal	JJ
cord-023873-fidpskcs	163	10	dosing	dose	VBG
cord-023873-fidpskcs	163	11	regimens	regimen	NNS
cord-023873-fidpskcs	163	12	.	.	.
cord-023873-fidpskcs	164	1	Recently	recently	RB
cord-023873-fidpskcs	164	2	voriconazole	voriconazole	NNP
cord-023873-fidpskcs	164	3	,	,	,
cord-023873-fidpskcs	164	4	a	a	DT
cord-023873-fidpskcs	164	5	derivative	derivative	NN
cord-023873-fidpskcs	164	6	of	of	IN
cord-023873-fidpskcs	164	7	fluconazole	fluconazole	NN
cord-023873-fidpskcs	164	8	,	,	,
cord-023873-fidpskcs	164	9	has	have	VBZ
cord-023873-fidpskcs	164	10	become	become	VBN
cord-023873-fidpskcs	164	11	the	the	DT
cord-023873-fidpskcs	164	12	new	new	JJ
cord-023873-fidpskcs	164	13	standard	standard	NN
cord-023873-fidpskcs	164	14	of	of	IN
cord-023873-fidpskcs	164	15	care	care	NN
cord-023873-fidpskcs	164	16	for	for	IN
cord-023873-fidpskcs	164	17	treating	treat	VBG
cord-023873-fidpskcs	164	18	IA	IA	NNP
cord-023873-fidpskcs	164	19	[	[	-LRB-
cord-023873-fidpskcs	164	20	41	41	CD
cord-023873-fidpskcs	164	21	]	]	-RRB-
cord-023873-fidpskcs	164	22	.	.	.
cord-023873-fidpskcs	165	1	Caspofungin	Caspofungin	NNP
cord-023873-fidpskcs	165	2	,	,	,
cord-023873-fidpskcs	165	3	micafungin	micafungin	NNP
cord-023873-fidpskcs	165	4	,	,	,
cord-023873-fidpskcs	165	5	and	and	CC
cord-023873-fidpskcs	165	6	anidulafungin	anidulafungin	NNP
cord-023873-fidpskcs	165	7	belong	belong	VBP
cord-023873-fidpskcs	165	8	to	to	IN
cord-023873-fidpskcs	165	9	a	a	DT
cord-023873-fidpskcs	165	10	new	new	JJ
cord-023873-fidpskcs	165	11	class	class	NN
cord-023873-fidpskcs	165	12	of	of	IN
cord-023873-fidpskcs	165	13	antifungal	antifungal	JJ
cord-023873-fidpskcs	165	14	drugs	drug	NNS
cord-023873-fidpskcs	165	15	,	,	,
cord-023873-fidpskcs	165	16	the	the	DT
cord-023873-fidpskcs	165	17	echinocandins	echinocandin	NNS
cord-023873-fidpskcs	165	18	,	,	,
cord-023873-fidpskcs	165	19	which	which	WDT
cord-023873-fidpskcs	165	20	act	act	VBP
cord-023873-fidpskcs	165	21	by	by	IN
cord-023873-fidpskcs	165	22	inhibiting	inhibit	VBG
cord-023873-fidpskcs	165	23	the	the	DT
cord-023873-fidpskcs	165	24	synthesis	synthesis	NN
cord-023873-fidpskcs	165	25	of	of	IN
cord-023873-fidpskcs	165	26	ß-(1,3)-D	ß-(1,3)-D	NNP
cord-023873-fidpskcs	165	27	-	-	HYPH
cord-023873-fidpskcs	165	28	glucan	glucan	NN
cord-023873-fidpskcs	165	29	in	in	IN
cord-023873-fidpskcs	165	30	the	the	DT
cord-023873-fidpskcs	165	31	fungal	fungal	JJ
cord-023873-fidpskcs	165	32	cell	cell	NN
cord-023873-fidpskcs	165	33	wall	wall	NN
cord-023873-fidpskcs	165	34	.	.	.
cord-023873-fidpskcs	166	1	Echinocandins	Echinocandins	NNP
cord-023873-fidpskcs	166	2	display	display	NN
cord-023873-fidpskcs	166	3	activity	activity	NN
cord-023873-fidpskcs	166	4	against	against	IN
cord-023873-fidpskcs	166	5	Aspergillus	aspergillus	NN
cord-023873-fidpskcs	166	6	species	specie	NNS
cord-023873-fidpskcs	166	7	,	,	,
cord-023873-fidpskcs	166	8	as	as	IN
cord-023873-fidpskcs	166	9	demonstrated	demonstrate	VBN
cord-023873-fidpskcs	166	10	in	in	IN
cord-023873-fidpskcs	166	11	several	several	JJ
cord-023873-fidpskcs	166	12	salvage	salvage	NN
cord-023873-fidpskcs	166	13	studies	study	NNS
cord-023873-fidpskcs	166	14	,	,	,
cord-023873-fidpskcs	166	15	but	but	CC
cord-023873-fidpskcs	166	16	convincing	convince	VBG
cord-023873-fidpskcs	166	17	first	first	JJ
cord-023873-fidpskcs	166	18	-	-	HYPH
cord-023873-fidpskcs	166	19	line	line	NN
cord-023873-fidpskcs	166	20	data	datum	NNS
cord-023873-fidpskcs	166	21	are	be	VBP
cord-023873-fidpskcs	166	22	still	still	RB
cord-023873-fidpskcs	166	23	lacking	lack	VBG
cord-023873-fidpskcs	166	24	.	.	.
cord-023873-fidpskcs	167	1	However	however	RB
cord-023873-fidpskcs	167	2	,	,	,
cord-023873-fidpskcs	167	3	most	most	JJS
cord-023873-fidpskcs	167	4	patients	patient	NNS
cord-023873-fidpskcs	167	5	recruited	recruit	VBN
cord-023873-fidpskcs	167	6	in	in	IN
cord-023873-fidpskcs	167	7	these	these	DT
cord-023873-fidpskcs	167	8	first	first	JJ
cord-023873-fidpskcs	167	9	-	-	HYPH
cord-023873-fidpskcs	167	10	and	and	CC
cord-023873-fidpskcs	167	11	second	second	JJ
cord-023873-fidpskcs	167	12	-	-	HYPH
cord-023873-fidpskcs	167	13	line	line	NN
cord-023873-fidpskcs	167	14	treatment	treatment	NN
cord-023873-fidpskcs	167	15	studies	study	NNS
cord-023873-fidpskcs	167	16	suffered	suffer	VBD
cord-023873-fidpskcs	167	17	from	from	IN
cord-023873-fidpskcs	167	18	an	an	DT
cord-023873-fidpskcs	167	19	underlying	underlying	JJ
cord-023873-fidpskcs	167	20	haematological	haematological	JJ
cord-023873-fidpskcs	167	21	disorder	disorder	NN
cord-023873-fidpskcs	167	22	or	or	CC
cord-023873-fidpskcs	167	23	were	be	VBD
cord-023873-fidpskcs	167	24	transplant	transplant	NN
cord-023873-fidpskcs	167	25	recipients	recipient	NNS
cord-023873-fidpskcs	167	26	.	.	.
cord-023873-fidpskcs	168	1	Patients	patient	NNS
cord-023873-fidpskcs	168	2	with	with	IN
cord-023873-fidpskcs	168	3	baseline	baseline	JJ
cord-023873-fidpskcs	168	4	characteristics	characteristic	NNS
cord-023873-fidpskcs	168	5	that	that	WDT
cord-023873-fidpskcs	168	6	are	be	VBP
cord-023873-fidpskcs	168	7	commonly	commonly	RB
cord-023873-fidpskcs	168	8	seen	see	VBN
cord-023873-fidpskcs	168	9	in	in	IN
cord-023873-fidpskcs	168	10	ICU	ICU	NNP
cord-023873-fidpskcs	168	11	patients	patient	NNS
cord-023873-fidpskcs	168	12	have	have	VBP
cord-023873-fidpskcs	168	13	usually	usually	RB
cord-023873-fidpskcs	168	14	been	be	VBN
cord-023873-fidpskcs	168	15	excluded	exclude	VBN
cord-023873-fidpskcs	168	16	from	from	IN
cord-023873-fidpskcs	168	17	these	these	DT
cord-023873-fidpskcs	168	18	studies	study	NNS
cord-023873-fidpskcs	168	19	,	,	,
cord-023873-fidpskcs	168	20	including	include	VBG
cord-023873-fidpskcs	168	21	those	those	DT
cord-023873-fidpskcs	168	22	with	with	IN
cord-023873-fidpskcs	168	23	liver	liver	NN
cord-023873-fidpskcs	168	24	function	function	NN
cord-023873-fidpskcs	168	25	abnormalities	abnormality	NNS
cord-023873-fidpskcs	168	26	,	,	,
cord-023873-fidpskcs	168	27	coagulation	coagulation	NN
cord-023873-fidpskcs	168	28	disorders	disorder	NNS
cord-023873-fidpskcs	168	29	,	,	,
cord-023873-fidpskcs	168	30	or	or	CC
cord-023873-fidpskcs	168	31	renal	renal	JJ
cord-023873-fidpskcs	168	32	dysfunction	dysfunction	NN
cord-023873-fidpskcs	168	33	,	,	,
cord-023873-fidpskcs	168	34	and	and	CC
cord-023873-fidpskcs	168	35	patients	patient	NNS
cord-023873-fidpskcs	168	36	in	in	IN
cord-023873-fidpskcs	168	37	need	need	NN
cord-023873-fidpskcs	168	38	of	of	IN
cord-023873-fidpskcs	168	39	advanced	advanced	JJ
cord-023873-fidpskcs	168	40	cardiovascular	cardiovascular	JJ
cord-023873-fidpskcs	168	41	or	or	CC
cord-023873-fidpskcs	168	42	pulmonary	pulmonary	JJ
cord-023873-fidpskcs	168	43	support	support	NN
cord-023873-fidpskcs	168	44	including	include	VBG
cord-023873-fidpskcs	168	45	mechanical	mechanical	JJ
cord-023873-fidpskcs	168	46	ventilation	ventilation	NN
cord-023873-fidpskcs	168	47	.	.	.
cord-023873-fidpskcs	169	1	Therefore	therefore	RB
cord-023873-fidpskcs	169	2	,	,	,
cord-023873-fidpskcs	169	3	data	datum	NNS
cord-023873-fidpskcs	169	4	on	on	IN
cord-023873-fidpskcs	169	5	antifungal	antifungal	JJ
cord-023873-fidpskcs	169	6	treatment	treatment	NN
cord-023873-fidpskcs	169	7	in	in	IN
cord-023873-fidpskcs	169	8	the	the	DT
cord-023873-fidpskcs	169	9	ICU	ICU	NNP
cord-023873-fidpskcs	169	10	remain	remain	VBP
cord-023873-fidpskcs	169	11	anecdotal	anecdotal	JJ
cord-023873-fidpskcs	169	12	.	.	.
cord-023873-fidpskcs	170	1	In	in	IN
cord-023873-fidpskcs	170	2	addition	addition	NN
cord-023873-fidpskcs	170	3	,	,	,
cord-023873-fidpskcs	170	4	many	many	JJ
cord-023873-fidpskcs	170	5	aspects	aspect	NNS
cord-023873-fidpskcs	170	6	of	of	IN
cord-023873-fidpskcs	170	7	antifungal	antifungal	JJ
cord-023873-fidpskcs	170	8	therapy	therapy	NN
cord-023873-fidpskcs	170	9	that	that	WDT
cord-023873-fidpskcs	170	10	are	be	VBP
cord-023873-fidpskcs	170	11	relevant	relevant	JJ
cord-023873-fidpskcs	170	12	to	to	IN
cord-023873-fidpskcs	170	13	the	the	DT
cord-023873-fidpskcs	170	14	ICU	ICU	NNP
cord-023873-fidpskcs	170	15	population	population	NN
cord-023873-fidpskcs	170	16	have	have	VBP
cord-023873-fidpskcs	170	17	not	not	RB
cord-023873-fidpskcs	170	18	been	be	VBN
cord-023873-fidpskcs	170	19	sufficiently	sufficiently	RB
cord-023873-fidpskcs	170	20	addressed	address	VBN
cord-023873-fidpskcs	170	21	in	in	IN
cord-023873-fidpskcs	170	22	clinical	clinical	JJ
cord-023873-fidpskcs	170	23	studies	study	NNS
cord-023873-fidpskcs	170	24	,	,	,
cord-023873-fidpskcs	170	25	including	include	VBG
cord-023873-fidpskcs	170	26	the	the	DT
cord-023873-fidpskcs	170	27	pharmacokinetic	pharmacokinetic	JJ
cord-023873-fidpskcs	170	28	profile	profile	NN
cord-023873-fidpskcs	170	29	of	of	IN
cord-023873-fidpskcs	170	30	antifungals	antifungal	NNS
cord-023873-fidpskcs	170	31	in	in	IN
cord-023873-fidpskcs	170	32	patients	patient	NNS
cord-023873-fidpskcs	170	33	with	with	IN
cord-023873-fidpskcs	170	34	underlying	underlying	JJ
cord-023873-fidpskcs	170	35	renal	renal	JJ
cord-023873-fidpskcs	170	36	,	,	,
cord-023873-fidpskcs	170	37	hepatic	hepatic	JJ
cord-023873-fidpskcs	170	38	and/or	and/or	CC
cord-023873-fidpskcs	170	39	cardiac	cardiac	JJ
cord-023873-fidpskcs	170	40	dysfunction	dysfunction	NN
cord-023873-fidpskcs	170	41	;	;	:
cord-023873-fidpskcs	170	42	the	the	DT
cord-023873-fidpskcs	170	43	dose	dose	JJ
cord-023873-fidpskcs	170	44	-	-	HYPH
cord-023873-fidpskcs	170	45	response	response	NN
cord-023873-fidpskcs	170	46	relationship	relationship	NN
cord-023873-fidpskcs	170	47	;	;	:
cord-023873-fidpskcs	170	48	and	and	CC
cord-023873-fidpskcs	170	49	the	the	DT
cord-023873-fidpskcs	170	50	best	good	JJS
cord-023873-fidpskcs	170	51	route	route	NN
cord-023873-fidpskcs	170	52	of	of	IN
cord-023873-fidpskcs	170	53	administration	administration	NN
cord-023873-fidpskcs	170	54	(	(	-LRB-
cord-023873-fidpskcs	170	55	oral	oral	JJ
cord-023873-fidpskcs	170	56	,	,	,
cord-023873-fidpskcs	170	57	enteral	enteral	NN
cord-023873-fidpskcs	170	58	,	,	,
cord-023873-fidpskcs	170	59	or	or	CC
cord-023873-fidpskcs	170	60	parenteral	parenteral	NN
cord-023873-fidpskcs	170	61	)	)	-RRB-
cord-023873-fidpskcs	170	62	.	.	.
cord-023873-fidpskcs	171	1	For	for	IN
cord-023873-fidpskcs	171	2	instance	instance	NN
cord-023873-fidpskcs	171	3	,	,	,
cord-023873-fidpskcs	171	4	a	a	DT
cord-023873-fidpskcs	171	5	recent	recent	JJ
cord-023873-fidpskcs	171	6	study	study	NN
cord-023873-fidpskcs	171	7	showed	show	VBD
cord-023873-fidpskcs	171	8	found	find	VBN
cord-023873-fidpskcs	171	9	nasogastric	nasogastric	NN
cord-023873-fidpskcs	171	10	/	/	SYM
cord-023873-fidpskcs	171	11	gastric	gastric	JJ
cord-023873-fidpskcs	171	12	administration	administration	NN
cord-023873-fidpskcs	171	13	of	of	IN
cord-023873-fidpskcs	171	14	voriconazole	voriconazole	NNP
cord-023873-fidpskcs	171	15	to	to	TO
cord-023873-fidpskcs	171	16	be	be	VB
cord-023873-fidpskcs	171	17	an	an	DT
cord-023873-fidpskcs	171	18	independent	independent	JJ
cord-023873-fidpskcs	171	19	predictor	predictor	NN
cord-023873-fidpskcs	171	20	for	for	IN
cord-023873-fidpskcs	171	21	undetectable	undetectable	JJ
cord-023873-fidpskcs	171	22	voriconazole	voriconazole	NN
cord-023873-fidpskcs	171	23	serum	serum	NN
cord-023873-fidpskcs	171	24	concentrations	concentration	NNS
cord-023873-fidpskcs	171	25	[	[	-LRB-
cord-023873-fidpskcs	171	26	42	42	CD
cord-023873-fidpskcs	171	27	]	]	-RRB-
cord-023873-fidpskcs	171	28	.	.	.
cord-023873-fidpskcs	172	1	Other	other	JJ
cord-023873-fidpskcs	172	2	important	important	JJ
cord-023873-fidpskcs	172	3	questions	question	NNS
cord-023873-fidpskcs	172	4	that	that	WDT
cord-023873-fidpskcs	172	5	should	should	MD
cord-023873-fidpskcs	172	6	be	be	VB
cord-023873-fidpskcs	172	7	better	well	RBR
cord-023873-fidpskcs	172	8	addressed	address	VBN
cord-023873-fidpskcs	172	9	include	include	VBP
cord-023873-fidpskcs	172	10	the	the	DT
cord-023873-fidpskcs	172	11	monitoring	monitoring	NN
cord-023873-fidpskcs	172	12	of	of	IN
cord-023873-fidpskcs	172	13	drug	drug	NN
cord-023873-fidpskcs	172	14	-	-	HYPH
cord-023873-fidpskcs	172	15	related	relate	VBN
cord-023873-fidpskcs	172	16	toxicities	toxicity	NNS
cord-023873-fidpskcs	172	17	,	,	,
cord-023873-fidpskcs	172	18	and	and	CC
cord-023873-fidpskcs	172	19	especially	especially	RB
cord-023873-fidpskcs	172	20	drug	drug	NN
cord-023873-fidpskcs	172	21	interactions	interaction	NNS
cord-023873-fidpskcs	172	22	with	with	IN
cord-023873-fidpskcs	172	23	frequently	frequently	RB
cord-023873-fidpskcs	172	24	used	use	VBN
cord-023873-fidpskcs	172	25	"	"	``
cord-023873-fidpskcs	172	26	ICU	ICU	NNP
cord-023873-fidpskcs	172	27	-	-	HYPH
cord-023873-fidpskcs	172	28	drugs	drug	NNS
cord-023873-fidpskcs	172	29	"	"	''
cord-023873-fidpskcs	172	30	.	.	.
cord-023873-fidpskcs	173	1	In	in	IN
cord-023873-fidpskcs	173	2	an	an	DT
cord-023873-fidpskcs	173	3	era	era	NN
cord-023873-fidpskcs	173	4	of	of	IN
cord-023873-fidpskcs	173	5	increased	increase	VBN
cord-023873-fidpskcs	173	6	availability	availability	NN
cord-023873-fidpskcs	173	7	of	of	IN
cord-023873-fidpskcs	173	8	new	new	JJ
cord-023873-fidpskcs	173	9	immunosuppressive	immunosuppressive	JJ
cord-023873-fidpskcs	173	10	drugs	drug	NNS
cord-023873-fidpskcs	173	11	and	and	CC
cord-023873-fidpskcs	173	12	better	well	JJR
cord-023873-fidpskcs	173	13	intensive	intensive	JJ
cord-023873-fidpskcs	173	14	care	care	NN
cord-023873-fidpskcs	173	15	with	with	IN
cord-023873-fidpskcs	173	16	prolonged	prolonged	JJ
cord-023873-fidpskcs	173	17	survival	survival	NN
cord-023873-fidpskcs	173	18	,	,	,
cord-023873-fidpskcs	173	19	we	-PRON-	PRP
cord-023873-fidpskcs	173	20	can	can	MD
cord-023873-fidpskcs	173	21	expect	expect	VB
cord-023873-fidpskcs	173	22	a	a	DT
cord-023873-fidpskcs	173	23	continuing	continue	VBG
cord-023873-fidpskcs	173	24	rise	rise	NN
cord-023873-fidpskcs	173	25	in	in	IN
cord-023873-fidpskcs	173	26	the	the	DT
cord-023873-fidpskcs	173	27	incidence	incidence	NN
cord-023873-fidpskcs	173	28	of	of	IN
cord-023873-fidpskcs	173	29	IA	IA	NNP
cord-023873-fidpskcs	173	30	.	.	.
cord-023873-fidpskcs	174	1	Its	-PRON-	PRP$
cord-023873-fidpskcs	174	2	occurrence	occurrence	NN
cord-023873-fidpskcs	174	3	in	in	IN
cord-023873-fidpskcs	174	4	ICU	ICU	NNP
cord-023873-fidpskcs	174	5	usually	usually	RB
cord-023873-fidpskcs	174	6	entails	entail	VBZ
cord-023873-fidpskcs	174	7	a	a	DT
cord-023873-fidpskcs	174	8	poor	poor	JJ
cord-023873-fidpskcs	174	9	prognosis	prognosis	NN
cord-023873-fidpskcs	174	10	despite	despite	IN
cord-023873-fidpskcs	174	11	major	major	JJ
cord-023873-fidpskcs	174	12	recent	recent	JJ
cord-023873-fidpskcs	174	13	improvements	improvement	NNS
cord-023873-fidpskcs	174	14	in	in	IN
cord-023873-fidpskcs	174	15	the	the	DT
cord-023873-fidpskcs	174	16	diagnosis	diagnosis	NN
cord-023873-fidpskcs	174	17	and	and	CC
cord-023873-fidpskcs	174	18	treatment	treatment	NN
cord-023873-fidpskcs	174	19	of	of	IN
cord-023873-fidpskcs	174	20	IA	IA	NNP
cord-023873-fidpskcs	174	21	in	in	IN
cord-023873-fidpskcs	174	22	patients	patient	NNS
cord-023873-fidpskcs	174	23	with	with	IN
cord-023873-fidpskcs	174	24	haematological	haematological	JJ
cord-023873-fidpskcs	174	25	diseases	disease	NNS
cord-023873-fidpskcs	174	26	.	.	.
cord-023873-fidpskcs	175	1	Multicenter	multicenter	JJ
cord-023873-fidpskcs	175	2	studies	study	NNS
cord-023873-fidpskcs	175	3	are	be	VBP
cord-023873-fidpskcs	175	4	warranted	warrant	VBN
cord-023873-fidpskcs	175	5	to	to	TO
cord-023873-fidpskcs	175	6	explore	explore	VB
cord-023873-fidpskcs	175	7	the	the	DT
cord-023873-fidpskcs	175	8	exact	exact	JJ
cord-023873-fidpskcs	175	9	incidence	incidence	NN
cord-023873-fidpskcs	175	10	of	of	IN
cord-023873-fidpskcs	175	11	IA	IA	NNP
cord-023873-fidpskcs	175	12	in	in	IN
cord-023873-fidpskcs	175	13	the	the	DT
cord-023873-fidpskcs	175	14	ICU	ICU	NNP
cord-023873-fidpskcs	175	15	and	and	CC
cord-023873-fidpskcs	175	16	to	to	TO
cord-023873-fidpskcs	175	17	better	better	RB
cord-023873-fidpskcs	175	18	delineate	delineate	VB
cord-023873-fidpskcs	175	19	the	the	DT
cord-023873-fidpskcs	175	20	difference	difference	NN
cord-023873-fidpskcs	175	21	between	between	IN
cord-023873-fidpskcs	175	22	hospital	hospital	NN
cord-023873-fidpskcs	175	23	-	-	HYPH
cord-023873-fidpskcs	175	24	acquired	acquire	VBN
cord-023873-fidpskcs	175	25	,	,	,
cord-023873-fidpskcs	175	26	ICU	ICU	NNP
cord-023873-fidpskcs	175	27	-	-	HYPH
cord-023873-fidpskcs	175	28	acquired	acquire	VBN
cord-023873-fidpskcs	175	29	and	and	CC
cord-023873-fidpskcs	175	30	community	community	NN
cord-023873-fidpskcs	175	31	-	-	HYPH
cord-023873-fidpskcs	175	32	acquired	acquire	VBN
cord-023873-fidpskcs	175	33	aspergillosis	aspergillosis	NN
cord-023873-fidpskcs	175	34	.	.	.
cord-023873-fidpskcs	176	1	Evaluating	evaluate	VBG
cord-023873-fidpskcs	176	2	the	the	DT
cord-023873-fidpskcs	176	3	value	value	NN
cord-023873-fidpskcs	176	4	of	of	IN
cord-023873-fidpskcs	176	5	galactomannan	galactomannan	NNP
cord-023873-fidpskcs	176	6	,	,	,
cord-023873-fidpskcs	176	7	β	β	NN
cord-023873-fidpskcs	176	8	-	-	HYPH
cord-023873-fidpskcs	176	9	D	D	NNP
cord-023873-fidpskcs	176	10	-	-	HYPH
cord-023873-fidpskcs	176	11	glucan	glucan	NN
cord-023873-fidpskcs	176	12	and	and	CC
cord-023873-fidpskcs	176	13	PCR	PCR	NNP
cord-023873-fidpskcs	176	14	in	in	IN
cord-023873-fidpskcs	176	15	non	non	JJ
cord-023873-fidpskcs	176	16	-	-	JJ
cord-023873-fidpskcs	176	17	neutropenic	neutropenic	JJ
cord-023873-fidpskcs	176	18	critically	critically	RB
cord-023873-fidpskcs	176	19	ill	ill	VBP
cord-023873-fidpskcs	176	20	patients	patient	NNS
cord-023873-fidpskcs	176	21	in	in	IN
cord-023873-fidpskcs	176	22	different	different	JJ
cord-023873-fidpskcs	176	23	sample	sample	NN
cord-023873-fidpskcs	176	24	types	type	NNS
cord-023873-fidpskcs	176	25	(	(	-LRB-
cord-023873-fidpskcs	176	26	and	and	CC
cord-023873-fidpskcs	176	27	especially	especially	RB
cord-023873-fidpskcs	176	28	in	in	IN
cord-023873-fidpskcs	176	29	respiratory	respiratory	JJ
cord-023873-fidpskcs	176	30	samples	sample	NNS
cord-023873-fidpskcs	176	31	)	)	-RRB-
cord-023873-fidpskcs	176	32	is	be	VBZ
cord-023873-fidpskcs	176	33	urgently	urgently	RB
cord-023873-fidpskcs	176	34	needed	need	VBN
cord-023873-fidpskcs	176	35	as	as	RB
cord-023873-fidpskcs	176	36	well	well	RB
cord-023873-fidpskcs	176	37	as	as	IN
cord-023873-fidpskcs	176	38	a	a	DT
cord-023873-fidpskcs	176	39	better	well	JJR
cord-023873-fidpskcs	176	40	delineation	delineation	NN
cord-023873-fidpskcs	176	41	of	of	IN
cord-023873-fidpskcs	176	42	the	the	DT
cord-023873-fidpskcs	176	43	patient	patient	JJ
cord-023873-fidpskcs	176	44	population	population	NN
cord-023873-fidpskcs	176	45	at	at	IN
cord-023873-fidpskcs	176	46	risk	risk	NN
cord-023873-fidpskcs	176	47	for	for	IN
cord-023873-fidpskcs	176	48	IA	IA	NNP
cord-023873-fidpskcs	176	49	in	in	IN
cord-023873-fidpskcs	176	50	the	the	DT
cord-023873-fidpskcs	176	51	broad	broad	JJ
cord-023873-fidpskcs	176	52	group	group	NN
cord-023873-fidpskcs	176	53	of	of	IN
cord-023873-fidpskcs	176	54	critically	critically	RB
cord-023873-fidpskcs	176	55	ill	ill	JJ
cord-023873-fidpskcs	176	56	patients	patient	NNS
cord-023873-fidpskcs	176	57	.	.	.
cord-023873-fidpskcs	177	1	Finally	finally	RB
cord-023873-fidpskcs	177	2	,	,	,
cord-023873-fidpskcs	177	3	antifungal	antifungal	JJ
cord-023873-fidpskcs	177	4	pharmacokinetics	pharmacokinetic	NNS
cord-023873-fidpskcs	177	5	and	and	CC
cord-023873-fidpskcs	177	6	pharmacodynamics	pharmacodynamic	NNS
cord-023873-fidpskcs	177	7	and	and	CC
cord-023873-fidpskcs	177	8	interactions	interaction	NNS
cord-023873-fidpskcs	177	9	with	with	IN
cord-023873-fidpskcs	177	10	other	other	JJ
cord-023873-fidpskcs	177	11	drugs	drug	NNS
cord-023873-fidpskcs	177	12	need	need	VBP
cord-023873-fidpskcs	177	13	to	to	TO
cord-023873-fidpskcs	177	14	be	be	VB
cord-023873-fidpskcs	177	15	explored	explore	VBN
cord-023873-fidpskcs	177	16	more	more	RBR
cord-023873-fidpskcs	177	17	thoroughly	thoroughly	RB
cord-023873-fidpskcs	177	18	.	.	.
cord-023873-fidpskcs	178	1	Meanwhile	meanwhile	RB
cord-023873-fidpskcs	178	2	,	,	,
cord-023873-fidpskcs	178	3	all	all	DT
cord-023873-fidpskcs	178	4	new	new	JJ
cord-023873-fidpskcs	178	5	diagnostic	diagnostic	JJ
cord-023873-fidpskcs	178	6	techniques	technique	NNS
cord-023873-fidpskcs	178	7	and	and	CC
cord-023873-fidpskcs	178	8	therapeutic	therapeutic	JJ
cord-023873-fidpskcs	178	9	measures	measure	NNS
cord-023873-fidpskcs	178	10	must	must	MD
cord-023873-fidpskcs	178	11	be	be	VB
cord-023873-fidpskcs	178	12	validated	validate	VBN
cord-023873-fidpskcs	178	13	against	against	IN
cord-023873-fidpskcs	178	14	post	post	JJ
cord-023873-fidpskcs	178	15	-	-	JJ
cord-023873-fidpskcs	178	16	mortem	mortem	JJ
cord-023873-fidpskcs	178	17	findings	finding	NNS
cord-023873-fidpskcs	178	18	,	,	,
cord-023873-fidpskcs	178	19	since	since	IN
cord-023873-fidpskcs	178	20	only	only	RB
cord-023873-fidpskcs	178	21	proven	prove	VBN
cord-023873-fidpskcs	178	22	cases	case	NNS
cord-023873-fidpskcs	178	23	offer	offer	VBP
cord-023873-fidpskcs	178	24	the	the	DT
cord-023873-fidpskcs	178	25	most	most	RBS
cord-023873-fidpskcs	178	26	valuable	valuable	JJ
cord-023873-fidpskcs	178	27	information	information	NN
cord-023873-fidpskcs	178	28	.	.	.
cord-023873-fidpskcs	179	1	Trends	trend	NNS
cord-023873-fidpskcs	179	2	in	in	IN
cord-023873-fidpskcs	179	3	the	the	DT
cord-023873-fidpskcs	179	4	postmortem	postmortem	JJ
cord-023873-fidpskcs	179	5	epidemiology	epidemiology	NN
cord-023873-fidpskcs	179	6	of	of	IN
cord-023873-fidpskcs	179	7	invasive	invasive	JJ
cord-023873-fidpskcs	179	8	fungal	fungal	JJ
cord-023873-fidpskcs	179	9	infections	infection	NNS
cord-023873-fidpskcs	179	10	at	at	IN
cord-023873-fidpskcs	179	11	a	a	DT
cord-023873-fidpskcs	179	12	university	university	NN
cord-023873-fidpskcs	179	13	hospital	hospital	NN
cord-023873-fidpskcs	179	14	Revised	revise	VBN
cord-023873-fidpskcs	179	15	definitions	definition	NNS
cord-023873-fidpskcs	179	16	of	of	IN
cord-023873-fidpskcs	179	17	invasive	invasive	JJ
cord-023873-fidpskcs	179	18	fungal	fungal	JJ
cord-023873-fidpskcs	179	19	disease	disease	NN
cord-023873-fidpskcs	179	20	from	from	IN
cord-023873-fidpskcs	179	21	the	the	DT
cord-023873-fidpskcs	179	22	European	European	NNP
cord-023873-fidpskcs	179	23	Organization	Organization	NNP
cord-023873-fidpskcs	179	24	for	for	IN
cord-023873-fidpskcs	179	25	Research	Research	NNP
cord-023873-fidpskcs	179	26	and	and	CC
cord-023873-fidpskcs	179	27	Treatment	Treatment	NNP
cord-023873-fidpskcs	179	28	of	of	IN
cord-023873-fidpskcs	179	29	Cancer	Cancer	NNP
cord-023873-fidpskcs	179	30	/	/	SYM
cord-023873-fidpskcs	179	31	Invasive	invasive	JJ
cord-023873-fidpskcs	179	32	Fungal	Fungal	NNP
cord-023873-fidpskcs	179	33	Infections	Infections	NNPS
cord-023873-fidpskcs	179	34	Cooperative	Cooperative	NNP
cord-023873-fidpskcs	179	35	Group	Group	NNP
cord-023873-fidpskcs	179	36	and	and	CC
cord-023873-fidpskcs	179	37	the	the	DT
cord-023873-fidpskcs	179	38	Comparison	Comparison	NNP
cord-023873-fidpskcs	179	39	of	of	IN
cord-023873-fidpskcs	179	40	premortem	premortem	NNP
cord-023873-fidpskcs	179	41	clinical	clinical	JJ
cord-023873-fidpskcs	179	42	diagnoses	diagnosis	NNS
cord-023873-fidpskcs	179	43	in	in	IN
cord-023873-fidpskcs	179	44	critically	critically	RB
cord-023873-fidpskcs	179	45	iII	iii	CD
cord-023873-fidpskcs	179	46	patients	patient	NNS
cord-023873-fidpskcs	179	47	and	and	CC
cord-023873-fidpskcs	179	48	subsequent	subsequent	JJ
cord-023873-fidpskcs	179	49	autopsy	autopsy	JJ
cord-023873-fidpskcs	179	50	findings	finding	NNS
cord-023873-fidpskcs	179	51	Invasive	invasive	JJ
cord-023873-fidpskcs	179	52	aspergillosis	aspergillosis	NN
cord-023873-fidpskcs	179	53	in	in	IN
cord-023873-fidpskcs	179	54	critically	critically	RB
cord-023873-fidpskcs	179	55	ill	ill	JJ
cord-023873-fidpskcs	179	56	patients	patient	NNS
cord-023873-fidpskcs	179	57	without	without	IN
cord-023873-fidpskcs	179	58	malignancy	malignancy	NN
cord-023873-fidpskcs	179	59	Post	post	NN
cord-023873-fidpskcs	179	60	mortem	mortem	NN
cord-023873-fidpskcs	179	61	examination	examination	NN
cord-023873-fidpskcs	179	62	in	in	IN
cord-023873-fidpskcs	179	63	the	the	DT
cord-023873-fidpskcs	179	64	intensive	intensive	JJ
cord-023873-fidpskcs	179	65	care	care	NN
cord-023873-fidpskcs	179	66	unit	unit	NN
cord-023873-fidpskcs	179	67	:	:	:
cord-023873-fidpskcs	179	68	still	still	RB
cord-023873-fidpskcs	179	69	useful	useful	JJ
cord-023873-fidpskcs	179	70	?	?	.
cord-023873-fidpskcs	180	1	Duration	duration	NN
cord-023873-fidpskcs	180	2	of	of	IN
cord-023873-fidpskcs	180	3	hypotension	hypotension	NN
cord-023873-fidpskcs	180	4	before	before	IN
cord-023873-fidpskcs	180	5	initiation	initiation	NN
cord-023873-fidpskcs	180	6	of	of	IN
cord-023873-fidpskcs	180	7	effective	effective	JJ
cord-023873-fidpskcs	180	8	antimicrobial	antimicrobial	JJ
cord-023873-fidpskcs	180	9	therapy	therapy	NN
cord-023873-fidpskcs	180	10	is	be	VBZ
cord-023873-fidpskcs	180	11	the	the	DT
cord-023873-fidpskcs	180	12	critical	critical	JJ
cord-023873-fidpskcs	180	13	determinant	determinant	NN
cord-023873-fidpskcs	180	14	of	of	IN
cord-023873-fidpskcs	180	15	survival	survival	NN
cord-023873-fidpskcs	180	16	in	in	IN
cord-023873-fidpskcs	180	17	human	human	JJ
cord-023873-fidpskcs	180	18	septic	septic	JJ
cord-023873-fidpskcs	180	19	shock	shock	NN
cord-023873-fidpskcs	180	20	Clinical	clinical	JJ
cord-023873-fidpskcs	180	21	relevance	relevance	NN
cord-023873-fidpskcs	180	22	of	of	IN
cord-023873-fidpskcs	180	23	Aspergillus	aspergillus	NN
cord-023873-fidpskcs	180	24	isolation	isolation	NN
cord-023873-fidpskcs	180	25	from	from	IN
cord-023873-fidpskcs	180	26	respiratory	respiratory	JJ
cord-023873-fidpskcs	180	27	tract	tract	NN
cord-023873-fidpskcs	180	28	samples	sample	NNS
cord-023873-fidpskcs	180	29	in	in	IN
cord-023873-fidpskcs	180	30	critically	critically	RB
cord-023873-fidpskcs	180	31	ill	ill	JJ
cord-023873-fidpskcs	180	32	patients	patient	NNS
cord-023873-fidpskcs	181	1	A	a	DT
cord-023873-fidpskcs	181	2	7-year	7-year	CD
cord-023873-fidpskcs	181	3	study	study	NN
cord-023873-fidpskcs	181	4	of	of	IN
cord-023873-fidpskcs	181	5	severe	severe	JJ
cord-023873-fidpskcs	181	6	hospital	hospital	NN
cord-023873-fidpskcs	181	7	-	-	HYPH
cord-023873-fidpskcs	181	8	acquired	acquire	VBN
cord-023873-fidpskcs	181	9	pneumonia	pneumonia	NN
cord-023873-fidpskcs	181	10	requiring	require	VBG
cord-023873-fidpskcs	181	11	ICU	ICU	NNP
cord-023873-fidpskcs	181	12	admission	admission	NN
cord-023873-fidpskcs	181	13	Comparison	comparison	NN
cord-023873-fidpskcs	181	14	of	of	IN
cord-023873-fidpskcs	181	15	epidemiological	epidemiological	JJ
cord-023873-fidpskcs	181	16	,	,	,
cord-023873-fidpskcs	181	17	clinical	clinical	JJ
cord-023873-fidpskcs	181	18	,	,	,
cord-023873-fidpskcs	181	19	and	and	CC
cord-023873-fidpskcs	181	20	biological	biological	JJ
cord-023873-fidpskcs	181	21	features	feature	NNS
cord-023873-fidpskcs	181	22	of	of	IN
cord-023873-fidpskcs	181	23	invasive	invasive	JJ
cord-023873-fidpskcs	181	24	aspergillosis	aspergillosis	NN
cord-023873-fidpskcs	181	25	in	in	IN
cord-023873-fidpskcs	181	26	neutropenic	neutropenic	JJ
cord-023873-fidpskcs	181	27	and	and	CC
cord-023873-fidpskcs	181	28	nonneutropenic	nonneutropenic	JJ
cord-023873-fidpskcs	181	29	patients	patient	NNS
cord-023873-fidpskcs	181	30	:	:	:
cord-023873-fidpskcs	181	31	a	a	DT
cord-023873-fidpskcs	181	32	6-year	6-year	NNP
cord-023873-fidpskcs	181	33	survey	survey	NN
cord-023873-fidpskcs	181	34	Galactomannan	Galactomannan	NNP
cord-023873-fidpskcs	181	35	in	in	IN
cord-023873-fidpskcs	181	36	bronchoalveolar	bronchoalveolar	NNP
cord-023873-fidpskcs	181	37	lavage	lavage	NN
cord-023873-fidpskcs	181	38	fluid	fluid	NN
cord-023873-fidpskcs	181	39	:	:	:
cord-023873-fidpskcs	181	40	a	a	DT
cord-023873-fidpskcs	181	41	tool	tool	NN
cord-023873-fidpskcs	181	42	for	for	IN
cord-023873-fidpskcs	181	43	diagnosing	diagnose	VBG
cord-023873-fidpskcs	181	44	aspergillosis	aspergillosis	NN
cord-023873-fidpskcs	181	45	in	in	IN
cord-023873-fidpskcs	181	46	intensive	intensive	JJ
cord-023873-fidpskcs	181	47	care	care	NN
cord-023873-fidpskcs	181	48	unit	unit	NN
cord-023873-fidpskcs	181	49	patients	patient	VBZ
cord-023873-fidpskcs	181	50	Immunoparalysis	Immunoparalysis	NNP
cord-023873-fidpskcs	181	51	as	as	IN
cord-023873-fidpskcs	181	52	a	a	DT
cord-023873-fidpskcs	181	53	cause	cause	NN
cord-023873-fidpskcs	181	54	for	for	IN
cord-023873-fidpskcs	181	55	invasive	invasive	JJ
cord-023873-fidpskcs	181	56	aspergillosis	aspergillosis	NN
cord-023873-fidpskcs	181	57	?	?	.
cord-023873-fidpskcs	182	1	Effect	effect	NN
cord-023873-fidpskcs	182	2	of	of	IN
cord-023873-fidpskcs	182	3	treatment	treatment	NN
cord-023873-fidpskcs	182	4	with	with	IN
cord-023873-fidpskcs	182	5	low	low	JJ
cord-023873-fidpskcs	182	6	doses	dose	NNS
cord-023873-fidpskcs	182	7	of	of	IN
cord-023873-fidpskcs	182	8	hydrocortisone	hydrocortisone	NN
cord-023873-fidpskcs	182	9	and	and	CC
cord-023873-fidpskcs	182	10	fludrocortisone	fludrocortisone	NN
cord-023873-fidpskcs	182	11	on	on	IN
cord-023873-fidpskcs	182	12	mortality	mortality	NN
cord-023873-fidpskcs	182	13	in	in	IN
cord-023873-fidpskcs	182	14	patients	patient	NNS
cord-023873-fidpskcs	182	15	with	with	IN
cord-023873-fidpskcs	182	16	septic	septic	JJ
cord-023873-fidpskcs	182	17	shock	shock	NN
cord-023873-fidpskcs	182	18	Glucocorticoids	Glucocorticoids	NNP
cord-023873-fidpskcs	182	19	and	and	CC
cord-023873-fidpskcs	182	20	invasive	invasive	JJ
cord-023873-fidpskcs	182	21	fungal	fungal	JJ
cord-023873-fidpskcs	182	22	infections	infection	NNS
cord-023873-fidpskcs	183	1	Corticosteroid	corticosteroid	JJ
cord-023873-fidpskcs	183	2	treatment	treatment	NN
cord-023873-fidpskcs	183	3	as	as	IN
cord-023873-fidpskcs	183	4	a	a	DT
cord-023873-fidpskcs	183	5	risk	risk	NN
cord-023873-fidpskcs	183	6	factor	factor	NN
cord-023873-fidpskcs	183	7	for	for	IN
cord-023873-fidpskcs	183	8	invasive	invasive	JJ
cord-023873-fidpskcs	183	9	aspergillosis	aspergillosis	NN
cord-023873-fidpskcs	183	10	in	in	IN
cord-023873-fidpskcs	183	11	patients	patient	NNS
cord-023873-fidpskcs	183	12	with	with	IN
cord-023873-fidpskcs	183	13	lung	lung	NN
cord-023873-fidpskcs	183	14	disease	disease	NN
cord-023873-fidpskcs	183	15	Chronic	Chronic	NNP
cord-023873-fidpskcs	183	16	obstructive	obstructive	JJ
cord-023873-fidpskcs	183	17	pulmonary	pulmonary	JJ
cord-023873-fidpskcs	183	18	disease	disease	NN
cord-023873-fidpskcs	183	19	patients	patient	NNS
cord-023873-fidpskcs	183	20	with	with	IN
cord-023873-fidpskcs	183	21	invasive	invasive	JJ
cord-023873-fidpskcs	183	22	pulmonary	pulmonary	JJ
cord-023873-fidpskcs	183	23	aspergillosis	aspergillosis	NN
cord-023873-fidpskcs	183	24	:	:	:
cord-023873-fidpskcs	183	25	benefits	benefit	NNS
cord-023873-fidpskcs	183	26	of	of	IN
cord-023873-fidpskcs	183	27	intensive	intensive	JJ
cord-023873-fidpskcs	183	28	care	care	NN
cord-023873-fidpskcs	183	29	?	?	.
cord-023873-fidpskcs	184	1	Invasive	invasive	JJ
cord-023873-fidpskcs	184	2	pulmonary	pulmonary	JJ
cord-023873-fidpskcs	184	3	aspergillosis	aspergillosis	NN
cord-023873-fidpskcs	184	4	in	in	IN
cord-023873-fidpskcs	184	5	patients	patient	NNS
cord-023873-fidpskcs	184	6	with	with	IN
cord-023873-fidpskcs	184	7	chronic	chronic	JJ
cord-023873-fidpskcs	184	8	obstructive	obstructive	JJ
cord-023873-fidpskcs	184	9	pulmonary	pulmonary	JJ
cord-023873-fidpskcs	184	10	disease	disease	NN
cord-023873-fidpskcs	184	11	:	:	:
cord-023873-fidpskcs	184	12	report	report	NN
cord-023873-fidpskcs	184	13	of	of	IN
cord-023873-fidpskcs	184	14	eight	eight	CD
cord-023873-fidpskcs	184	15	cases	case	NNS
cord-023873-fidpskcs	184	16	and	and	CC
cord-023873-fidpskcs	184	17	review	review	VB
cord-023873-fidpskcs	184	18	Invasive	invasive	JJ
cord-023873-fidpskcs	184	19	Pulmonary	Pulmonary	NNP
cord-023873-fidpskcs	184	20	Aspergillosis	Aspergillosis	NNP
cord-023873-fidpskcs	184	21	(	(	-LRB-
cord-023873-fidpskcs	184	22	IPA	IPA	NNP
cord-023873-fidpskcs	184	23	)	)	-RRB-
cord-023873-fidpskcs	184	24	in	in	IN
cord-023873-fidpskcs	184	25	Patients	patient	NNS
cord-023873-fidpskcs	184	26	with	with	IN
cord-023873-fidpskcs	184	27	COPD	COPD	NNP
cord-023873-fidpskcs	184	28	:	:	:
cord-023873-fidpskcs	185	1	A	a	DT
cord-023873-fidpskcs	185	2	Description	description	NN
cord-023873-fidpskcs	185	3	of	of	IN
cord-023873-fidpskcs	185	4	57	57	CD
cord-023873-fidpskcs	185	5	48th	48th	NN
cord-023873-fidpskcs	185	6	Interscience	Interscience	NNP
cord-023873-fidpskcs	185	7	Conference	Conference	NNP
cord-023873-fidpskcs	185	8	on	on	IN
cord-023873-fidpskcs	185	9	Antimicrobial	Antimicrobial	NNP
cord-023873-fidpskcs	185	10	Agents	Agents	NNPS
cord-023873-fidpskcs	185	11	and	and	CC
cord-023873-fidpskcs	185	12	Chemotherapy	Chemotherapy	NNP
cord-023873-fidpskcs	185	13	Chronic	Chronic	NNP
cord-023873-fidpskcs	185	14	Obstructive	obstructive	JJ
cord-023873-fidpskcs	185	15	Pulmonary	Pulmonary	NNP
cord-023873-fidpskcs	185	16	Disease	Disease	NNP
cord-023873-fidpskcs	185	17	(	(	-LRB-
cord-023873-fidpskcs	185	18	COPD	COPD	NNP
cord-023873-fidpskcs	185	19	)	)	-RRB-
cord-023873-fidpskcs	185	20	is	be	VBZ
cord-023873-fidpskcs	185	21	Currently	currently	RB
cord-023873-fidpskcs	185	22	the	the	DT
cord-023873-fidpskcs	185	23	Most	most	RBS
cord-023873-fidpskcs	185	24	Common	common	JJ
cord-023873-fidpskcs	185	25	Predisposing	Predisposing	NNP
cord-023873-fidpskcs	185	26	Condition	condition	NN
cord-023873-fidpskcs	185	27	to	to	IN
cord-023873-fidpskcs	185	28	Invasive	invasive	JJ
cord-023873-fidpskcs	185	29	Aspergillosis	Aspergillosis	NNP
cord-023873-fidpskcs	185	30	Invasive	invasive	JJ
cord-023873-fidpskcs	185	31	aspergillosis	aspergillosis	NN
cord-023873-fidpskcs	185	32	in	in	IN
cord-023873-fidpskcs	185	33	a	a	DT
cord-023873-fidpskcs	185	34	"	"	``
cord-023873-fidpskcs	185	35	healthy	healthy	JJ
cord-023873-fidpskcs	185	36	"	"	''
cord-023873-fidpskcs	185	37	patient	patient	JJ
cord-023873-fidpskcs	185	38	Infectious	infectious	JJ
cord-023873-fidpskcs	185	39	complications	complication	NNS
cord-023873-fidpskcs	185	40	associated	associate	VBN
cord-023873-fidpskcs	185	41	with	with	IN
cord-023873-fidpskcs	185	42	alemtuzumab	alemtuzumab	JJ
cord-023873-fidpskcs	185	43	use	use	NN
cord-023873-fidpskcs	185	44	for	for	IN
cord-023873-fidpskcs	185	45	lymphoproliferative	lymphoproliferative	JJ
cord-023873-fidpskcs	185	46	disorders	disorder	NNS
cord-023873-fidpskcs	185	47	Aspergillus	Aspergillus	NNP
cord-023873-fidpskcs	185	48	wound	wind	VBD
cord-023873-fidpskcs	185	49	infection	infection	NN
cord-023873-fidpskcs	185	50	following	follow	VBG
cord-023873-fidpskcs	185	51	laparostomy	laparostomy	JJ
cord-023873-fidpskcs	185	52	Post	post	JJ
cord-023873-fidpskcs	185	53	-	-	JJ
cord-023873-fidpskcs	185	54	operative	operative	JJ
cord-023873-fidpskcs	185	55	aspergillosis	aspergillosis	NN
cord-023873-fidpskcs	185	56	Unusual	unusual	JJ
cord-023873-fidpskcs	185	57	cause	cause	NN
cord-023873-fidpskcs	185	58	of	of	IN
cord-023873-fidpskcs	185	59	lethal	lethal	JJ
cord-023873-fidpskcs	185	60	pulmonary	pulmonary	JJ
cord-023873-fidpskcs	185	61	aspergillosis	aspergillosis	NN
cord-023873-fidpskcs	185	62	in	in	IN
cord-023873-fidpskcs	185	63	patients	patient	NNS
cord-023873-fidpskcs	185	64	with	with	IN
cord-023873-fidpskcs	185	65	chronic	chronic	JJ
cord-023873-fidpskcs	185	66	obstructive	obstructive	JJ
cord-023873-fidpskcs	185	67	pulmonary	pulmonary	JJ
cord-023873-fidpskcs	185	68	disease	disease	NN
cord-023873-fidpskcs	186	1	Nosocomial	nosocomial	JJ
cord-023873-fidpskcs	186	2	aspergillosis	aspergillosis	NN
cord-023873-fidpskcs	186	3	is	be	VBZ
cord-023873-fidpskcs	186	4	waterborne	waterborne	JJ
cord-023873-fidpskcs	186	5	Differences	difference	NNS
cord-023873-fidpskcs	186	6	in	in	IN
cord-023873-fidpskcs	186	7	patterns	pattern	NNS
cord-023873-fidpskcs	186	8	of	of	IN
cord-023873-fidpskcs	186	9	infection	infection	NN
cord-023873-fidpskcs	186	10	and	and	CC
cord-023873-fidpskcs	186	11	inflammation	inflammation	NN
cord-023873-fidpskcs	186	12	for	for	IN
cord-023873-fidpskcs	186	13	corticosteroid	corticosteroid	NN
cord-023873-fidpskcs	186	14	treatment	treatment	NN
cord-023873-fidpskcs	186	15	and	and	CC
cord-023873-fidpskcs	186	16	chemotherapy	chemotherapy	NN
cord-023873-fidpskcs	186	17	in	in	IN
cord-023873-fidpskcs	186	18	experimental	experimental	JJ
cord-023873-fidpskcs	186	19	invasive	invasive	JJ
cord-023873-fidpskcs	186	20	pulmonary	pulmonary	JJ
cord-023873-fidpskcs	186	21	aspergillosis	aspergillosis	NN
cord-023873-fidpskcs	186	22	Invasive	invasive	JJ
cord-023873-fidpskcs	186	23	fungal	fungal	JJ
cord-023873-fidpskcs	186	24	infections	infection	NNS
cord-023873-fidpskcs	186	25	in	in	IN
cord-023873-fidpskcs	186	26	patients	patient	NNS
cord-023873-fidpskcs	186	27	with	with	IN
cord-023873-fidpskcs	186	28	hematologic	hematologic	JJ
cord-023873-fidpskcs	186	29	malignancies	malignancy	NNS
cord-023873-fidpskcs	186	30	in	in	IN
cord-023873-fidpskcs	186	31	a	a	DT
cord-023873-fidpskcs	186	32	tertiary	tertiary	JJ
cord-023873-fidpskcs	186	33	care	care	NN
cord-023873-fidpskcs	186	34	cancer	cancer	NN
cord-023873-fidpskcs	186	35	center	center	NN
cord-023873-fidpskcs	186	36	:	:	:
cord-023873-fidpskcs	186	37	an	an	DT
cord-023873-fidpskcs	186	38	autopsy	autopsy	JJ
cord-023873-fidpskcs	186	39	study	study	NN
cord-023873-fidpskcs	186	40	over	over	IN
cord-023873-fidpskcs	186	41	a	a	DT
cord-023873-fidpskcs	186	42	15-year	15-year	JJ
cord-023873-fidpskcs	186	43	period	period	NN
cord-023873-fidpskcs	186	44	Imaging	Imaging	NNP
cord-023873-fidpskcs	186	45	findings	finding	NNS
cord-023873-fidpskcs	186	46	in	in	IN
cord-023873-fidpskcs	186	47	acute	acute	JJ
cord-023873-fidpskcs	186	48	invasive	invasive	JJ
cord-023873-fidpskcs	186	49	pulmonary	pulmonary	JJ
cord-023873-fidpskcs	186	50	aspergillosis	aspergillosis	NN
cord-023873-fidpskcs	186	51	:	:	:
cord-023873-fidpskcs	186	52	clinical	clinical	JJ
cord-023873-fidpskcs	186	53	significance	significance	NN
cord-023873-fidpskcs	186	54	of	of	IN
cord-023873-fidpskcs	186	55	the	the	DT
cord-023873-fidpskcs	186	56	halo	halo	NN
cord-023873-fidpskcs	186	57	sign	sign	NN
cord-023873-fidpskcs	186	58	Isolation	isolation	NN
cord-023873-fidpskcs	186	59	of	of	IN
cord-023873-fidpskcs	186	60	Aspergillus	aspergillus	NN
cord-023873-fidpskcs	186	61	spp	spp	NNS
cord-023873-fidpskcs	186	62	.	.	.
cord-023873-fidpskcs	187	1	from	from	IN
cord-023873-fidpskcs	187	2	the	the	DT
cord-023873-fidpskcs	187	3	respiratory	respiratory	JJ
cord-023873-fidpskcs	187	4	tract	tract	NN
cord-023873-fidpskcs	187	5	in	in	IN
cord-023873-fidpskcs	187	6	critically	critically	RB
cord-023873-fidpskcs	187	7	ill	ill	JJ
cord-023873-fidpskcs	187	8	patients	patient	NNS
cord-023873-fidpskcs	187	9	:	:	:
cord-023873-fidpskcs	187	10	risk	risk	NN
cord-023873-fidpskcs	187	11	factors	factor	NNS
cord-023873-fidpskcs	187	12	,	,	,
cord-023873-fidpskcs	187	13	clinical	clinical	JJ
cord-023873-fidpskcs	187	14	presentation	presentation	NN
cord-023873-fidpskcs	187	15	and	and	CC
cord-023873-fidpskcs	187	16	outcome	outcome	NN
cord-023873-fidpskcs	187	17	Diagnosis	diagnosis	NN
cord-023873-fidpskcs	187	18	of	of	IN
cord-023873-fidpskcs	187	19	invasive	invasive	JJ
cord-023873-fidpskcs	187	20	aspergillosis	aspergillosis	NN
cord-023873-fidpskcs	187	21	using	use	VBG
cord-023873-fidpskcs	187	22	a	a	DT
cord-023873-fidpskcs	187	23	galactomannan	galactomannan	NNP
cord-023873-fidpskcs	187	24	assay	assay	NN
cord-023873-fidpskcs	187	25	:	:	:
cord-023873-fidpskcs	187	26	a	a	DT
cord-023873-fidpskcs	187	27	meta	meta	JJ
cord-023873-fidpskcs	187	28	-	-	HYPH
cord-023873-fidpskcs	187	29	analysis	analysis	NN
cord-023873-fidpskcs	187	30	Prospective	prospective	JJ
cord-023873-fidpskcs	187	31	assessment	assessment	NN
cord-023873-fidpskcs	187	32	of	of	IN
cord-023873-fidpskcs	187	33	Platelia	Platelia	NNP
cord-023873-fidpskcs	187	34	Aspergillus	Aspergillus	NNP
cord-023873-fidpskcs	187	35	galactomannan	galactomannan	NN
cord-023873-fidpskcs	187	36	antigen	antigen	NN
cord-023873-fidpskcs	187	37	for	for	IN
cord-023873-fidpskcs	187	38	the	the	DT
cord-023873-fidpskcs	187	39	diagnosis	diagnosis	NN
cord-023873-fidpskcs	187	40	of	of	IN
cord-023873-fidpskcs	187	41	invasive	invasive	JJ
cord-023873-fidpskcs	187	42	aspergillosis	aspergillosis	NN
cord-023873-fidpskcs	187	43	in	in	IN
cord-023873-fidpskcs	187	44	lung	lung	NN
cord-023873-fidpskcs	187	45	transplant	transplant	NN
cord-023873-fidpskcs	187	46	recipients	recipient	NNS
cord-023873-fidpskcs	187	47	Efficacy	Efficacy	NNP
cord-023873-fidpskcs	187	48	of	of	IN
cord-023873-fidpskcs	187	49	galactomannan	galactomannan	NNP
cord-023873-fidpskcs	187	50	antigen	antigen	NN
cord-023873-fidpskcs	187	51	in	in	IN
cord-023873-fidpskcs	187	52	the	the	DT
cord-023873-fidpskcs	187	53	Platelia	Platelia	NNP
cord-023873-fidpskcs	187	54	Aspergillus	Aspergillus	NNP
cord-023873-fidpskcs	187	55	enzyme	enzyme	NN
cord-023873-fidpskcs	187	56	immunoassay	immunoassay	NN
cord-023873-fidpskcs	187	57	for	for	IN
cord-023873-fidpskcs	187	58	diagnosis	diagnosis	NN
cord-023873-fidpskcs	187	59	of	of	IN
cord-023873-fidpskcs	187	60	invasive	invasive	JJ
cord-023873-fidpskcs	187	61	aspergillosis	aspergillosis	NN
cord-023873-fidpskcs	187	62	in	in	IN
cord-023873-fidpskcs	187	63	liver	liver	NN
cord-023873-fidpskcs	187	64	transplant	transplant	NN
cord-023873-fidpskcs	187	65	recipients	recipient	NNS
cord-023873-fidpskcs	187	66	Bronchoalveolar	Bronchoalveolar	NNP
cord-023873-fidpskcs	187	67	lavage	lavage	NN
cord-023873-fidpskcs	187	68	galactomannan	galactomannan	NN
cord-023873-fidpskcs	187	69	in	in	IN
cord-023873-fidpskcs	187	70	diagnosis	diagnosis	NN
cord-023873-fidpskcs	187	71	of	of	IN
cord-023873-fidpskcs	187	72	invasive	invasive	JJ
cord-023873-fidpskcs	187	73	pulmonary	pulmonary	JJ
cord-023873-fidpskcs	187	74	aspergillosis	aspergillosis	NN
cord-023873-fidpskcs	187	75	among	among	IN
cord-023873-fidpskcs	187	76	solid	solid	JJ
cord-023873-fidpskcs	187	77	-	-	HYPH
cord-023873-fidpskcs	187	78	organ	organ	NN
cord-023873-fidpskcs	187	79	transplant	transplant	NN
cord-023873-fidpskcs	187	80	recipients	recipient	NNS
cord-023873-fidpskcs	187	81	Performance	performance	NN
cord-023873-fidpskcs	187	82	characteristics	characteristic	NNS
cord-023873-fidpskcs	187	83	of	of	IN
cord-023873-fidpskcs	187	84	the	the	DT
cord-023873-fidpskcs	187	85	platelia	platelia	NNP
cord-023873-fidpskcs	187	86	Aspergillus	Aspergillus	NNP
cord-023873-fidpskcs	187	87	enzyme	enzyme	NN
cord-023873-fidpskcs	187	88	immunoassay	immunoassay	NN
cord-023873-fidpskcs	187	89	for	for	IN
cord-023873-fidpskcs	187	90	detection	detection	NN
cord-023873-fidpskcs	187	91	of	of	IN
cord-023873-fidpskcs	187	92	Aspergillus	Aspergillus	NNP
cord-023873-fidpskcs	187	93	galactomannan	galactomannan	NN
cord-023873-fidpskcs	187	94	antigen	antigen	NN
cord-023873-fidpskcs	187	95	in	in	IN
cord-023873-fidpskcs	187	96	bronchoalveolar	bronchoalveolar	NNP
cord-023873-fidpskcs	187	97	lavage	lavage	NN
cord-023873-fidpskcs	187	98	fluid	fluid	NN
cord-023873-fidpskcs	187	99	Use	Use	NNP
cord-023873-fidpskcs	187	100	of	of	IN
cord-023873-fidpskcs	187	101	bronchoalveolar	bronchoalveolar	NNP
cord-023873-fidpskcs	187	102	lavage	lavage	NN
cord-023873-fidpskcs	187	103	to	to	TO
cord-023873-fidpskcs	187	104	detect	detect	VB
cord-023873-fidpskcs	187	105	galactomannan	galactomannan	NNP
cord-023873-fidpskcs	187	106	for	for	IN
cord-023873-fidpskcs	187	107	diagnosis	diagnosis	NN
cord-023873-fidpskcs	187	108	of	of	IN
cord-023873-fidpskcs	187	109	pulmonary	pulmonary	JJ
cord-023873-fidpskcs	187	110	aspergillosis	aspergillosis	NN
cord-023873-fidpskcs	187	111	among	among	IN
cord-023873-fidpskcs	187	112	nonimmunocompromised	nonimmunocompromise	VBN
cord-023873-fidpskcs	187	113	hosts	host	NNS
cord-023873-fidpskcs	188	1	A	a	DT
cord-023873-fidpskcs	188	2	bad	bad	JJ
cord-023873-fidpskcs	188	3	bug	bug	NN
cord-023873-fidpskcs	188	4	takes	take	VBZ
cord-023873-fidpskcs	188	5	on	on	RP
cord-023873-fidpskcs	188	6	a	a	DT
cord-023873-fidpskcs	188	7	new	new	JJ
cord-023873-fidpskcs	188	8	role	role	NN
cord-023873-fidpskcs	188	9	as	as	IN
cord-023873-fidpskcs	188	10	a	a	DT
cord-023873-fidpskcs	188	11	cause	cause	NN
cord-023873-fidpskcs	188	12	of	of	IN
cord-023873-fidpskcs	188	13	ventilator	ventilator	NN
cord-023873-fidpskcs	188	14	-	-	HYPH
cord-023873-fidpskcs	188	15	associated	associate	VBN
cord-023873-fidpskcs	188	16	pneumonia	pneumonia	NN
cord-023873-fidpskcs	188	17	Pathogenesis	Pathogenesis	NNP
cord-023873-fidpskcs	188	18	of	of	IN
cord-023873-fidpskcs	188	19	Aspergillus	Aspergillus	NNP
cord-023873-fidpskcs	188	20	fumigatus	fumigatus	NN
cord-023873-fidpskcs	188	21	and	and	CC
cord-023873-fidpskcs	188	22	the	the	DT
cord-023873-fidpskcs	188	23	kinetics	kinetics	NNP
cord-023873-fidpskcs	188	24	of	of	IN
cord-023873-fidpskcs	188	25	galactomannan	galactomannan	NNP
cord-023873-fidpskcs	188	26	in	in	IN
cord-023873-fidpskcs	188	27	an	an	DT
cord-023873-fidpskcs	188	28	in	in	FW
cord-023873-fidpskcs	188	29	vitro	vitro	FW
cord-023873-fidpskcs	188	30	model	model	NN
cord-023873-fidpskcs	188	31	of	of	IN
cord-023873-fidpskcs	188	32	early	early	JJ
cord-023873-fidpskcs	188	33	invasive	invasive	JJ
cord-023873-fidpskcs	188	34	pulmonary	pulmonary	JJ
cord-023873-fidpskcs	188	35	aspergillosis	aspergillosis	NN
cord-023873-fidpskcs	188	36	:	:	:
cord-023873-fidpskcs	188	37	implications	implication	NNS
cord-023873-fidpskcs	188	38	for	for	IN
cord-023873-fidpskcs	188	39	antifungal	antifungal	JJ
cord-023873-fidpskcs	188	40	therapy	therapy	NN
cord-023873-fidpskcs	188	41	Aspergillus	Aspergillus	NNP
cord-023873-fidpskcs	188	42	galactomannan	galactomannan	NN
cord-023873-fidpskcs	188	43	testing	testing	NN
cord-023873-fidpskcs	188	44	in	in	IN
cord-023873-fidpskcs	188	45	patients	patient	NNS
cord-023873-fidpskcs	188	46	with	with	IN
cord-023873-fidpskcs	188	47	long	long	JJ
cord-023873-fidpskcs	188	48	-	-	HYPH
cord-023873-fidpskcs	188	49	term	term	NN
cord-023873-fidpskcs	188	50	neutropenia	neutropenia	NN
cord-023873-fidpskcs	188	51	:	:	:
cord-023873-fidpskcs	189	1	implications	implication	NNS
cord-023873-fidpskcs	189	2	for	for	IN
cord-023873-fidpskcs	189	3	clinical	clinical	JJ
cord-023873-fidpskcs	189	4	management	management	NN
cord-023873-fidpskcs	189	5	Serum	serum	NN
cord-023873-fidpskcs	189	6	glucan	glucan	NN
cord-023873-fidpskcs	189	7	levels	level	NNS
cord-023873-fidpskcs	189	8	are	be	VBP
cord-023873-fidpskcs	189	9	not	not	RB
cord-023873-fidpskcs	189	10	specific	specific	JJ
cord-023873-fidpskcs	189	11	for	for	IN
cord-023873-fidpskcs	189	12	presence	presence	NN
cord-023873-fidpskcs	189	13	of	of	IN
cord-023873-fidpskcs	189	14	fungal	fungal	JJ
cord-023873-fidpskcs	189	15	infections	infection	NNS
cord-023873-fidpskcs	189	16	in	in	IN
cord-023873-fidpskcs	189	17	intensive	intensive	JJ
cord-023873-fidpskcs	189	18	care	care	NN
cord-023873-fidpskcs	189	19	unit	unit	NN
cord-023873-fidpskcs	189	20	patients	patient	NNS
cord-023873-fidpskcs	189	21	False	false	JJ
cord-023873-fidpskcs	189	22	positive	positive	JJ
cord-023873-fidpskcs	189	23	test	test	NN
cord-023873-fidpskcs	189	24	for	for	IN
cord-023873-fidpskcs	189	25	Aspergillus	Aspergillus	NNP
cord-023873-fidpskcs	189	26	antigenemia	antigenemia	NN
cord-023873-fidpskcs	189	27	related	relate	VBN
cord-023873-fidpskcs	189	28	to	to	IN
cord-023873-fidpskcs	189	29	concomitant	concomitant	JJ
cord-023873-fidpskcs	189	30	administration	administration	NN
cord-023873-fidpskcs	189	31	of	of	IN
cord-023873-fidpskcs	189	32	piperacillin	piperacillin	NNP
cord-023873-fidpskcs	189	33	and	and	CC
cord-023873-fidpskcs	189	34	tazobactam	tazobactam	NNP
cord-023873-fidpskcs	189	35	Steady	steady	JJ
cord-023873-fidpskcs	189	36	-	-	HYPH
cord-023873-fidpskcs	189	37	state	state	NN
cord-023873-fidpskcs	189	38	plasma	plasma	NN
cord-023873-fidpskcs	189	39	and	and	CC
cord-023873-fidpskcs	189	40	intrapulmonary	intrapulmonary	JJ
cord-023873-fidpskcs	189	41	concentrations	concentration	NNS
cord-023873-fidpskcs	189	42	of	of	IN
cord-023873-fidpskcs	189	43	piperacillin	piperacillin	NNP
cord-023873-fidpskcs	189	44	/	/	SYM
cord-023873-fidpskcs	189	45	tazobactam	tazobactam	NNS
cord-023873-fidpskcs	189	46	4	4	CD
cord-023873-fidpskcs	189	47	g/0.5	g/0.5	NN
cord-023873-fidpskcs	189	48	g	g	XX
cord-023873-fidpskcs	189	49	administered	administer	VBN
cord-023873-fidpskcs	189	50	to	to	TO
cord-023873-fidpskcs	189	51	critically	critically	RB
cord-023873-fidpskcs	189	52	ill	ill	VB
cord-023873-fidpskcs	189	53	patients	patient	NNS
cord-023873-fidpskcs	189	54	with	with	IN
cord-023873-fidpskcs	189	55	severe	severe	JJ
cord-023873-fidpskcs	189	56	nosocomial	nosocomial	JJ
cord-023873-fidpskcs	189	57	pneumonia	pneumonia	NN
cord-023873-fidpskcs	189	58	Voriconazole	Voriconazole	NNP
cord-023873-fidpskcs	189	59	versus	versus	IN
cord-023873-fidpskcs	189	60	amphotericin	amphotericin	NNS
cord-023873-fidpskcs	189	61	B	b	NN
cord-023873-fidpskcs	189	62	for	for	IN
cord-023873-fidpskcs	189	63	primary	primary	JJ
cord-023873-fidpskcs	189	64	therapy	therapy	NN
cord-023873-fidpskcs	189	65	of	of	IN
cord-023873-fidpskcs	189	66	invasive	invasive	JJ
cord-023873-fidpskcs	189	67	aspergillosis	aspergillosis	NNP
cord-023873-fidpskcs	189	68	Clinical	clinical	JJ
cord-023873-fidpskcs	189	69	Risk	Risk	NNP
cord-023873-fidpskcs	189	70	Factors	Factors	NNPS
cord-023873-fidpskcs	189	71	for	for	IN
cord-023873-fidpskcs	189	72	Undetectable	undetectable	JJ
cord-023873-fidpskcs	189	73	Voriconazole	Voriconazole	NNP
cord-023873-fidpskcs	189	74	(	(	-LRB-
cord-023873-fidpskcs	189	75	V	v	NN
cord-023873-fidpskcs	189	76	)	)	-RRB-
cord-023873-fidpskcs	189	77	Serum	serum	NN
cord-023873-fidpskcs	189	78	Concentrations	Concentrations	NNPS
cord-023873-fidpskcs	189	79	voriconazole	voriconazole	NN
cord-023873-fidpskcs	189	80	level	level	NN
cord-023873-fidpskcs	189	81	,	,	,
cord-023873-fidpskcs	189	82	risk	risk	NN
cord-023873-fidpskcs	189	83	factors	factor	NNS
cord-023873-fidpskcs	189	84	Improved	improve	VBN
cord-023873-fidpskcs	189	85	management	management	NN
cord-023873-fidpskcs	189	86	of	of	IN
cord-023873-fidpskcs	189	87	invasive	invasive	JJ
cord-023873-fidpskcs	189	88	pulmonary	pulmonary	JJ
cord-023873-fidpskcs	189	89	aspergillosis	aspergillosis	NN
cord-023873-fidpskcs	189	90	in	in	IN
cord-023873-fidpskcs	189	91	neutropenic	neutropenic	JJ
cord-023873-fidpskcs	189	92	patients	patient	NNS
cord-023873-fidpskcs	189	93	using	use	VBG
cord-023873-fidpskcs	189	94	early	early	JJ
cord-023873-fidpskcs	189	95	thoracic	thoracic	JJ
cord-023873-fidpskcs	189	96	computed	compute	VBN
cord-023873-fidpskcs	189	97	tomographic	tomographic	JJ
cord-023873-fidpskcs	189	98	scan	scan	NN
cord-023873-fidpskcs	189	99	and	and	CC
cord-023873-fidpskcs	189	100	surgery	surgery	NN
cord-023873-fidpskcs	190	1	The	the	DT
cord-023873-fidpskcs	190	2	impact	impact	NN
cord-023873-fidpskcs	190	3	of	of	IN
cord-023873-fidpskcs	190	4	culture	culture	NN
cord-023873-fidpskcs	190	5	isolation	isolation	NN
cord-023873-fidpskcs	190	6	of	of	IN
cord-023873-fidpskcs	190	7	Aspergillus	aspergillus	NN
cord-023873-fidpskcs	190	8	species	specie	NNS
cord-023873-fidpskcs	190	9	:	:	:
cord-023873-fidpskcs	190	10	a	a	DT
cord-023873-fidpskcs	190	11	hospital	hospital	NN
cord-023873-fidpskcs	190	12	-	-	HYPH
cord-023873-fidpskcs	190	13	based	base	VBN
cord-023873-fidpskcs	190	14	survey	survey	NN
cord-023873-fidpskcs	190	15	of	of	IN
cord-023873-fidpskcs	190	16	aspergillosis	aspergillosis	NNP
cord-023873-fidpskcs	190	17	Workload	Workload	NNP
cord-023873-fidpskcs	190	18	due	due	IN
cord-023873-fidpskcs	190	19	to	to	IN
cord-023873-fidpskcs	190	20	Aspergillus	aspergillus	NN
cord-023873-fidpskcs	190	21	fumigatus	fumigatus	NN
cord-023873-fidpskcs	190	22	and	and	CC
cord-023873-fidpskcs	190	23	significance	significance	NN
cord-023873-fidpskcs	190	24	of	of	IN
cord-023873-fidpskcs	190	25	the	the	DT
cord-023873-fidpskcs	190	26	organism	organism	NN
cord-023873-fidpskcs	190	27	in	in	IN
cord-023873-fidpskcs	190	28	the	the	DT
cord-023873-fidpskcs	190	29	microbiology	microbiology	NN
cord-023873-fidpskcs	190	30	laboratory	laboratory	NN
cord-023873-fidpskcs	190	31	of	of	IN
cord-023873-fidpskcs	190	32	a	a	DT
cord-023873-fidpskcs	190	33	general	general	JJ
cord-023873-fidpskcs	190	34	hospital	hospital	NN
cord-023873-fidpskcs	190	35	A	a	DT
cord-023873-fidpskcs	190	36	systematic	systematic	JJ
cord-023873-fidpskcs	190	37	literature	literature	NN
cord-023873-fidpskcs	190	38	review	review	NN
cord-023873-fidpskcs	190	39	on	on	IN
cord-023873-fidpskcs	190	40	the	the	DT
cord-023873-fidpskcs	190	41	diagnosis	diagnosis	NN
cord-023873-fidpskcs	190	42	of	of	IN
cord-023873-fidpskcs	190	43	invasive	invasive	JJ
cord-023873-fidpskcs	190	44	aspergillosis	aspergillosis	NN
cord-023873-fidpskcs	190	45	using	use	VBG
cord-023873-fidpskcs	190	46	polymerase	polymerase	NN
cord-023873-fidpskcs	190	47	chain	chain	NN
cord-023873-fidpskcs	190	48	reaction	reaction	NN
cord-023873-fidpskcs	190	49	(	(	-LRB-
cord-023873-fidpskcs	190	50	PCR	PCR	NNP
cord-023873-fidpskcs	190	51	)	)	-RRB-
cord-023873-fidpskcs	190	52	from	from	IN
cord-023873-fidpskcs	190	53	bronchoalveolar	bronchoalveolar	NNP
cord-023873-fidpskcs	190	54	lavage	lavage	NN
cord-023873-fidpskcs	190	55	clinical	clinical	JJ
cord-023873-fidpskcs	190	56	samples	sample	NNS